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ABSTRACT 
Lawsonia intracellularis is an obligate intracellular microorganism which causes diseases 
known as porcine ileitis or porcine proliferative enteropathy. Due to its obligate intracellular 
nature, characterization of L. intracellularis antigens and proteins involved in host-pathogen 
interaction and immune recognition have been difficult to accomplish using conventional 
microbiological techniques. The overall goal of this thesis is to identify, characterize and evaluate 
L. intracellularis bacterial proteins as neutralizing antibody targets which may then be suitable 
candidates for subunit vaccine development. In this thesis, 2-dimensional (2-D) gel electrophoresis 
coupled with Western-immunoblotting, mass spectrometry, and bioinformatics were used to 
identify proteins on the surface of the bacteria that interact in vitro with pig intestinal cells (IPEC-
1) and have immunogenic properties. Eleven immunogenic bacterial proteins were detected of 
which LI0710 (annotated as fliC), LI1153 (annotated as Putative protein N), LI0649 (annotated as 
autotransporter), and LI0169 (OppA; annotated as ABC dipeptide transport system) were predicted 
to be expressed on the outer membrane. The genes coding for these four proteins were cloned and 
expressed in Escherichia coli and the corresponding recombinant proteins were purified using 
affinity chromatography. Porcine hyperimmune serum against whole L. intracellularis lysate 
established that all four recombinant proteins were immunogenic.  
To be able to quantify invasion of the vaccine strain of L. intracellularis in McCoy and 
IPEC-1 cells and to determine whether antibodies specific for the recombinant L. intracellularis 
proteins inhibit the bacterial attachment and penetration into eukaryotic cells, the bacteria were 
labeled with cell-permeable fluorescent dye 5’-carboxyfluoroscein succidyl ester (CFSE) prior to 
cell infection. Flow cytometry was applied to determine the percentage of eukaryotic cells which 
were infected with fluorescent bacteria. As obligate intracellular bacteria, their replication is 
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dependant on eukaryotic cells and thus qPCR analysis was applied to quantify bacterial growth. 
qPCR analysis showed increase of bacterial DNA over the course of five days, indirectly showing  
that bacterial invasion and growth took place. The CFSE+ (i.e. infected) McCoy cells were sorted 
from the CFSE- (i.e. non-infected) McCoy cells using fluorescence-activated cell sorting (FACS) 
while confocal microscopy was performed to visually confirm bacterial invasion and cytosolic 
localization of CFSE-L. intracellularis. Rabbit hyperimmune serum was generated against each 
recombinant protein and we investigated the effect that hyperimmune sera had on invasion of 
IPEC-1 cells. Serum antibodies significantly inhibited invasion and replication of CFSE-bacteria, 
thus indicating that each of the recombinant proteins is a potential neutralizing antibody target and 
a candidate for subunit vaccine formulation. In conclusion, we used 2-D gel electrophoresis 
coupled with mass spectrometry to identify four antigens that, when formulated in a vaccine, may 
lead to production of neutralizing antibodies and disease protection. 
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1. LITERATURE REVIEW 
1.1 PROLIFERATIVE ENTEROPATHY 
1.1.1 Etiology and clinical findings in different animal species 
Proliferative enteropathy (PE) is an enteric infectious disease caused by Lawsonia 
intracellularis, which is an obligate intracellular, Gram-negative bacterium (1). This bacterium is 
endemic with wide geographical distribution in swine herds all over the world. PE is a major cause 
of weight loss and mortality in pigs and presents significant economic burden and losses for the 
swine industry. PE has been diagnosed in other animal species, horses, especially foals (2), rabbits, 
hamsters, ferrets, dogs, foxes, rats, sheep, deer, emus, guinea pigs, ostriches, and nonhuman 
primates (3).  
The causative agent for PE remained elusive for more than 70 years until 1993 when 
Lawson’s group managed to isolate intracellular bacteria from infected pigs and successfully 
propagated and maintained them in a rat enterocyte cell line (4). In 1995, this intracellular 
bacterium was described and a new genus and species was introduced as L. intracellularis, in 
honor of Dr. Lawson (1).  
PE in pigs has two distinct clinical and pathologic forms, porcine intestinal adenomatosis 
(PIA) and proliferative hemorrhagic enteropathy (PHE). Porcine intestinal adenomatosis (PIA) 
affects young, post-weaned pigs, usually between 6 and 20 weeks of age and the major symptoms 
of include diarrhea, anorexia and weight loss (5). This form of the disease is mild and it is often 
subclinical in form with major characteristics including thickening of the wall of intestine due to 
proliferating immature crypt epithelial cells. Evidence of infection is usually only observed at 
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slaughter when pathologic lesions can be observed in the alimentary tract, especially in the 
terminal ileum (Fig. 1.1). Despite these lesions, the pig immune system does not respond to 
infection with infiltration by inflammatory cells at this stage of the disease, which may indicate 
that the bacteria have an immunosuppressive effect on the host’s immune system (6). Although 
clinical signs are mild, infected animals shed the bacteria in the feces and are a source of disease 
transmission. Despite the overt lack of clinical signs of disease, PIA impedes weight gain, thus 
negatively affects barn profitability, making it an important swine disease. 
 
 
(Guedes et al 2017, Veterinary pathology Vol. 54(4) 620-628) 
 
Figure 1.1 Proliferative enteropathy, ileum, pig. Corrugation of the mucosa and hyperemia of folds, day 
11. Representative image from 5-week-old pigs experimentally infected with 4.37 x 109 L. intracellularis.  
 
PHE is the acute form of the disease that mainly affects young, adult pigs, 4 to 12 months 
of age such as finishing pigs, gilts, and boars (5). The main symptoms of PHE are profuse 
hemorrhagic diarrhea leading to the sudden death of the animals. The pathological findings include 
thickened and rugose mucosa of the terminal ileum replete with blood in the intestinal lumen (Fig. 
1.2). Histological analysis indicates that the ileal crypts have undergone extensive proliferation 
and there may be evidence of bacteria in the apical cytoplasm of the epithelial cells, in 
macrophages in the lamina propria and submucosa, within epithelial capillaries, and within the 
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lymphatics (7). An obvious inflammatory response is present in the PHE form of the disease and 
this inflammatory response may be the reason for more severe symptoms and high mortality rate 
relative to the PIA form of the disease. 
 
Figure 1.2 Proliferative hemorrhagic enteropathy, ileum from gilt. Corrugation of the mucosa and 
profuse hemorrhagic inflammation with blood filling the entire length of ileal lumen. Intestine was received 
from a Saskatchewan pig farm experiencing an outbreak of PE. 
 
Equine proliferative enteropathy (EPE) is intestinal disease in horses, especially foals, 
caused by L. intracellularis strain adapted to horses.  These adapted strains of  L. intracellularis 
also cause disease in rabbits but do not cause characteristic PE disease in pigs and hamsters (8). 
The genotypic analysis did not reveal any significant differences between swine and horse isolates 
and the cause of species adaptability has not yet been elucidated (3).  
EPE is characterized by gastrointestinal symptoms that can range from mild watery 
diarrhea to bloody diarrhea and colic. Except for intestinal symptoms, horses develop lethargy, 
fever, anorexia, weight loss and peripheral edema, which is a symptom very specific for EPE (3). 
Edema is localized in lower parts of the body, usually in distal limbs (3). Further, another important 
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clinical finding in horses is hypoproteinemia due to low serum albumin levels. The normal range 
of total protein concentration in horses is 5.7-7.9 g/dl and albumin is 2.5-3.8 g/dl but EPE can lead 
to total serum protein concentrations less than 5 g/dl and 2 g/dl albumin (3). The pathologic 
mechanism responsible for peripheral edema and hypoproteinemia/hypoalbuminemia is not yet 
clear but it is suggested that decreased feed intake combined with the deficient absorption of 
nutrients due to errant enterocyte proliferation and lack of enterocyte differentiation may lead to 
lower protein uptake and higher protein loss (9).   
 
1.1.2 Infection and pathogenesis 
L. intracellularis infection and pathogenesis have been studied in different animal models 
but understanding this disease has been hampered by the bacteria’s obligate intracellular nature, 
the competition with numerous and diverse commensal bacterial flora, and the complicated and 
often distinct biochemical environment in different parts of pig’s intestine. Its primary route of 
transmission is oral ingestion of contaminated feces from infected herd mates or rodents. Feces 
from mice experimentally infected with L. intracellularis were able to infect pigs thus showing 
the potential of rodents to be important factors in transmission of infection to pigs and possibly 
horses (10). The bacteria have adapted to survive the biochemical and immune defense challenges 
of a mammalian organism such as the low pH and pepsin in the stomach. The bacteria move with 
the chyme to the small intestine where the microenvironment is adequate for infection of 
enterocytes in the middle and distal jejunum and ileum. The possible reasons for preferring 
jejunum and ileum mucosa for invasion may be the favourable nutrient and pH environment, the 
presence of specific commensal bacterial flora and/or some yet uncharacterized receptors 
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expressed on enterocytes in these segments but not in the duodenum or large intestine. The 
importance of commensal bacteria for L. intracellularis infection of pigs have been shown in an 
experiment where germ-free pigs were resistant to infection with pure L. intracellularis culture 
but were susceptible to infection when commensal flora was restored (11). Commensal bacteria 
could provide necessary nutrients, pH environment, immune regulation or other stimulatory 
signals that benefit L. intracellularis survival, attachment, and penetration in mucosal enterocytes. 
Due to the complexity of commensal flora and region-specific distribution patterns, the 
determinants of infection remain unsolved. 
L. intracellularis are obligate intracellular bacteria that must attach to and penetrate cells 
to be able to colonize and multiply (Fig. 1.3). These bacteria have an affinity towards immature 
and undifferentiated enterocytes inside jejunal and ileal crypts (Fig. 1.3). Upon infection, L. 
intracellularis arrests epithelial cell differentiation and maturation thus keeping them in a state of 
continuous proliferation, which benefits bacterial division and spreading. These proliferating cells 
change the normal architecture of intestinal mucosa, leading to the absence of goblet cells, the 
destruction of brush border area, and the presence of many proliferating, undifferentiated 
enterocytes (Described in more detail in 1.3.4 Immune response to infection with L. 
intracellularis). Together, these microscopic changes progress to macroscopic evidence of 
thickened, corrugated mucosal folds often covered with fibrinonecrotic membranes or blood in 
cases of PHE.     
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Figure 1.3. Small intestine crypt epithelial cells and initial attachment of L. intracellularis to 
immature enterocytes. L. intracellularis are able to survive bactericidal molecules released by crypt 
intestinal cells and it can persist despite commensal competition. Their motility is controlled by flagella 
and, using an unknown mechanism, they can traverse through thick mucus and attach to immature 
epithelial cells inside the crypt. L. intracellularis have affinity towards immature epithelial cells, most 
likely transit amplifying cells (light blue), where they invade and multiply. They impact the eukaryotic 
cell cycle to inhibit differentiation while inducing proliferation of these immature cells.  
 
There are several studies describing the progression of infection and PE lesions in hamsters 
but most clinically relevant studies were performed in pig models (12, 13, 7). Boutup and al. 2010 
described the early pathogenesis of L. intracellularis infection and explored small intestinal loops 
as a model to study early infection. This group reported that L. intracellularis contacts the 
microvilli of mature enterocytes between 3 and 6 h after surgical inoculation into intestinal loops 
of pigs (12). In their small intestine loop model, they reported bacterial contact with jejunum 
enterocytes 6 h after bacterial inoculum into the loop (12). Although interesting, care must be taken 
to avoid over-interpretation of these results due to the intestinal loop model being an imperfect 
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model. First, the route of infection is not natural as the bacteria are injected directly into the 
intestinal loop and this method of infection could impair normal intestinal peristalsis as it 
concentrates the bacteria in a small area. Second, the creation of ligated intestinal loops could 
impact local microvasculature and nerves thus potentially changing pH and oxygen concentration 
inside the loop, which may in turn impact L. intracellularis penetration and growth. Despite these 
limitations, this study shows the usefulness of this intestinal loop model and shows that it has the 
potential to be used to explore the properties of bacteria during early pathogenesis. 
Guedes and al. 2017 (7) has presented the most comprehensive study to date of progression 
of gross and histologic lesions during L. intracellularis infection of 5 weeks old pigs from 1 to 35 
days post-infection (dpi) with oral inoculation of a dose of 4.37 x 109 L. intracellularis. Three 
animals, two from the challenged group and one from the control group, were euthanized on days 
1, 3, 5, 8, 11, 15, 19, 24, 29 and 35 dpi (7). Macroscopic and histologic lesions of PE were first 
identified 11 days after oral inoculation but the first detection of L. intracellularis antigen using 
immunohistochemistry (IHC) was at 5 dpi (7). These data indicate that bacteria establish 
themselves in the small intestine during the first 5 dpi and that they need at least 11 dpi to induce 
characteristic lesions in the small intestine mucosa. The lesions in small intestine on day 15 were 
characterized as a thickening and corrugation of the ileum and middle jejunum serosa (7). The 
mucosa of ileum and distal jejunum (1 m length) and colon (5 cm in length) were also affected 
with characteristic corrugations and thick folds covered with fibrin (7). The most severe lesions 
were observed in the middle jejunum with areas of mucosal necrosis and findings of fibronectin 
membranes. Between 9 and 28 dpi all infected animals had watery diarrhea with traces of blood, 
abdominal lymph nodes were 3 times the normal size and 200 ml of a yellowish transudate was 
present (7). The peak of gross mucosal lesions and the highest number of bacteria in enterocytes 
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were recorded between 15 and 24 dpi (7). At necropsy on day 19 after infection, one pig showed 
progression of macroscopic lesions and spreading further into jejunum and colon. In correlation 
with the microscopic lesions and number of bacteria present in enterocytes, an apoptotic index was 
measured using the terminal deoxyuridine nick-end labeling (TUNEL) method and caspase-3 was 
measured using IHC (7). From 11 to 24 dpi, the apoptotic index increased and then returned to 
control values at 29 dpi (7). These data correspond well with previous findings by MacIntyre at al. 
where the peak of infection and the spread of characteristic lesions were detected at the same 
period in 7 weeks old pigs infected orally with a dose of 2 x 108 of L. intracellularis (13). This 
group also explored the immune response 41 dpi and found evidence of immune down-regulation. 
Guedes et al 2017 reported the detection of the highest titres of antigen-specific IgA in intestinal 
lavages between 15 and 29 dpi but they did not explore the correlation of protection and the 
importance of the local humoral response (7). L. intracellularis antigens in the intestine could be 
detected up to 29 dpi but macroscopic and microscopic lesions were resolved (7). Also, after 35 
days, no bacterial DNA on intestinal samples could be detected by PCR analysis which indicates 
complete clearance of the pathogen 35 dpi (7). These studies provide insight into stages of L. 
intracellularis infection and pathogenesis, which added to knowledge of the L. intracellularis life 
cycle.     
 
1.1.3 Diagnosis 
Porcine PE was first reported under the name PIA in 1931 by Biester and Schwarte (14). 
The first diagnosis was based on symptoms, postmortem gross pathology, and microscopic 
examination of small and large intestine. This diagnosis can be problematic because the 
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interpretation is subjective and other enteric diseases in pigs may have similar symptoms, 
macroscopic and microscopic lesions that could interfere with the precise diagnosis of PE. Thus, 
the true nature and the causative agent of PE was elusive and not known until the invention of 
more sensitive and specific diagnostic techniques, such as specific L. intracellularis DNA 
detection by PCR and IHC of tissue samples (5, 15). 
The post-mortem techniques previously used to diagnose PE included using hematoxylin 
and eosin (H&E) and Warthin Starry (WS) silver staining slices of tissue with characteristic 
macroscopic lesions. The H&E staining is able to detect the characteristic proliferative changes of 
immature enterocytes and to confirm the absence of goblet cells. This stain can confirm cell 
abnormalities in small intestinal tissue but it does not identify the causative agent and it lacks 
specificity. The WS silver staining can detect curved, rod-shaped intracellular bacteria in intestinal 
histological samples, but it is also not specific because it can stain other bacterial species. Despite 
not being specific for L. intracellularis, the WS silver stain helped to show that PE is caused by 
rod-shaped intracellular bacteria and to distinguish PE from viral intestinal diseases. One 
disadvantage of the WS silver staining is that it cannot detect bacteria in necrotic tissue, which can 
be one of the forms of PE disease (16, 17, 18).  
IHC utilizes specific monoclonal antibodies against L. intracellularis to detect bacteria in 
tissue sections from infected animals. Guedes et al. 2002, compared sensitivity and specificity of 
IHC, H&E and WS staining of ileum tissue of pigs experimentally infected with L. intracellularis 
(19). IHC showed higher sensitivity of 86.8% compared to 36.8% sensitivity using H&E staining 
and 50% sensitivity using WS staining (19). The authors concluded that the higher sensitivity of 
IHC could be explained by the specific binding of the monoclonal antibody to the 21 kDa outer 
membrane protein of L. intracellularis (19|). In contrast to the WS method of staining, IHC can be 
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used to identify L. intracellularis antigens in necrotic intestinal tissues or in cases of  resolving 
stage of infection where the bacteria are found only in the cytoplasm of lamina propria 
mononuclear cells (19).  
Histopathology and IHC methods are important diagnostic tools to detect L. intracellularis 
in tissue samples of infected animals but they are not suitable for the monitoring of active infection 
of pig herds. The serological methods that detect specific antibodies against L. intracellularis in 
animal serum are suitable to detect prior exposure, to survey L. intracellularis infected animals 
within herds, and/or to detect vaccinated animals. The serology assays that are used for this 
purpose are indirect fluorescent antibody test (IFAT), immunoperoxidase monolayer antibody 
assay (IPMA) and enzyme-linked immunosorbent assay (ELISA) (5).  
Developed by Dr. Lawson and his group (20), IFAT was the first assay to detect L. 
intracellularis-specific IgM and IgA in serum of naturally infected pigs. Later, an IFAT that 
detected IgG antibodies was developed using bacteria grown in pure culture stained with pig serum 
as the primary antibody and fluorescin isothiocyanate (FITC) labeled anti-swine IgG was used as 
the secondary antibody (21). IFAT was used to detect L. intracellularis antibodies 21 to 28 days 
after a challenge with a pure culture, which showed 90% sensitivity and 96% specificity. In 
addition,  IFAT was more sensitive than PCR which only showed 47% sensitivity but less specific 
than PCR which detected 100% specificity (21).  
Immune peroxidase monolayer assay (IPMA) is assay developed as an alternative to IFAT 
and has similar workflow and procedures with the exception that IPMA anti-swine IgG secondary 
antibody are labeled with peroxidase and require elimination of endogenous H2O2 activity in tissue 
(22). IPMA uses light microscopy to detect antibodies, which can have an advantage over IFAT 
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that requires fluorescent microscopy. However, plate preparation is complicated and data 
interpretation can be subjective leading to discrepancies in results across labs (23). When 
compared to each other, both assays share a high level of agreement (98%) in controlled infection 
studies which indicate equal diagnostic usefulness in the detection of L. intracellularis seropositive 
pigs (24).      
Numerous enzyme-linked immunosorbent assays (ELISA) have been developed for L. 
intracellularis including indirect ELISA which uses whole cell antigen from sonicated bacteria 
(SoELISA) (25), sodium deoxycholate (DOC) extracted antigen (26), bacterial targets such as LPS 
(27), and LsaA protein ELISAs (28). Not all these assays are commercially available nor are they 
readily available for clinical use in the field. To bridge this gap and to provide a clinically useful 
assay to detect seropositive animals, commercially-available blocked ELISAs were developed 
(bioScreen Ileitis Antibody ELISA, Synbiotics Corporation, Lyon, France and SVANOVIR® L. 
intracellularis/Ileitis-antibody, Svanova, Sweden). Blocked ELISA detects anti-L. intracellularis 
antibodies in pig’s serum. Antigen are fixed to the bottom of the plate. If serum is positive, anti-
Lawsonia antibodies will bind to the fixed antigen and the remaining serum components will be 
rinsed away (i.e. blocked). If there are no specific antibodies present in serum, antigen will remain 
free to bind to horseradish peroxidase (HRP)-conjugated monoclonal anti-Lawsonia antibody 
which will result in a distinctive blue colour. Pigs that have been exposed to L. intracellularis or 
have been vaccinated against L. intracellularis will have sera with specific anti-Lawsonia 
antibodies present and results will show a weaker reaction and a lighter colour. The reaction optical 
density (OD) is measured in an ELISA plate reader and the percentage of inhibition is calculated. 
An OD above 30 is considered positive, between 20 and 30 is questionable and below 20 is 
considered negative. Blocked ELISAs allow the direct quantification of data, the ability to test 184 
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samples in one plate, the removal of subjective bias across labs and they are major advantage over 
other serological tests to detect animals with L. intracellularis antibodies in their sera. 
The commercial blocking L. intracellularis ELISA has been compared to the IFAT, IPMA 
and LPS ELISA to assess agreement, sensitivity, and specificity to this bacterium (29, (30) (23). 
Compared to IFAT, the sensitivity of the blocking ELISA was 72% and the specificity was 93% 
(calculated with Bayesian modeling techniques to account for the absence of true gold standard) 
(29). In another study using different statistical models, the reported sensitivity of the blocking 
ELISA was 90% and with a 83% specificity with significant association between tests as 
determined using Fisher’s exact Chi-square test (P = 0.0001), kappa test 0.74 (P< 0.0001, one-
tailed test) and McNemar’s Chi-square test (3.84) (30). The results from this study suggest that 
there is a high agreement between the two assays and that users of the commercial blocking ELISA 
can be confident in its sensitivity and specificity. In the study by Magtoto et al 2014 (23), the 
blocking ELISA sensitivity was compared to the IPMA and LPS-ELISA. The three assays showed 
a 95 % correlation. Compared to IPMA, the commercial blocking ELISA showed 91% sensitivity 
and 100% specificity whereas the non-commercial LPS-ELISA was 95% sensitive and 100% 
specific (23). The IPMA assays showed the highest sensitivity and specificity of all tested 
serological assays but the blocked ELISA is the most practical for herd surveillance because it is 
a high throughput assay, easy to use, economical, and has high sensitivity and specificity.   
Serologic tests are useful to monitor exposure to L. intracellularis and seroconversion of 
animals, but they cannot distinguish between animals vaccinated with live-attenuated or killed 
vaccine and those naturally exposed to the bacteria. Serum antibodies against L. intracellularis do 
not necessarily correlate with lesions or clinical manifestation caused by these bacteria. To be able 
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to demonstrate that clinical symptoms of ileitis are caused by L. intracellularis, the molecular 
technique PCR must be used. 
PCR can successfully detect L. intracellularis in feces or in intestinal tissue of infected 
pigs. It is an antemortem assay that is highly sensitive, highly specific and a relatively economical 
method to detect even low levels of intracellular microorganism (31) (32). Several PCR methods 
have been developed for L. intracellularis detection: conventional, nested, PCR-ELISA, real-time 
PCR, multiplex and quantitative RT-PCR. Diagnostic performance of multiple fecal L. 
intracellularis-specific PCR assays for PE in pigs across seven publications was evaluated by 
Pedersen et al 2010 (32). Four studies assessed PCR analysis under experimental conditions while 
three studies evaluated diagnostic sensitivity/specificity of PCR under field conditions (32). This 
study presents data of different PCR tests including conventional, nested, real-time and multiplex-
based OCR with the reported range in diagnostic sensitivity (36–100%) and specificity (50–100%) 
(32). The nested PCR techniques are considered to be the most sensitive but in this study they 
showed equal sensitivity to conventional PCR (32). The studies had technical differences that 
could interfere with objective comparison of sensitivity/specificity such as variation in sample 
sizes, DNA extraction methods and PCR conditions (32). Despite these discrepancies the authors 
concluded that under conditions where up to 30% of the pigs in a herd have histologic lesions from 
PE, the risk of false positives will usually exceed the risk of false negatives when applying the 
PCR tests (32). PCR could detects shedding of L. intracellularis from 7 to 8 dpi after infection and 
that shedding could was observed for 15 days or, in some reported subclinical cases, up to 12 
weeks (32). In experimentally infected pigs, PCR could detect shedding of L. intracellularis as 
early as 3 dpi (7). Taken together, these data confirm high sensitivity/specificity of PCR to detect 
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L. intracellularis in feces of infected animals early in course of infection and also, to monitor 
prolonged shedding even in subclinical cases.  
The presence of L. intracellularis in fecal material was established using a quantitative 
PCR (qPCR) assay using SYBER green (33) with primers specific for the target gene, aspartate 
ammonia-lyase (aspA). This qPCR assay could detect bacterial DNA from spiked fecal samples 
in concentration of between 2.55 x 104 and 2.55 x 103 L. intracellularis/g (33). Under field 
conditions, L.  intracellularis was detected by qPCR in feces from 91 pigs (29.1%) (32) where an 
nonparametric receiver operating characteristic (ROC) analysis provided an area under the ROC 
curve (0.93) and an optimal cutoff value of 4.8 log10 L. intracellularis bacteria/g feces. This cut-
off provided a diagnostic sensitivity of 0.84 and diagnostic specificity of 0.93 (32). This study 
concluded that performance of fecal qPCR testing for detection of pigs with L. intracellularis–
associated PE under field conditions was adequate and that fecal qPCR analysis can be used as an 
accurate diagnostic tool.  
In summary, diagnosis of PE and detection of the causative agent L. intracellularis can be 
established using a combination of serology, histology, and molecular techniques. Serum antibody 
titres indicate previous exposure to L. intracellularis but not necessarily current infection. 
Histology can be used to identify characteristic microscopic lesions and IHC can be used to 
identify L. intracellularis in enterocytes. However, because these histological techniques must be 
performed post-mortem, they cannot be used for surveillance of PE in herds. Instead, PCR analysis 
of feces is useful to monitor health status of the animals but it can detect bacteria only when 
animals are shedding which may mean that some non-shedding but subclinical infected animals 
may be missed. Detection of subclinical infected animals is still a challenge for available 
diagnostic techniques and further research is needed to find adequate diagnostic solutions. Finally, 
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there is no current diagnostic test that can distinguish between vaccinated from infected animals, 
which poses problem in the inaccurate assessment of PE prevalence and herd infection status. 
Currently, PCR of feces or tissue and IHC of intestine are considered the standard tests for PE 
diagnosis (15). The serological results and molecular tests are necessary to monitor prevalence and 
disease spread and to implement proper management measures to treat or prevent occurrence of 
PE.    
 
1.1.4 Epidemiology 
L. intracellularis has been found in swine herds all around the world. Serological data 
indicate that US (96%) and Northern Europe (70-90%) have a higher prevalence of L. 
intracellularis than Southern Europe (50-70%) (34). Evaluation of L. intracellularis antibodies 
using specific blocking ELISA in intensive pig farms in China revealed that the true prevalence 
(i.e. prevalence corrected for the imperfect sensitivity and specificity of the testing method) was 
77% (35) and the highest prevalence was detected in fattening pigs, breeding sows and boars and 
in Northern or Southern regions where intensive pig production is highest (35). These data 
correspond to a serological investigation in Australia and Korea, where high prevalence was 
detected among intensive production systems. In Australia, commercial blocking ELISA indicated 
72% seroprevalence for Western Australia and 88% for Queensland, while the mean percentage 
of seropositive animals within the herds was 84% (36). A study from South Korea reported 
seroprevalence in growing and fattening pigs of 45% and 59%, respectively, while 100% of herds 
had seropositive animals (37). These results should be taken with caution because the Korean study 
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used IFAT assay to detect L. intracellularis-specific antibodies, which has not been standardized 
and may lead to sizable variations across different laboratories.  
When PCR was used to detect bacteria in five large pig intensive production farms in 
Denmark, all examined herds were seropositive for L. intracellularis and 75% of animals were 
infected (38). The results from PCR testing of nursery herds in Sweden revealed that 48% of herds 
were actively infected with L. intracellularis (39). These data confirm worldwide distribution of 
causative agent of PE. PCR can be used to detect L. intracellularis in feces, which can positively 
identify individual animals that actively shed bacteria and are a source of infection. Studies in the 
field and in controlled challenge exposure showed that the PCR method detected bacteria in pig 
feces 1-2 weeks before serum antibodies could be detected with IPMA (40, 19). These data indicate 
that adequate timing and application of diagnostic tests are very important for acquiring 
representative data. Positive animals identified by serology or PCR may not show the clinical signs 
of PE or may only be determined as positive by one diagnostic method. In a recent study where 
authors followed the progression of lesions associated with PE in experimentally infected pigs, 
they detected fecal shedding using PCR as early as 3 dpi and detection in feces remained positive 
up to 35 dpi (7). IgA secretion in intestinal lavage was detected at day 15 and was still detectable 
up to day 29 (7). Although this study did not evaluate serum antibodies, it indicates that PCR 
analysis may be a sufficient diagnostic method to detect early stages of infection prior to induction 
of humoral immunity. In the case where pigs tested positive via serological methods but negative 
with fecal PCR, animals did not actively shed bacteria but were previously exposed to bacteria 
(41). Data from different studies where seroprevalence and bacterial presence in feces were 
examined emphasize the need of applying both serology and PCR to generate representative data 
that could be used in the prevention and better management of PE. 
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The high prevalence and global distribution of L. intracellularis reflect the superb 
capability of these bacteria to be transmitted among animals. Transmission may occur through 
three main sources: 1) via fecal material that persists due to poor sanitation measures and by 
housing of large numbers of susceptible animals of different ages in small spaces (42, 43, 2) by 
persistence of bacteria in sows that act as subclinical carriers (44); and 3) transmission by rodents 
present in and around pig farms (45, 10). The fecal-oral route is the mode of transmission that 
provides bacteria an efficient mode to spread among susceptible animals as the bacteria can survive 
outside the host and remain infectious for two weeks in feces at 5-15 oC (46). The infectious dose 
in feces is 104 – 106 L. intracellularis but because infected pigs can shed 7 x 108 bacteria per g of 
feces, the fecal material is highly likely to be adequate for transmission (47). Subclinically infected 
animals can shed bacteria intermittently for extended periods of time (at least for 10-12 weeks 
after initial infection in asymptomatic experimentally infected pigs) (48, 49). The ease by which 
the bacteria can be transmitted via feces stresses the importance of proper hygiene, sanitary and 
disinfectant measures in pig farms. Slatted concrete flooring is a major factor aiding in the high 
prevalence of L. intracellularis seropositive pigs (42) and animals raised in modern intensive 
production systems tend to have higher seropositive prevalence than animals raised outdoor (42, 
37, 36, 35). The modern pig production systems tend to intensify production by adding more 
animals in limited spaces thus providing ideal conditions for L. intracellularis to spread through 
animal to animal contact or via feces and that allowing adequate cleaning, disinfecting and drying 
time is necessary to promote proper sanitation (46). Biosecurity is important in preventing the 
introduction of L. intracellularis into farms and quarantine showed efficacy in keeping some herds 
free from PE (50, 39). The role of rodents in L. intracellularis transmission had been speculated 
due to bacteria capability to infect hamsters (51), mice and rats (52, 53, 54), and the prevalence of 
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rodents in and around pig farms (45). A study showed as high as ≥70.6% of wild rats captured in 
pig farms were infected with L. intracellularis and some specimen shed a high number of bacteria 
per gram feces (1010 per g) (45). The duration of fecal shedding in experimentally infected mice 
and rats from the same study persisted for 14-21 days and humoral immunity in both species lasted 
for 40 days (45) suggesting that these animals could readily infect pigs through their contaminated 
feces. Mice fed L. intracellularis–infected pig feces became infected and actively shed bacteria in 
feces (104 bacterial cells per day) (10). In turn, pigs that consumed the rodent feces were infected 
and shed an average 104 bacteria per g of feces (10). These studies indicate that rodents may act as 
reservoirs for bacteria and they may play an important role in transmission of L. intracellularis.   
Persistence of L. intracellularis in sows with subclinical disease are a major source of 
bacterial transmission within the herd (44). Sow group housing increases the transmission of 
bacteria between sows and piglets and this housing practice can increase the number of shed 
bacteria in feces within rooms (50). The age and parity of the sows are important factors that 
impact bacteria shedding (42). Older sows with 3-5 parity or more are associated with fewer 
numbers of seropositive offspring whereas offspring from gilts have increased risk of being 
seropositive after 5 to 26 weeks (55). These results suggest that higher parity sows have developed 
protective immunity to L. intracellularis which can benefit the offspring through passive immunity 
or that these multiparous sows may shed lower numbers of bacteria that are insufficient to cause 
infection. The role of passive immunity in protection of piglets is not clear although sows with 
anti-L. intracellularis serum antibodies that do not shed the bacteria have been shown to protect 
offspring suggesting that passive immunity may be protective (22, 44).  
Transmission between herds occurs mainly through the introduction of infected animals 
into a naïve herd. Newly introduced subclinically infected replacement stock experience stress 
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during transport and by being introduced to a new environment. This increased stress may result 
in them actively shedding L. intracellularis into the barn, which may lead to infection of co-housed 
animals. 
      
1.1.5 Treatment and management of PE 
The global prevalence of PE in wildlife, in backyard, farmed pigs, and in intensive pig 
systems poses a challenge in the control, treatment, and eradication of this disease. Although PE 
is not as devastating to pig herds as other pig diseases such as porcine reproductive and respiratory 
syndrome (PRRS), porcine epidemic diarrhea virus (PEDV) or Classical or African Swine Fever, 
the economic losses due to subclinical infections and/or outbreaks after stress remain a great 
challenge for pig farmers. Biosecurity measures coupled with treatment and vaccination are the 
best currently available solutions to control L. intracellularis transmission. Modern pig farming 
has adopted management practices that can lower the possibility of bacteria transmission such as 
increasing sanitation and disinfection, applying an ‘all in, all-out’ system for herds, and using older 
sows with higher parity in rotation (42).   
Rodent control and stringent biosecurity including thorough cleaning and disinfection of 
animal spaces are important management practices to prevent transmission of L. intracellularis in 
pig farms (45, 10, 42). The most effective disinfectants include quaternary ammonium compounds 
and povidone-iodine (46). For cleaning and disinfection to be successful, it is important to leave 
sufficient time for the disinfectant to work before populating pens with animals (46). Thus, the 
practice of all in-all out husbandry in pig farms has shown to be associated with lower risk of PE 
in herds (42). Segregated early weaning, medicated early weaning, and the establishment of high 
 
 
20 
 
health herds free of L. intracellularis are other management measures that reduce the risk of PE in 
herds (5). Finally, the association of farm building type, type of production system and materials 
used in construction can contribute to increased risk of PE (56, 42). For example, slatted concrete 
flooring was associated with a higher risk of infection due to inefficient cleaning and disinfection 
of those types of floors (42) with the alternative of straw bedding and solid floors leading to 
reduced disease prevalence.   
Animals with PE can be treated with administration of antibiotics into animal feed or via 
intramuscular injections. Ideally, antibiotics should have high efficacy and specificity against L. 
intracellularis, adequate pharmacodynamics, they should be distributed throughout the entire 
gastrointestinal tract with intracellular absorption and retained activity, all the while being cost-
effective (15). Evaluation of antimicrobial activity of different antibiotics on L. intracellularis has 
been a challenging task due to the obligate intracellular nature of these bacteria and the difficulties 
in isolating and maintaining them, in vitro. A study from 2009 tested the antimicrobial activity of 
select antibiotics on ten L. intracellularis isolates from North America and Europe (57). They 
reported that carbadox, tiamulin, and valnemulin displayed the highest intracellular bactericidal 
activity (0.5 mg/ml minimum inhibitory concentrations (MICs)) against six L. intracellularis 
isolates from North America (57). Chlortetracycline and tylosin had moderate bactericidal activity 
against L. intracellularis (0.125 to 64 mg/ml and 0.25 to 32 mg/ml MICs, respectively) (57). 
Lincomycin had the lowest bactericidal activity against the majority of L. intracellularis isolates 
with a MIC range from 16 to >128 mg/ml (57). Valnemulin had highest bactericidal activity 
against extracellular L. intracellularis with MICs ranging from 0.125 to 4 mg/ml followed by 
carbadox (4 to 32 mg/ml MICs), chlortetracycline (32 to 64 mg/ml MIC), tiamulin (1 to 32 mg/ml 
MICs), tylosin (1 to >128 mg/ml MICs) and lincomycin (>128 mg/ml MICs) (57). Antibiotics with 
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no antimicrobial activity against L. intracellularis included aminoglycosides and aminocyclitols 
including neomycin and gentamicin (58).  Because neomycin and gentamycin suppress the growth 
of other enteric bacteria without interfering with L. intracellularis survival, they are used in 
medium for L. intracellularis isolation and in vitro growth (4). 
Another study using four European isolates of L. intracellularis showed similar 
susceptibility to carbadox, tiamulin, and valnemulin as the North American isolates including 
tylosin with a MIC range of 0.5–2 mg/ml, chlortetracycline with a MIC range of 0.25–16 mg/ml 
and lincomycin with a MIC range of 8–64 mg/ml (57). Valnemulin had the highest extracellular 
activity against L. intracellularis; all isolates had MICs of 0.25 mg/ml (57). Antimicrobials that 
had moderate activity against L. intracellularis included tiamulin with an MIC range of 1–4 mg/ml, 
carbadox with an MIC range of 1–4 mg/ml, tylosin with an MIC range of 2–16 mg/ml and 
chlortetracycline with an MIC range of 16–64 mg/ml (57). The antimicrobial that showed the 
lowest activity against L. intracellularis was lincomycin with MICs of 32–128 mg/ml (57). Based 
on these results, the authors suggest that carbadox, tiamulin, and valnemulin are the most active 
antimicrobials, followed by chlortetracycline and tylosin which have moderate antimicrobial effect 
with lincomycin having the least antimicrobial effect against L. intracellularis (57). Because the 
antimicrobial activity was performed on bacteria grown in cell culture, the antimicrobial activity 
of the antibiotics may or may not show comparable activity under field settings in animals with a 
clinical case of PE.  
Pig farms with cases of PE commonly treat infections with tiamulin at 120 ppm, tylosin at 
100 ppm, lincomicyn at 110 ppm, or chlortetracycline (CTC) at 300 ppm given orally mixed with 
feed (59). Elimination of L. intracellularis (confirmed by PCR and ELISA analysis) was achieved 
in 11 Danish farms with nine farms showing no clinical symptoms for PE.  Specific pathogen-free 
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(SPF) gilts were treated with tylosin (5 mg per kg body weight) for 14 days followed by washing 
them with a 2% Vicron solution (60). However, even with strict biosecurity measures in place, 
most farms became re-infected within 1.5 years with only 2 farms stayed free of L. intracellularis 
for 5 years (60). Despite reinfection, animals from re-infected farms had improved feed conversion 
rates and increased average weight gain in excess of 100 grams over animals from the farms where 
animals were fed with medicated feed to control ileitis (60) indicating that reinfection did not have 
a significant effect on animals in these herds.     
Currently, there are two commercially available vaccines on the market. Enterisol® is a live 
avirulent vaccine from Boehringer Ingelheim which has been available since 2004. Porcilis is an 
inactivated whole cell vaccine available since 2016 from Merck Animal Health. They are an 
important part in all prevention measures on farms all around the world and present an efficient 
and economical solution for limiting the effect of PE on pig herds. Their properties and protection 
characteristics are discussed in Section 1.3.5: Immune protection against L. intracellularis 
infection. 
Despite all available prevention measures and treatment options discussed here, L. 
intracellularis is still prevalent in intensive pig productions around the world. The omnipresence 
of this bacteria and increased pressure to reduce the use of antibiotics in food-producing animals 
have influenced all involved parties in the pig industry to actively seek and implement new 
methods to control PE. Biosecurity measures, disinfection, rodent control, modification of diets 
and use of vaccines have shown promising results in the prevention of PE and eliminating the use 
of antibiotics.  
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1.1.6 Economic impact and importance of PE for the swine industry 
PE has emerged as an important disease in pig farms with significant associated economic 
losses. Accurate estimation of economic losses has been challenging to accomplish due to the 
complexity of PE disease and because most of the studies simply cite approximations of the 
economic impact. Cost increases contributing to PE are likely due to higher feed consumption, 
longer facility time to reach market weight, loss of animals, antibiotic treatment costs and reduced 
reproduction rates in infected sows/gilts (55).  
PE has an economic impact on breeding pigs, weaners and finishing pigs. Losses derived 
from poor growth in fattening pigs suffering from PIA and the associated elevated mortality and 
treatment costs have been estimated in the UK as $3-11 USD per growing pig and the $3-6.5 
million USD total annual cost (61, 62, 63). The annual cost to pig producers in the US has been 
estimated at 20 million USD (63). McOrist et al 2005 and Mauch and Bilekei 2005 estimated that 
financial losses in the UK exceed €100 (121 USD) per affected breeding pig which extrapolates to 
an additional €0.50 (0.61 USD) per growing pig (64, 55).  
In Denmark, the banned use of antibiotics in the feed as growth promoters for production 
animals has had a significant impact in management practices in pig industries. With reduced 
antibiotics in feed, there was an increased prevalence of diarrhea due to L. intercellularis which in 
turn led to decreased production performance of 18 g to 50 g per day in daily gain and reduced 
mortality by an extra 0.6% to 1.5%, especially in the weaner period (44). The use of therapeutic 
antibiotics to treat the infection was estimated to cost between, 1 to 3 USD per animal (44) which 
amounted to less than 50% of the amount of antibiotics used before the ban (44). These data 
indicate the importance of applying adequate management practices such as stringent biosecurity 
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measures and finding alternative to antibiotics to protect against disease. Vaccines offer the most 
cost-effective preventive measure, which can protect animals with the least economic burden to 
pig producers while minimizing the use of antibiotics as therapeutics.  
 
1.2 LAWSONIA INTRACELLULARIS 
1.2.1 Taxonomy 
Identification and characterization of L. intracellularis was hindered by its intracellular 
niche where it thrives as well as the inherent difficulties in isolating and growing this bacterium in 
vitro. For years, PE was thought to be caused by Campylobacter spp., which were often isolated 
and cultured from PE cases but it failed to induce characteristic symptoms of PE when infecting 
conventional pigs (65). DNA restriction enzymes and probe analysis by McOrist 1990 and Gebhart 
1991 showed that the organism responsible was not Campylobacter spp. so it was described as 
‘Campylobacter-like’ or ‘ileal symbiont intracellularis’ (66, 67). This nomenclature was used until 
1995 when McOrist at al. sequenced the 16S DNA and finally classified and named bacteria as 
Lawsonia intracellularis, in honor of Dr. Lawson (1).    
L. intracellularis belongs to delta subdivision of Proteobacteria in the Desulfovibrionaceae 
family (68). Genetically, the closest relative of L. intracellularis is Bilophila wadsworthia showing 
92% similarity of 16S ribosomal sequence (3). Interestingly, B. wadsworthia is an extracellular 
anaerobic human pathogen that constitutes less than 0.01% of the normal human gut microbiota 
but is the third most common anaerobe isolated from intestinal samples from patients with 
perforated and gangrenous appendicitis (69). It is asaccharolytic and characterized by its strong 
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production of hydrogen sulfide, and growth stimulation by bile (oxgall) and pyruvate (69). More 
than 85% of strains demonstrate β-lactamase production when pyruvate-containing media was 
used for bacterial growth (69). Although B. wadsworthia shares 92% similarity with 16S ribosomal 
gene from L. intracellularis, their cultivation, growth, and pathogenesis are markedly different.  
L. intracellularis is 91% genetically similar to Desulfovibrio desulfuricans, a sulfate 
reducing bacteria usually found in water, soil and in feces (3, 70). It encodes mechanisms of 
mercury methylation which could be of importance to protect itself from the environment (70). L. 
intracellularis does not have the capability of reducing sulfate nor methylate mercury thus 
differing from D. desulfuricans. Phenotypic differences also exist between these two species.  L. 
intracellularis are acid-fast when stained with modified Zhiel-Nielsen and the L. intracellularis 
pellet is a pale tan colour. D. desulfuricans are not stained with modified Zhiel-Nielsen and its 
pellet is black in colour. Despite using 80 different media that were known to support D. 
desulfuricans growth, L. intracellularis could not be cultivated (1). This research shows that L. 
intracellularis is unique obligate intracellular bacteria with unique specific characteristics and 
pathogenesis.  
 
1.2.2 Characteristics of L. intracellularis  
L. intracellularis are curved, non-spore forming, microaerophilic obligate intracellular 
organisms that replicates by binary fission and cannot grow in cell-free media (31). It is a rod-
shaped bacterium 1.25-1.75 μm in length and 0.25-0.43 μm in width (1). Trilaminar outer 
membrane and unipolar flagella were observed in extracellular L. intracellularis that helps in 
propulsion and translocation during infection (6). L. intracellularis have one chromosome 
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(1,475,619 bp) and three plasmids (plasmid A, 27,048 bp; plasmid B, 39,794 bp; and plasmid C 
194,553 bp) (71).  
 Seventeen isolates L. intracellularis have been reported so far (3) but they are considered 
to belong to one species with no major phenotypic or genetic differences yet discovered. There are 
some specificities of isolates derived from pigs and horses and proof of species adaptability of 
these strains. For example, foals and pigs infected with species-adapted isolates showed 
characteristic clinical symptoms, longer times of bacterial shedding and stronger immunological 
response (72). In contrast, foals challenged with porcine isolate or pigs challenged with an equine 
isolate showed milder or no clinical symptoms, low levels of bacterial shedding and lowered 
immunological response to infection (72). This species adaptability expands to rabbits and 
hamsters, which are susceptible to specific isolates and manifest the clinical symptoms of equine 
or porcine PE, respectively. Rabbits are susceptible to equine isolates and show characteristic 
symptoms thus are a good model for equine PE (73). A comparative genome sequencing study on 
porcine and equine isolates reported an 18-kb prophage-associated genomic island in the 
pathogenic variant of the porcine isolate which was missing from the equine isolate and from the 
cell-culture-adapted non-pathogenic-variant porcine isolate (73). This genomic island was absent 
from isolates obtained from 21 clinically affected horses and four wild rabbits trapped from this 
horse farm (73). This research was the first reporting genetic difference between two isolates. 
However, data suggest that this genomic island is not essential for pathogenesis but is speculated 
to have potential benefits for adaptation of porcine isolate to the host (73).  
Attenuation of virulence of L. intracellularis occurs between 20 and 40 passages in cell 
culture and these changes occur at the transcriptional level while the genotype remains unchanged 
(74). Transcriptional analysis of low passage/pathogenic variant (passage 10) and high 
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passage/non-pathogenic (passage 60) variant identified 401 genes expressed uniquely in the 
pathogenic variant and just 11 uniquely expressed genes in the non-pathogenic variant, while 319 
were commonly expressed between both variants (74). The major differences were detected in 
plasmid-encoded genes, regulatory factors and ATP-binding cassette (ABC) transporter-
associated genes (74). The non-pathogenic variant suppressed the whole transcriptional repertoire 
of plasmid A (which included virulence factor genes) and transcription level differences were 
detected in 3 and 10 genes present on plasmid B and C (74). Analysis of putative biological gene 
functions revealed that the most important reduction in gene expression was in membrane transport 
(72%), followed by general predicted functions (64%), cell membrane and motility (61%) and 
adaptation and stress response (61%) genes (74). This attenuation and altered transcriptional 
profile between variants could be due to the abundance of nutrients in cell culture and the lack of 
pressures found in host intestinal environment.        
The obligate intracellular nature of L. intracellularis is likely an evolutionary adaptation 
to the microbiological and biochemical environment in the small intestine that provides protection 
against the influence of host immune system, commensal bacteria in the gut or influence and 
competition with other enteric pathogens. L. intracellularis may have adapted to intracellular life 
in the intestine by not reducing sulfates and the production of  hydrogen sulfide, which is toxic to 
host cells, such as performed by Desulfovibrio species (1). A microaerophilic environment is 
required to grow L. intracellularis in vitro in different cell lines which highlights how well the 
bacteria have evolved to adapt to life in the porcine ileum, where oxygen tension is 5 to 10% (75). 
Genes that regulate pH homeostasis such as glutamate decarboxylase (GAD) system and the F0 F1-
ATPase operon have been detected in a L. intracellularis in vitro infection (73). The proteins 
produced by these systems play an important role in protecting intestinal pathogenic bacteria 
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against acid stress experienced in the gastric environment (76). L. intracellularis are well equipped 
to survive in the vastly different environments of the pig digestive tract and to arrive and establish 
infection in the small intestine crypts where pH and biochemical conditions are suitable for 
infection of enterocytes.   
The bacterium has an affinity towards immature, undifferentiated enterocytes for invasion 
and growth. The conditions required for bacterial attachment and mechanism of entry into the 
enterocytes are not clear yet (3). An in vitro study of L. intracellularis entry into rats IEC-18 and 
porcine IPEC-J2 cells using electron microscopy showed that the bacteria were closely associated 
with the mammalian cell membrane in the first three hours of incubation (Fig. 1.3, A) (77). No 
specific contact structures were detected and no projecting structures were observed in uninfected 
control cells (77). When bacteria and mammalian cells were centrifuged together, a zone of 
electron-dense material known as a cap junction was formed between bacteria and cells (Fig. 1.3, 
B) (77). Between 3 and 24 hours post-incubation, L. intracellularis were internalized within 
membrane-bound endocytic vacuoles with only one vacuole per cell observed (Fig. 1.3, C) (77). 
No multiplication of L. intracellularis were observed in those vacuoles, and they were often found 
in close proximity with the mitochondria during this time (77). Also, between 3 and 24 hours post-
incubation, some L. intracellularis were detected free in the cytoplasm and empty vacuoles could 
be observed which implies that they escaped the endocytic vacuoles (Fig. 1.3, D) (77). Between 2 
and 6 dpi, numerous free dividing bacteria were present in the cytoplasm with no bacteria in 
vacuoles (77). Groups of bacteria were found adjacent to the nucleus and heavily infected cells 
had numerous bacteria in proximity or in contact with mitochondria and endoplasmic reticulum 
(77).  
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(McOrist et al 1995, Research in Veterinary Science 1995, 59, 255-260) 
Figure 1.4 Transmission electron micrographs of thin sections of IEC-18 cells after inoculation with 
L. intracellularis. (A) Association of bacteria with cell, three hours after inoculation, x 52,000; (B) 
Formation of cap junctions between cell and bacteria centrifuged on to cells, 10 minutes after inoculation, 
x 52,000;(C) Bacterium internalized within membrane-bound vacuole, 10 minutes after inoculation, x 
45,000; (D) Internalised bacteria associated with coated pit (arrow) and vesicles, 24 hours after inoculation, 
x 32,000. 
 
The ability of L. intracellularis to escape endocytic vacuoles and to reside and multiply in 
the cytoplasm is speculated to require expression of genes included in operon related to the 
Salmonella pathogenicity island 2 (SPI2) (78). The SPI2 genes play an important role in 
Salmonella survival and proliferation in infected macrophages by interfering with trafficking of 
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transferrin receptor and inhibiting the fusion of Salmonella‐containing phagosomes with 
lysosomes and endosomes (79). The presence of L. intracellularis were reported by using 
fluorescence in situ hybridization (FISH) in lamina propria macrophages (12) although it was not 
clear whether they could persist and multiply in macrophages or whether they were phagocyted 
and would be subsequently processed by the macrophages. During L. intracellularis infection of 
enterocytes, expression of SPI2 operon-like genes may help bacteria to escape the vacuole. Once 
in the cytoplasm, they remain in close proximity to the mitochondria and ribosomes where they 
can obtain energy and nutrients for persistence and multiplication inside the cell. The presence of 
genes encoding ATP/ADP translocase in L. intracellularis genome confirms that the bacterium is 
dependent on host cells energy sources, which may explain why L. intracellularis thrive in close 
proximity to mitochondria (80). The L. intracellularis ATP/ADP translocase plays an important 
role in the exchange of bacterial ADP with ATP from the host cells and it shares 47% sequence 
similarity with the Rickettsia and Chlamydia ATP/ADP translocases (80). This ‘energy parasitism’ 
is essential for the survival of obligate intracellular bacteria inside eukaryotic cells.  
The RNA sequence analysis and comparative transcriptional analysis of pathogenic and 
non-pathogenic L. intracellularis genome revealed the expression of genes related to oxidative 
protection mechanism (71). Also, Cu-Zn superoxide dismutase (sodC) genes, rubrerythrin-
rubredoxin (rubyY-rubA) operon and dioxygenase genes (dioxygenases related to 2-nitropropane 
dioxygenase) were highly expressed by L. intracellularis in the enterocytes cytoplasm in study 
using laser microdissection with RNA-seq analysis (71, 78). These genes code for proteins that 
allow the bacteria to cope with oxidative stress by neutralizing reactive oxygen species inside the 
endosome (81).  
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Copper is a metal used by mammalian cells during the process of oxygen reduction by 
cytochrome C oxidase which is essential for ATP production (82). Controlling copper levels is one 
of the innate immune mechanisms by which mammalian cells defend themselves from intracellular 
pathogens (78, 82). Infected cells have a high upregulation of high-affinity copper uptake genes 
on the apical membrane (78) which may prove toxic to the invading pathogen. However, L. 
intracellularis has developed ways to use the host cell’s energy and defense mechanisms to its 
own advantage and to thrive in the cytoplasmic environment despite high copper concentration. L. 
intracellularis expresses Cu-Zu superoxide dismutase to take up intracellular copper to promote 
survival in the intracellular environment.  
Other studies show that many important genes involved in host cell nutrient acquisition 
such as genes responsible for uptake of Vitamin B12, bile acid, glucose, amino acids, disaccharide, 
and lipids are down-regulated after infection (78). Further, genes that code for proteins responsible 
for electrolyte secretion on the apical membrane were shown to be highly downregulated. In 
contrast, genes encoding glucose transporter 1 (also known as solute carrier family 2, glucose 
transporter member 1) and the high-affinity copper uptake protein (CTR1) involved in copper 
absorption were highly upregulated. Altogether, these changes in gene expression may produce an 
excessive concentration of nutrients and electrolytes in the intestinal lumen which may correspond 
to induction of osmotic diarrhea, the main symptom of PE in pigs (78).   
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1.2.3 Induction of proliferation and inhibition of differentiation of infected 
enterocytes 
L. intracellularis has evolved to exploit the intracellular environment and to rely on host 
cell multiplication for its own propagation. Proliferating cells offer a suitable microenvironment 
for the bacteria to acquire the necessary nutrients and energy for replication. Upon entry into the 
undifferentiated small intestine crypt cells, L. intracellularis thrive and, using a mechanism that is 
not yet fully understood, induces cellular proliferation and prevents differentiation of immature 
crypt cells into different subsets. To elucidate the mechanism behind proliferation of invaded 
immature cells, several studies with diverse approaches including microarray analysis (83), laser 
microdissection with RNAseq (78) and immunofluorescence (IF) coupled with quantitative 
reverse transcriptase PCR (RTqPCR) (84), were undertaken. 
Microarray analysis was used to examine the effect of L. intracellularis infection on gene 
expression of a mouse fibroblast (McCoy) cell line (83). Mouse DNA microarrays with 44,498 
genes targets were probed with cDNA from infected McCoy cells led to identification of over 40 
genes with ≥ 4-fold change in expression between 0 and 3 dpi (83). This study showed that L. 
intracellularis infection induced transcription of genes important in the regulation of the cell cycle 
or cell differentiation genes, such as usp18, Hr, Elavl2 and Slfn2 (83) as well as genes that play a 
role in the host cell “alarm response” to invading microbes, such as interferon-related genes Isgf3g 
and Igtp (83). Unfortunately, murine fibroblasts infected with L. intracellularis may not accurately 
represent infection, propagation, and alteration of the transcriptome in porcine intestinal epithelial 
cells. Fibroblast may have more a pronounced anti-bacteria “alarm” response due to their role in 
antigen-processing and immune response. Further, McCoy cells do not express genes coding for 
intestinal enzymes or other factors that influence proliferation and differentiation in enterocytes, 
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in vivo (83). L. intracellularis proliferates within immature intestinal cells in vivo thus proper 
insight into the mechanism that induces this phenomenon can more accurately be achieved by 
analyzing gene or protein expression changes in these cells, in vivo.       
A study from Vannucci et al 2013 (78) applied laser microdissection coupled with RNA 
sequence (RNA seq) analysis on porcine enterocytes infected with L. intracellularis to obtain 
detailed information on gene expression in targeted cells. Laser microdissection allows precise 
selection of infected enterocytes in the small intestine. This study identified induced expression of 
genes associated with cell cycle regulation such as the Rho family of genes (RhoA, RhoB and Rho 
GTPase) (78). The Rho family of proteins influence the G1-checkpoint of the cell cycle when cell 
receive signals to enter proliferative stage (78). If these signals are absent or inhibited, the cell 
enters a non-proliferative stage (G0) and therefore induction of these genes may contribute to 
cellular proliferation (85). Rho proteins could also be activated by bacterial toxins known as 
cyclomodulins (85). Although cyclomodulins in L. intracellularis have not been established, 
significant activation of the Rho family of genes in host cells and expression of hypothetical 
proteins in these bacteria suggest that yet uncharacterized cyclomodulins may be responsible for 
induction of proliferation (78). More functional studies focusing on the changes of expression of 
these genes and their corresponding proteins are needed to reveal the process behind the induction 
of the Rho family of genes and the involvement of hypothetical bacterial proteins.   
To be able to precisely monitor all stages in L. intracellularis infection, Huan et al. 2017 
collected samples of pig ileum at 3, 7, 14, 21 and 28 dpi (84). Limited L. intracellularis staining 
were observed in crypts at 3 and 28 dpi and the strongest staining of bacteria was observed at 7 
and 14 dpi (84). These results correlate well with previous reports that indicated that the peak of 
L. intracellularis infection and characteristic cell alterations were observed 14 dpi (13, 10). The 
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depletion of goblet cells is an important hallmark of L. intracellularis infection and is an important 
step during pathogenesis. Goblet cells secrete mucins and form the first line of defense against 
intestinal bacteria. MUC2 plays an important role in maintaining the mucosal integrity and 
depletion of Muc2 in knockout mice leads to improper colonic mucosal layer formation and 
subsequent increased permeability that aids to bacterial adhesion to the epithelial cells and colonic 
infection (86). By using immunofluorescence to stain for MUC2 (a marker for goblet cells) they 
obtained evidence that goblet cells were absent at 14 dpi but were present at 3, 7 and at 28 dpi 
(84). Further, transcript levels of MUC2 were significantly downregulated at 14 dpi compared to 
the other points and uninfected crypts (84). These results indicate that depletion of goblet cells 
occurs between 7 and 14 dpi and that their presence is restored at 28 dpi (84). Decreased levels of 
MUC2 together with TFF2, TFF3, RETNLB (genes encoding the proteins produced only by goblet 
cells) and CLDN15 were decreased between 3- and 9- fold at 14 dpi which correlates well with 
previous studies (87) and strengthens the claim that disturbance in mucosal integrity and loss of 
goblet cells are due to L. intracellularis infection of intestinal crypt cells (88). Also, this study 
reported down-regulation of ATOH1 at the 14 dpi and implies that Notch signaling during infection 
leads to inhibition of secretory lineage cells (84).  
The intestinal epithelium is segmented into crypts and villi with the distinctive difference 
in cell types. The crypts are comprised of proliferative cells, divided into intestinal stem cells and 
their progeny, transit amplifying (TA) cells which remain in the crypt around two days, dividing 
4-5 times before they undergo differentiation into specialized differentiated cells (89). The villi 
are comprised of differentiated cells which include: absorptive enterocytes, mucus-secreting goblet 
cells and hormone-secreting endocrine cells (89). TA are differentiated cells that move up along 
villi and after three days they undergo apoptosis and are released into the intestinal lumen (90). In 
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contrast, Paneth cells which are important for innate immunity and antibacterial defense, are 
differentiated in crypts and migrate downward instead of upward (89).  
Cellular proliferation and differentiation are finely balanced processes regulated by 
different biological factors within and outside the cells. The β-catenin/Wnt pathway plays an 
important role in regulating epithelial cell proliferation. In a resting state, β-catenin is bound by 
adenomatous polyposis coli protein (APC protein), casein kinase I (CKI), Glycogen Synthase 
Kinase 3 (GSK3), and axin protein complex which either promotes β-catenin degradation through 
the process of phosphorylation or it is bound to E-cadherin and form the membrane complex (91). 
The β-catenin/Wnt pathway is activated by the binding of Wnt to Frizzled and low-density 
lipoprotein, which initiates degradation of a protein complex that inhibits β-catenin (89). 
Ultimately, this leads to increased levels of β-catenin in the cell (89). β-catenin is now free to enter 
the nucleus where it binds to the TCF transcription factor which in turn leads to expression of Wnt 
targeted genes (89). Induced expression of these genes induces proliferation of cells and is an 
important physiological process for renewal of cells in the intestine. Mutations in the Wnt signaling 
pathway leads to accumulation of β-catenin and transcriptional activation of WNT/TCF4 targeted 
genes which begin the transformation of intestinal epithelial cells (92). These mutations are 
responsible for intestinal hyperplasia and developing colorectal cancer (93).  
The Notch pathway is another imported cellular pathway in the intestine that regulates 
intestinal stem cell survival, drives maturation of TA cells into absorptive enterocytes and 
suppresses the secretory lineage but no mutations in Notch signaling were reported in intestinal 
tumorigenesis (89, 94). Mutations or disturbance in β-catenin/Wnt and Notch signaling pathways 
lead to hyperplasia and secretory cell dysplasia of intestinal cell epithelium which is also 
characteristic for L. intercellularis infection. Thus Huan et al 2017 explored the changes in β-
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catenin/Wnt and Notch signaling pathways during L. intracellularis infection of intestinal 
epithelial cells. 
In a recent study, Huan et al 2017 used IF coupled with RT-PCR to gain insight into 
biological mechanisms behind induced proliferation and inhibition of differentiation in ileal crypt 
intestinal cells infected with L. intracellularis (84). The authors speculated that L. intracellularis 
infection of crypt cells must alter the β-catenin/WNT signaling which is necessary for normal 
intestinal stem cell  proliferation and self-renewal and at the same time impacts the Notch signaling 
which is essential regulator of differentiation of transit amplifying cells (TA) to secretory and 
absorptive cell lineage (84).   
To have a better understanding of the proliferative effect of L. intracellularis on crypt cells, 
Huan et al 2017 applied a more targeted approach to explore gene changes in expression of genes 
known to be involved in intestinal stem cell proliferation and differentiation (84). Their targets 
were c-MYC, which encodes a “master regulator” oncogene responsible for control of multiple 
stages in cell growth and metabolism, and ASCL2 which encodes intestinal stem cell marker 
necessary for proliferation (84). Down-regulation of these two genes after 7 dpi onwards implies 
that intestinal stem cells are not the ones that proliferate but rather the proliferating cells are TA 
cells and/or absorptive progenitor cells (84). Interestingly, 21 dpi onward LGR5, a specific marker 
for intestinal stem cells, was down-regulated compared to uninfected cells from 21 dpi onward 
(84), which opens the possibility for further exploring subtle specificity in L. intracellularis 
affinity towards crypt cell subtypes. 
Analysis by IF showed that cells stained as positive for β-catenin in the cell membrane and 
cytoplasm of uninfected and L. intracellularis infected crypts, respectively, at 3 and 28 dpi (84). 
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As infection progressed, β-catenin staining intensified in infected crypts and it was highest 
corresponding to the peak of infection at 14 dpi (84). Also, infected cells showed increased staining 
for SOX9 and AXIN2 staining, negative regulators of β-catenin/WNT pathway, between 7 and 14 
dpi with significantly higher intensity in the lower than upper crypts (84). To further explore the 
effects of L. intracellularis on β-catenin/WNT pathway, expression of the Notch-1 receptor 
(NICD1) was examined by IF in infected and uninfected crypts (84). An increased NICD1 staining 
was observed in infected crypts at the peak of infection which indicates that Notch-1 signaling 
pathway is active (84). Active Notch-1 signaling inhibits atonol homolog 1 (ATOH1) expression 
which leads to differentiation of TA progenitor cells into absorptive cells (instead of secretory 
lineage) (84). The activation of the Notch-1 pathway was supported by down-regulation of ATOH1 
transcripts and low mRNA levels of β-catenin/WNT signaling ligand WNT3 which together 
implies that β-catenin/WNT pathway was altered (84). This result correlates well with research in 
mouse colons which showed that induction of β-catenin expression led to expression of genes that 
induced expansion of the LGR5+ intestinal stem cells and reduced TA progenitor cell proliferation. 
Further, they showed that down-regulation of β-catenin/WNT pathway enhanced proliferation of 
progenitor cells but not intestinal stem cells (95, 96). Huan et al 2017 found an increase in 
expression of Ki67, SOX9 and NICD1 in crypts at the peak of infection which implies 
multiplication of TA and/or absorptive progenitor cell population. This research may lead to 
determining differentiation state of epithelial cells which are susceptible to L. intracellularis 
infection.   
Hyperplasia of the small intestine mucosa, proliferation of the immature enterocytes, and 
depletion of goblet cells are an important characteristic of lesions induced by L. intracellularis in 
vivo. Current knowledge on the mechanism by which bacteria induces these changes suggest a 
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very complex mechanism and interplay between bacteria and host intestinal cells. The bacteria 
have developed molecular mechanisms to influence the molecular base of the cell cycle and impact 
the proliferation and differentiation of intestinal cells. Molecular signaling pathways such as Rho 
family genes (RhoA, RhoB and Rho GTPase) (which act on cell cycle), β-catenin/WNT and 
Notch-1 are altered and suspected to be the cause of altered cell proliferation and depletion of 
goblet cells. The proliferation of murine colon enterocytes have been described in C. rodentium 
infection but in this case, β-catenin/WNT and Notch-1 pathways were up-regulated at the peak of 
infection (97). Although histologically, proliferative lesions are similar histologically, molecular 
pathways and possible bacterial mechanisms are different between C. rodentium and L. 
intracellularis. These findings indicate a unique model by which L. intracellularis influence the 
intestinal cell proliferation and depletion of goblet cells. The exact mechanism by which L. 
intracellularis induces those cellular changes are still not known and further research is needed to 
elucidate first bacterial genes and proteins involved and then exact host cell signaling pathways 
that lead to observed lesions.    
 
  1.2.4 Isolation and maintenance, in vivo 
L. intracellularis resides in the apical cytoplasm of the immature crypt enterocytes (13). 
Successful isolation and propagation of L. intracellularis were achieved in 1993 by Dr. Lawson 
and his group after almost 30 years of research (4). Isolation of this intracellular pathogen from 
infected intestines requires quick processing, careful manipulation, and adequate tissue condition 
to maintain viability. Because L. intracellularis is resistant to vancomycin and neomycin, culturing 
in the presence of these antibiotics prevents the growth of many other intestinal bacteria. The 
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isolation process begins with longitudinal dissection of the small intestine and careful removal of 
intestinal content followed by scraping of the mucosa, followed by homogenization in the presence 
of 1% trypsin in PBS for 35 min at 37 ̊C (4). Ten ml of trypsinized and homogenized mucosa is 
diluted four times in Dulbecco's modified Eagle medium with 10% fetal calf serum and then 
ground in a tissue grinder and filtered through a 200-mesh stainless-steel filter, through a glass 
fibre filter, and through 1.2-, 0.8-, and 0.65-, μm-pore size membrane filters (4). From our 
experience with isolating L. intracellularis, including 40-, 10- and 5-μm pore size filters is 
advisable to gradually decrease the viscosity of suspension and to achieve better filtering through 
smaller pore filters. To achieve additional purification, 4 ml of the L. intracellularis filtrate can be 
loaded onto 30 ml of a 45% Percoll gradient and centrifuged 20000 x g for 45 min (98). After 
centrifugation bacteria is present in the lower band of the gradient which is collected and washed 
with 12 ml PBS at 8000 x g for 20 min (98). The supernatant is discarded and pellet is suspended 
in freezing medium. Filtered isolate is resuspended in dimethyl sulfoxide (DMSO) to a final 
volume of 10% at room temperature, and aliquots are frozen at -70°C (4). Instead of using DMSO, 
filtrates could be prepared for freezing by diluting with sucrose potassium glutamate solution with 
10% FCS (4).  
L. intracellularis can be cultivated and maintained in vitro in various mammalian cell lines 
such as rat small intestinal (IEC18 cells), McCoy cells, human fetal intestine cells, human intestinal 
cells (INT 407 cells), rat colonic adenocarcinoma cells, (CRL1677 cells), and pig kidney (PK-15) 
cells (4). L. intracellularis need a microaerophilic environment and dividing eukaryotic cells for 
growth. The conventional method for isolation and cultivation is in a static adherent monolayer 
cell culture with incubation in humidified tri-gas incubator with 83.2% nitrogen, 8.8% carbon 
dioxide and 8% oxygen at 37̊ C (4). An alternative method for cultivation is in chambers, (‘original 
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space bags or Zip lock bags’) which are inflated with a mixture of 10% hydrogen, 10% CO2 and 
80% nitrogen gas (99). To cultivate L. intracellularis at commercial scale for live attenuated 
vaccine production, bacteria are grown in automatized bioreactors with stirring and recording of 
temperature and gas mixture (100). Bacteria isolated from the infected intestine is grown in 
DMEM with 10% FCS, plus neomycin or gentamicin (50 μg/ml), vancomycin (100 μg/ml) and 
amphotericin B (2.0 μg/ml) to suppress growth of contaminating intestinal bacteria (4). Medium 
is changed every 2 to 3 days with DMEM plus 5% FCS and antibiotics. Cells are trypsinized at 
weekly intervals and seeded at 0.5 x 105/ml into fresh T-75 tissue flasks (4). After successful 
several propagation in cells, bacteria can be propagated in medium without antibiotics. 
Due to this specific in vitro growth requirements and the complexity of isolation of the 
bacteria from infected intestines, L. intracellularis are very difficult to cultivate and maintain in 
laboratories. These difficulties have led to a relative lack of information regarding virulence factors 
such as cell surface proteins and/or proteins responsible for the L. intracellularis pathogenesis.  
 
1.2.5 Immunogenic antigens of L. intracellularis 
L. intracellularis antigenic properties have still not been fully elucidated. Currently, it is 
known that L. intracellularis has 25 to 27 visible protein bands after electrophoresis on a one 
dimensional SDS-PAGE, from which 22 are conserved in six different isolates (1). The protein 
masses of the major bands are 53 kDa, 42 kDa, 37kda and 30 kDa (1). The serum polyclonal 
1999PAb antibody targets five outer membrane proteins (OMPs) with masses of 77, 69, 54, 42 
and 36 kDa while the monoclonal 2001MAb targets OMP of 77 kDa, and monoclonal IG4 targets 
a protein of 18 kDa (101). Other select proteins that constitute the outer membrane have been 
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detected and characterized such as LsaA (27 kDa), which is involved in cell attachment and 
invasion (102) and LatA autotransporter protein (72 kDa) (103).  
LsaA is predicted to have role in cell attachment and invasion and is expressed during in-
vitro infection of IEC-18 cells and also in infected enterocytes from ileum tissue (102). This 
antigen is recognized by the monoclonal antibody VPM53 using IHC detection in both IEC-18 
cells and tissue samples (102). Based on its similarity to proteins of other Gram-negative bacteria, 
LsaA is believed to have a role in pathogenicity during infection. Further studies are needed to 
characterize its function and cellular networks.  
The outer membrane protein LatA, LI0649 belonging to the family of autotransporter 
proteins was detected using liquid chromatography-electrospray ionization-tandem mass 
spectrometry (LC-ESI-MS/MS) (103). The predicted LatA molecular mass was 91.9 kDa but a 72 
kDa form of LatA was observed on SDS-PAGE gels which implies that protein cleavage occurred 
(103). This gene was cloned and the purified protein was recognized by the immune serum from 
pigs infected with L. intracellularis indicating that is antigenic (103). This protein is highly 
specific to L. intracellularis and it can be exploited for development of diagnostic tests for PE. 
The same group applied shotgun proteomics and identified 19 proteins in two L. 
intracellularis isolates (104). Two proteins, LI0841 and LI0902 were predicted as outer 
membrane-associated proteins (104). The rLI0841 protein was identified as a putative invasin with 
sequence similarity to proteins that promote invasion. The rLI0902 protein was predicted to be 
involved in protein-protein interactions. Both recombinant proteins were recognized by serum 
antibodies from infected pigs (104). Recognition of these two recombinant proteins by pig immune 
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sera indicate that they are expressed and available to host immune recognition thus making them 
potentially good diagnostic tools or antigens for a subunit vaccine.     
L. intracellularis, like all Gram-negative bacteria, have lipopolysaccharide (LPS) in the 
outer membrane which has been used as an antigen target for ELISA antibody detection in pig 
serum (27). LPS based ELISA are not ideal diagnostic tools due to the high cost of LPS antigen 
extraction and differences in background LPS reactivity among animals (27).  
Analysis of 20 genes highly expressed by L. intracellularis when it resides in the enterocyte 
cytoplasm led to identification of 7 unknown genes whose corresponding proteins are part of the 
outer membrane surface (78). These hypothetical OMPs could play roles in attachment and 
invasion of host cells and thus might be recognized by the immune system of the host. Further 
investigation into their immunogenicity is needed before it can be determined if this proteins are 
critically required for L. intracellularis infection of enterocytes.  
An antigenic and functional study was performed on the flagellin-like protein (LI0570) 
that was recently identified using in silico computational approaches (105). The recombinant 
LI0570 protein was detected in Western blots using mouse anti- L. intracellularis hyperimmune 
sera indicating that this protein is immunogenic (105). Further, HEK-Blue cells incubated with the 
rLI0570 protein led to stimulation of TLR-5 signaling and IL-8 production which implies its 
function in innate immune cell, in-vivo (105). Due to the potential immune-stimulatory effect of 
rLI0570, this recombinant protein have a dual role as antigen and adjuvant and may be an excellent 
candidate to develop recombinant subunit vaccine. 
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1.3 IMMUNE RESPONSE TO INFECTION WITH L. INTRACELLULARIS 
 
1.3.1 Characteristics of the mucosal immune system in the intestine 
The gastrointestinal system is a tubular structure that has evolved to have numerous 
important functions including food reception and storage, propulsive transport, digestion, 
absorption, barrier properties, and elimination/evacuation (106). This tubular structure is lined 
with a continuous layer of epithelial cells positioned on a basement membrane that separates 
epithelial cells and loose connective tissue called the lamina propria. The lamina propria is 
comprised of blood and lymphatic vessels and numerous immune cells organized in mucosal-
associated lymphoid tissue (MALT) or dispersed freely in connective tissue. Beneath the lamina 
propria lies the submucosa which is the layer of dense connective tissue that binds mucosa to the 
smooth muscle layer which is responsible for peristaltic movements. Intestines are segmented 
based on the specific anatomical structures and their role. The small intestine consist of duodenum, 
jejunum, and ileum, which together have a length between 5.5 m to 7 m in humans and 15 m to 22 
m in pigs (107). The human and pig small intestinal anatomy of the small intestine in humans and 
pigs is very similar, with the ratio of body weight to intestine length approximately 10:1 in both 
species, making the pig a good model for human intestinal disease investigation (107). The surface 
area of human intestine has been estimated to be between 300 (108) and 400 m2 (109) (often 
compared to the size of a tennis court) but recent studies showed that the estimated surface area is 
much smaller, around 32 m2 (106). This enormous surface area is due to the presence of small 
intestinal villi that are lined with absorptive and secretory enterocytes which themselves have 
microvilli (cellular membrane protrusions) on their surface. The main role of the intestine is the 
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digestion of food and absorption of nutrients but it also acts as an important barrier between the 
outside world and the sterile environment within the body. The lumen of the intestine is densely 
populated with bacteria which are often referred as commensal bacteria. The terminology is 
designated for two organisms living side by side wherein one organism benefits from the other and 
one organism is unaffected. These luminal bacteria can by defined more precise as mutualist due 
to the fact that both host and bacteria benefit from their relationship (110). The estimated number 
of bacteria in the small and large intestine is approximately 1014 which is 10 times more than the 
total number of cells in the human body (111). They play an important role in nutrient digestion, 
especially for degradation of mammalian dietary components that are not readily digestible by the 
host. The other important role that has been investigated more in recent years is a role in the 
regulation of the immune system of the mammalian host. Recently, evidence points to important 
cross-talk taking place between commensal bacteria and hosts epithelial and immune cells. 
Commensal bacteria promote the proper development of host immune system and provide 
protection against colonization by intestinal pathogenic bacteria. The sheer surface area of the 
intestinal mucosa and the vast number of commensal bacteria present in the lumen provide a 
complex environment for the intestinal immune system. The intestinal immune system has evolved 
to distinguish between resident commensal bacteria and pathogenic bacteria and to provide 
protection against invasion while maintaining the intestinal integrity and normal nutrient digestion 
and absorption. Thus, a major characteristic of the innate and adaptive intestinal immune system 
requires implementing immune tolerance to prevent excessive inflammation. 
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1.3.2 Intestinal innate immunity 
As part of innate immune system epithelial cells and antigen presenting cells comprise the 
first line of defense against intestinal pathogens. The epithelial cells that line the gut wall have 
tight connections between adjacent cells through proteins including claudins, zonula occludens 
and junctional adhesion molecules, which together form tight junction complexes. Tight junction 
complexes prevent the movement of pathogens from the lumen to the lamina propria. Most 
mammals are born with a semipermeable mucosal epithelial layer which is crucial for nutrient 
acquisition and immune cell transport from mother to her offspring. Epithelial cell subtypes 
develop from the intestinal stem cells at the bottom of the intestinal crypts. Proliferating stem cells 
give rise to transit amplifying cells which differentiate in response to cellular signals into Goblet 
cells, absorptive enterocytes, Paneth cells, endocrine cells, and antigen-sampling microfold (M) 
cells. Each epithelial cell plays a specific role in immune regulation and/or maintenance of gut 
barrier.  
The enterocytes belong to the absorptive lineage of intestinal cells responsible for 
absorbing and transporting nutrients from intestinal lumen to blood and lymphatic vessels in the 
lamina propria. They constitute more than 80% of all intestinal epithelial cells and form an 
important physical and chemical barrier that separate mammalian cells from microorganisms 
present in the intestinal lumen (89). They play an important role in maintaining immune gut 
homeostasis and they have mechanisms to detect and react to stimuli from various microorganisms 
in the intestinal lumen. These signals determine the type and magnitude of immune response and 
are crucial for maintaining optimal functioning of the intestinal immune system. 
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Absorptive enterocytes express pattern recognition receptors (PRRs that recognize specific 
conserved molecular structures produced by prokaryotes called pathogen-associated molecular 
patterns (PAMPs). PAMPs are conserved among prokaryotes and they include LPS, peptidoglycan 
and flagella from bacterial cells (112) and viral and bacterial nucleic acids (113). PAMPs bind to 
PRRs to initiate signaling cascades that regulate specific transcription of genes involved in immune 
defense or inflammation (112). 
The absorptive enterocytes express Toll-like receptors (TLRs) and cytoplasmic 
Nucleotide-binding ologomerization domain (NOD)-like receptors (NLRs). The TLRs are 
membrane-bound glycoproteins that recognize PAMPs via leucine-rich repeats (114). Twelve 
mice, ten human (112) and ten porcine TLRs have been described to date. They are expressed on 
innate immune cells such as macrophages, and neutrophils (115, 116), but intestinal epithelial cells 
have also been found to express TLR 1 to TLR 9 (116). TLR 3, 7, 8 and 9 were originally reported 
as localized within endosomes and TLR 1, 2, 4, 5 and 6 were characterized as exclusively 
expressed on the cell surface. The field has evolved to recognize that TLR localization may not be 
conserved across all cell-types and may change in response to stimulation, age, or disease.  
The binding of TLRs to PAMPs initiates signaling cascades (the specifics of which depend 
on the recognized PAMP and its cellular localization) through a cytoplasmic Toll/interleukin-1 
receptor (TIR) domain (115). TIR activation recruits the signaling adaptor proteins, MyD88 
(Myeloid differentiation primary response 88), MAL (Myelin and lymphocyte protein), TRIF 
(TIR-domain-containing adapter-inducing interferon-β) and TRAM (Translocation Associated 
Membrane Protein) and triggers the nuclear translocation of transcription factors such as NFκB, 
activation protein 1 (AP-1), interferon response factor 3 (IRF3) and IRF7 (117). NFκB and AP-1 
act as transcription factors to promote the expression of proinflammatory factors such as tumor 
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necrosis factor-α alpha (TNFα), interleukin IL-1 and IL-8 (118). The transcription factors IRF3 
and IRF7 are responsible for the production of type I interferons, IFNα and IFNβ.  
There are region-specific differences in the localization patterns of the TLRs in the 
enterocytes in the small and large intestine. Colonic epithelial cells express TLRs 1-9 but only 
TLR1-5 and TLR9 have been detected in intestinal epithelial cells of the human small intestine 
and they differ in the level of expression and cell localization (119). Expression of TLR2 and TLR4 
on ileal crypt enterocytes in the human fetus were localized to the basolateral surface (120). TLR2 
was expressed in both the follicle-associated epithelium (FAE) and the IECs of the villi and crypts 
in mice (121). In pigs, TLR localization changes with age. In pre-suckling piglets, TLR2 and TLR9 
expression was detected in the cytoplasm and on the apical surface of M cells but not on absorptive 
enterocytes (122) whereas TLR9 was highly expressed on the surface of enterocytes and FAE 
including M cells in adult pigs (123).  
Uncontrolled inflammation in the intestinal mucosa is detrimental to gut homeostasis and 
prolonged inflammation such as in case of Crohn’s disease or intestinal bowel disease (IBD), can 
lead to serious damage of the intestinal epithelium. Normal adult human colon shows low TLR2 
and TLR4 expression whereas patients with active Crohn’s disease (but not patients with ulcerative 
colitis) have high expression of TLR4 on the apical surface of colonic IECs (124). TLR5, a receptor 
for bacterial flagellin, is localized to the basolateral surface of enterocytes and thus can only bind 
to the flagellin of bacteria that have invaded the cell and traversed the gut barrier (116). By being 
localized away from the luminal surface, the inflammatory response is triggered only when 
microbe invaded through the gut barrier and not in response to commensal bacteria in the intestinal 
lumen.  
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Another large group of PRRs are the NLRs with the important role of sensing PAMPs in 
the host cells cytoplasm. NOD1 and NOD2 are located in the cytoplasm of intestinal epithelial 
cells and macrophages. NOD1 recognize muramyl tripeptides that are components of Gram-
negative bacteria (125) while NOD2 is activated by a specific muramyl dipeptide common to both 
Gram positive and Gram negative bacteria (126). NOD1 and NOD2 binding of their ligands leads 
to induced transcription of proinflammatory genes through adaptor molecules RIP2 and CARD, 
which activate NF-κB transcription factor (127, 128). NOD1 and NOD2 are important innate 
immune receptors for the clearance of gastrointestinal infections caused by Listeria 
monocytogenes and Helicobacter pylori (129, 130).  
The IECs contribute to immune protection by transporting secretory immunoglobulins 
across the epithelial barrier. Immunoglobulins are produced in plasma cells located in the lamina 
propria. To become secreted, dimeric IgA complexes bind the polymeric immunoglobulin receptor 
(pIgR) on the basolateral membrane of IECs and are then actively transcytosed to the apical surface 
(131). The pIgR is endoproteolytically cleaved and five extracellular Ig-like domains of the pIgR 
are released with IgA (two IgA bound by J chain) into the intestinal lumen (131). These pIgR 
cleaved components are known as the secretory component (SC) and together with IgA from the 
sIgA complex (131). The SC alone and as part of sIgA has mucus-binding properties, which helps 
to constrain bacteria in the mucus layer, stimulate biofilm formation, and prevent adhesion of 
bacteria to the epithelial surface (131). The SIgA antibodies in mucosal secretions are important 
for maintaining immune homeostasis. They limit contact of microbial and environmental antigens 
with the subepithelial tissue cells and blood vessels, maintain the integrity of the epithelial barrier, 
and influence the composition of the commensal microbiota (131). Recent data suggests that 
PAMPs stimulate expression of pIgR by IECs as part of a homeostatic loop in which the microbiota 
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enhance the production of SIgA, which in turn regulates the composition and function of the 
microbiota (131). Microbiota play an important role in the development of the intestinal immune 
system, including class switching to IgA and maturation of plasma cells (132).  
Goblet cells secrete glycosylated proteins called mucins to form the mucus layer that 
covers the intestinal mucosa. This gel-like substance is formed by MUC2, MUC5, and MUC6, and 
serve as a chemical and physical barrier to the pathogens by binding to proteins to block attachment 
to epithelial cells (86). Beneath this secreted mucus layer is the glycocalyx which tightly adheres 
to the apical surface of enterocytes and forms a dense physical barrier. Membrane-bound proteins 
present in the glycocalyx include MUC1, MUC3A/b, MUC12, MUC13, and MUC17. The 
glycocalyx is almost sterile in mice with only segmented filamentous bacteria (SFB) attached to 
enterocytes via their filaments. In contrast, the secreted mucus layer is home to various commensal 
bacteria that have evolved to thrive in this environment (133). Secretion of mucus is an important 
factor in maintaining the homeostasis of the intestinal mucosa. Disturbance in mucus production 
or secretion leads to increased inflammation and destruction of the epithelial barrier, and these are 
hallmarks of many intestinal diseases such as inflammatory bowel disease (IBD), Crohns’s 
disease, colorectal cancer, intestinal bacterial infections, etc. A signature trait of L. intracellularis 
infection includes increased proliferation of immature intestinal cells, reduced numbers of Goblet 
cells and lower expression of MUC2 (88). MUC2-deficient mice spontaneously developed colitis 
and inflammation-induced colorectal cancers which indicates that this protein plays an important 
role in regulating intestinal homeostasis (134, 135). These data indicate the indispensable role of 
mucin secretion from goblet cells in regulating integrity and proper functioning of the intestinal 
epithelial barrier. Recently it was determined that goblet cells play a role in antigen uptake and 
presentation to DCs in the lamina propria (136). Specifically, goblet cells transport low molecular 
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weight soluble antigens to CD103+ CX3CR1
- lamina propria dendritic cells (136). Upon antigen 
uptake, there is induced production of the non-inflammatory immunoglobulin, secretory IgA 
(SIgA) production, imprinting of gut homing on cognate lymphocytes, and induction of regulatory 
T cells (136). Thus antigen sampling through goblet cells induce immune tolerance and promotes 
in maintenance of gut homeostasis.  
The Paneth cells play an important role in innate immunity of the intestinal mucosa by 
secreting α-defensins, C-type lectins, lysozyme, and phospholipase A2 in the form of granules into 
the intestinal lumen, which provides antimicrobial protection for epithelial cells (137). Paneth cells 
also secrete epidermal growth factor (EGF), WNT3 and the delta-like canonical Notch ligand 4 
(Notch ligand Dll4), which are important signals for proliferating epithelial stem cells responsible 
for epithelial renewal (138, 139). Likely due to their role in secretion of antimicrobial peptides and 
proteins, they have evolved to avoid being sloughed off the villi by instead migrate downwards to 
the crypt bottom (89). 
The enteroendocrine cells constitute only around 1% of the total intestinal cells but they 
play an important role in the secretion of peptide hormones (140). Enteroendocrine cells in mice 
and humans express TLR1, TLR2, and TLR4 which co-localize with serotonin, a marker for 
enteroendocrine cells (141). Induction of these pathogen-sensing receptors leads to secretion of 
secreted peptide hormones such as secretin, gastric inhibitory polypeptide (GIP), serotonin, 
somatostatin, gastrin, and cholecystokinin (CCK). These hormones are important regulators of 
multiple metabolic and physiological processes in secretion of intestine-like fluid and electrolytes, 
intestine motility, blood flow and food intake (142). For example, after stimulation of TLR5 and 
TLR9 with flagellin and CpG oligodeoxynucleotides (CpG ODN), respectively, mouse 
enteroendocrine cells induced secretion of CCK, which lead to induced of gallbladder and small 
 
 
51 
 
intestine contractions (143). Recognition of PAMPs by enteroendocrine cells might aid in 
clearance of lumen pathogens by increasing peristaltic movement of the intestine and enhancing 
evacuation of lumen content.        
The M cells are modified epithelial cells that shuttle antigen from the lumen to the lamina 
propria. They are situated above the gut-associated lymphoid tissue (GALT) that includes isolated 
lymphoid follicles (ILFs), Peyer’s patches in the small intestine and their equivalent in caecum 
and colon, and isolated lymphoid follicles (ILFs) (144, 145). The M cells constitute approximately 
10% of the epithelial cells among these FAE (146), which are distinguished from other IECs by 
the presence of a much thinner glycocalyx, short, irregular microvilli and large openings on their 
surface. M cells have unique role in phagocytosis and transcytosis of gut lumen macromolecules, 
antigens, and pathogenic or commensal microorganisms through the epithelial barrier (144). The 
M cells deliver antigens across the FAE basolateral membrane to lymphocytes and heterogeneous 
populations of macrophages and classical DCs (147, 148). They transport antigens in endocytic 
vesicles and deliver them by exocytosis to DCs in the intraepithelial pocket of GALT structures 
but M cells do not process the antigens. While this transportation process is an important initial 
step in the induction of some mucosal immune responses, some pathogens such as Salmonella 
Typhimurium have evolved to exploit these cells to enter the subepithelium (144, 149). In response 
to a single effector molecule secreted by S. Typhimurium which transforms primed epithelial cells 
into M cells, M cells density increases during Salmonella infection to promote its colonization and 
invasion (149). 
There are numerous immune cells located in the  subepithelium that play an important role 
in the gut innate immune response including mast cells, macrophages, DCs, neutrophils, basophils, 
eosinophils, natural killer cells, and γδ T cells (114). These innate immune cells are responsible 
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for capturing and presenting antigen, phagocytosis, cytokine secretion and induction of adaptive 
immune response, which all contribute to the clearance of pathogen and restoration of immune 
homeostasis. The gut innate intestinal immune cells have some characteristics that distinguish 
them from their counterparts in other systems of the organism. They protect the intestinal tissue 
from pathogen invasion but at the same time recognize and tolerate a vast variety of food and 
commensal antigens that are constantly present in the intestinal lumen (150). The innate immune 
cells control inflammation and control both innate and adaptive cell function to avoid excessive 
inflammation and tissue damage. They are an important link between the innate and adaptive 
immune response but they also influence the other systems, such as blood and lymphoid system, 
with their secreted products.  
Macrophages and DCs are related in lineage and they differentiate from a common bone 
marrow precursor. They migrate into different parts of the body and acquire their characteristic 
phenotypes under the influence of secreted products within the local microenvironment. 
Differentiated macrophages and DCs are involved in the defense against pathogens by antigen 
uptake and presentation, production of cytokines and by induction of adaptive immunity (151). 
Subsets of these cells such as those found in the intestine are also capable of secreting anti-
inflammatory cytokines such as IL-10 and transforming growth factor beta (TGFβ) that suppress 
inflammation and initiate tissue repair. Within tissues, the function of macrophages and DCs 
overlap and they share many similar markers making it sometimes difficult to distinguish between 
them (114). Further complicating their identification and characterization, not all DC markers are 
conserved between mice, human and porcine (114). Small intestinal phagocytes in mice are 
distinguished by expression of specific ligands and; cluster of differentiation (CD). The CD103+ 
subsets of DCs are characterized by expression of the Flt3 ligand and they express CD11chigh MHC 
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class IIhigh while CX3CR1+ subsets of DCs and macrophages are characterized by expression of 
CSF-1R. Macrophages express CD11clow MHC class IIlow (152).  
The macrophage life cycle can be divided into four distinct stages based on function and 
their location: differentiation, priming, activation and resolution (153). Macrophage differentiation 
is influenced by macrophage colony-stimulating factor (M-CSF), granulocyte-macrophage-
colony-stimulating factor (GM-CSF), retinoic acid and lipoproteins (153). After differentiation, 
macrophages migrate into tissues where they undergo priming influenced by the specific cytokine 
environment (153). Activation in the presence of IFNγ leads to “classical” activation whereas the 
presence of IL-4 and/or IL-13 leads to “alternative” activation (114). “Classical” activation leads 
to activation of a Th1-type T cell response and resistance to viral infections (151), while 
“alternative” activation of macrophages promote a Th2-type T cell response with increased 
antibody production. Once mature macrophages encounter pathogen, their PRRs will recognize 
their cognate PAMPs, which in turn leads to increased phagocytosis to clear the pathogen as well 
as secretion of pro-inflammatory cytokines. After the pathogen is cleared, macrophages enter the 
resolution stage, which is characterized by secretion of anti-inflammatory cytokines, clearance of 
cells debris and restoration of homeostasis (153). Intestinal macrophages are characterized by 
lower TLR4 expression than in other tissues (117), thus indicating their specialization to inhibit 
inflammation in response to commensal bacteria and other food antigens encountered in intestine. 
The anti-inflammatory cytokine IL-10 plays an important role in maintaining gut homeostasis, 
partially by promoting the anti-inflammatory capabilities of macrophages. Mice with mutations in 
the IL-10 receptor in intestinal macrophages, but not IL-10 deficient mice, developed severe 
spontaneous colitis (154). Macrophages can also induce tissue repair by secreting  IL-13 and IL-
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4, while suppressing secretion of TNF-α and IFNγ (155, 156). Tregs may be the main source of 
IL-10 in providing immune suppression and homeostasis (157). 
Many pathogens have evolved to exploit immune suppressive trait of intestinal mucosal 
macrophages. S. Typhimurium invades macrophages and avoids their phagocytic activity by 
secreting virulence factors encoded in a SPI2 operon that interfere with cell trafficking (79). The 
SPI2 operon was also found to be expressed in L. intracellularis-infected enterocytes (78) and L. 
intracellularis have also been found in macrophages (158). However, whether they secrete 
virulence factors and survive phagocytosis has not yet been reported (3). Other enteric pathogens 
such as Shigella, Listeria and Rickettsia spp. avoid phagocytosis in macrophages by secreting lytic 
toxins, which help bacteria to escape from phagolysosome into the cytoplasm of the cell (159).  
The intestinal DCs are professional APCs present in GALT and all over the intestinal 
lamina propria (150). They arise from the common bone marrow progenitor for macrophages and 
DCs called the macrophage and DC progenitor (MDP) (160). Further, MDP differentiates into 
common DC progenitors (CDP) which give rise to two main types of DCs: classical DCs which 
specialize in antigen presentation and plasmacytoid DCs (pDCs) that produce IFNα in response to 
viral nucleic acids (161, 162). These heterogeneous cells have different phenotypes in mouse, 
human and porcine and research is still ongoing to characterize the phenotype of each cell species. 
So far, most markers of intestinal DCs have been characterized in mice and humans (Fig.1.4) (150). 
CD103+ CD11b+ DCs are the most abundant subtype in murine small intestine lamina propria, but 
the numbers are reduced in the colon where CD103+CD11b- and CD103-CD11b+ are prevalent 
(163). Porcine intestinal DCs have four main phenotypes based on the expression of CD11R1 and 
CD172a (164). Lamina propria DCs are mainly CD172a+CD11R1+, PP DCs are mainly 
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CD172a+CD11R1- in the subepithelial domes and CD172a-CD11R1- in the interfollicular regions 
(164). The Mesenteric lymph node (MLN) DCs are mostly CD172a-CD11R1+ (164).  
 
 
 
                              (Bekiaris et al 2014, Immunological Reviews Vol. 260: 86–101) 
Figure 1.5. Dendritic cell subsets in the mouse and human intestinal lamina propria. (A) Lamina 
propria (LP) dendritic cell (DC) subsets in the mouse and human can be identified by the differential 
expression of CD103 and the marker CD11b in the mouse or signal regulatory protein-α (SIRPα) in human 
and mouse. The indicated transcription factors have been implicated in regulating the development of each 
of the subsets. (B) Surface markers that can be used to identify human and mouse DC subsets in the 
intestinal LP. Common markers expressed by both murine and human DC subsets are highlighted. (C) Pie 
charts indicating the relative distribution of CD103+ CD11b-, CD103+ CD11b+, and CD103- CD11b+ DCs 
in the murine small intestine and colon (data are a mean ratio from six mice). 
 
The activation of TLRs in immature intestinal DCs promotes DC maturation trough 
changes in cell phenotype, upregulation of MHC II, altered cytokine secretion and antiviral 
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response (164). Activated DCs can recognize and engulf foreign antigens by phagocytosis, 
receptor-mediated endocytosis or by receptor-independent macropinocytosis and 
micropinocytosis. Intestinal DCs can acquire soluble antigens directly from intestinal lumen (155) 
or at the basolateral surface of Goblet cells, which transport low molecular soluble antigens from 
the lumen to the lamina propria (136). Recent experimental data suggest that in the murine model, 
intraluminal injection of fluorescently labeled ovalbumin resulted in high levels of uptake by 
CXCR1high DCs and only minor uptake from CD103+ DCs (165). Migratory DCs express MHC-II 
high and consist of almost equal number of CD103+CD11b+ and CD103+CD11b- and minor 
population of CD103- CD11b+ (166). In turn, CD103+CD11b+ DCs acquire antigenic material from 
CXCR1high macrophages via gap junctions formed by connexion 43 protein expressed on both 
subsets (167). Although these data require further investigation, it highlights the plasticity of 
intestinal DCs and macrophages, which often have overlapping roles. Once activated DCs have 
taken up foreign antigen, they undergo further maturation and express the chemokine receptor 
CCR7 that binds specifically to chemokine ligand, CCL19 and CCL21 chemokines produced by 
cells within the T cell zones of MLN. Mature DCs, therefore, migrate towards the MLN in response 
to the CCL19 and CCL21 gradient. Migration of DCs to MLNs may be influenced by local signals. 
For instance, oral or intraperitoneal administration of TLR agonist in mice resulted in increased 
DC migration from lamina propria to MLN (168). Because each DC subsets express different 
TLRs, TLR activation by PAMPs may result in migration of distinct lamina propria DC subsets 
to MLN to influence the downstream adaptive immune response (150). Once inside the MLN, DCs 
present antigen to T-cells via MHCII and initiate an appropriate adaptive immune response. The 
intestinal DCs have an important and versatile role in the intestinal immune system as essential 
conveyers of signals between innate and adaptive immune response. Migrating mature DCs from 
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various tissues present antigens to T-cells in the lymph node directly. Low molecular weight 
antigens transported in soluble form by the lymph enter the subscapular sinus and go through 
fibroblast reticular cell conduits where they are extracted and taken up by resident follicular DCs. 
Other soluble antigens are taken by macrophages and DCs which carries them into the cortex. 
Follicular DCs transport antigen and present the antigen to MHCII activated Th2-type T cells 
which leads to activation of B cells. B cells can act as APCs and present protein antigens to naïve 
and effector T cells that have been generated by previous antigen stimulation.  
Intestinal DCs induce expression of intestinal mucosal receptors α4β7 integrin and CCR9 
on T- and B-cells in MLN to produce gut-homing lymphocytes (169, 170). How this occurs is not 
completely elucidated but it is known that retinoic acid secretion by epithelial cells is important 
for DCs imprinting (171). Further, intestinal DCs express high levels of retinal dehydrogenase, 
RALDH2, which generates retinoic acid from Vitamin A and induces the expression of α4β7 
integrin and CCR9 on T- and B-cells in MLN (172). The mechanism by which the intestinal DCs 
(an the intermediary cells) communicate to the activated T and B cells is not yet clear but the effect 
is that the activated T and B cells migrate to the lamina propria of the intestine. Intestinal DCs can 
also preferentially secrete IL-10 and TGFβ to promote induction of T regulatory (FoxP3+ iTregs) 
cells or a Th2-type immune response rather than a Th1-type response which has important 
implications in oral tolerance and maintenance of intestinal immune homeostasis (164). An 
additional mechanism to maintain intestinal immune homeostasis is through promotion of the 
generation of IgA-secreting B cells and imprinting of gut-homing of these B cells (170). By 
promoting effector cells differentiation, gut migration of activated lymphocytes from MLN and 
oral tolerance, intestinal DCs are essential regulators of intestinal homeostasis.  
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1.3.3 Adaptive immune response in the intestine 
The mammalian intestinal adaptive immune system has evolved to provide antigen-
specific memory responses to intestinal pathogens, while at the same time maintaining tolerance 
to environmental, food or commensal antigens. Innate immune cells in the intestinal mucosa 
provide necessary signals in response to antigens which is communicated to and impacts the cells 
of the adaptive immune system cells. A dominant form of adaptive immunity in the gut is humoral 
immunity mediated by secreted IgA antibodies, induction of protective cell-mediated adaptive 
immunity mediated by Th17 cells, and induction of Treg cells that promote gut homeostasis and 
tolerance to food antigens (117). 
The PPs and lymphoglandular complexes are the primary inductive sites in the gut, but the 
functions of the isolated lymphoid follicles and cryptopatches are unclear (145). GALT is rich in 
effector T cells and it is the major site of secretion of antigen-specific IgA which is non-
inflammatory (173, 174). The PPs are at the highest density in jejunum and distal ileum with 
species-specific quantity and distribution patterns (175, 176, 177). They have germinal centres 
with B lymphocytes, follicular helper T cells, macrophages and follicular DCs (FDCs) surrounded 
by naïve B cells. Between follicles and intestinal M cells there is a dome region which also has an 
abundant population of B- and T-lymphocytes, macrophages and DCs. Although PPs share similar 
structure and function with lymph nodes, they lack a capsule and afferent lymphatics thus the main 
route of antigen delivery to immune cells is through M cells (178). Antigen is delivered to the 
APCs through M cells which then migrate to PPs to activate cognate T cells. In turn, the activated 
T cells bind to cognate B cells in the germinal centres. Migrating DCs can also carry the antigen 
to the MLN where lymphocytes become activation and receive instructions to home to the 
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intestinal lamina propria. The site of antigen uptake by APCs and the local environment thus 
impacts induction of a specific adaptive immune response.  
 
1.3.3.1 Humoral immunity in the intestine 
IgA is the main mediator of specific humoral immune protection and an important regulator 
of the commensal population (179). IgA antibodies are produced by plasma cells that stem from 
activated B lymphocytes which have undergone class-switch recombination in GALT (179). As 
detailed in Section 1. 3. 2, IgA antibodies are transported through the epithelial cells as dimers in 
which two IgA are joined with the J chain and transported into the lumen via the pIgR (179). At 
the epithelial apical membrane, this complex is cleaved and a small segment of the J chain remains 
associated with the dimeric IgA (referred to as secretory IgA (sIgA)), which is released into the 
lumen. Once in the lumen, sIgA can bind to pathogens or toxins and prevent their interaction with 
intestinal epithelial cells (180). Alternatively, IgA can bind pathogens in the lamina propria then 
bind to pIgR on the basolateral surface of the IECs resulting in transport and the release of the 
pathogen into the lumen. Intestinal IgA antibodies comprise around approximately 70% of all 
antibodies produced in mammals, making it the most abundant antibody class (132). Landsverk et 
al.  2017 reported three subsets of small intestinal plasma cells that secrete IgA in humans 
including the CD19- plasma cells population can remain active for >20 years and may contribute 
to a life-long protection against enteric pathogens (181). Oral vaccination that target activation of 
antigen-specific long-lived IgA secreting plasma cells may be a feasible strategy to induce long-
lasting protection against enteric pathogens while at the same time maintaining necessary immune 
balance in the intestinal mucosa.  
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Since the pioneering work of Craig and Cebra 1971, there has been a general consensus 
that PPs are the main anatomical sites for activation of IgA secreting plasma cells (182, 183). A 
more recent study from Barone et al. 2011 reported that IgA-producing plasma cells are derived 
from GALT germinal centres in humans and that B cell receptor engagement is important for the 
formation of GALT germinal centres (184). The PPs offer an adequate microenvironment for the 
interaction of B cells with follicular DC and local Th2-type CD4+ T cells leading to B cell 
activation and expression of IgM antibodies. Activated B cells then undergo B cell proliferation, 
class switching recombination (CSR), somatic hypermutation (SHM) and affinity maturation in 
the germinal centre (183).  
During T-dependant B-cell activation, B cells take up antigen via the B cell receptor 
(BCR), which is then internalized. Antigen is presented on MHCII to T cell receptor (TCR) with 
co-stimulatory molecule CD40 on B cell binding with CD40L on T cell (179). In response to the 
immunological synapse between these cells and regional cytokines such as IL-4, IL-10 and retinoic 
acid, B cells become activated and cytidine deaminase (AID) expression is induced (179). High 
levels of AID expression were found in PP IgM+ B cells, which suggest that AID may be a major 
contributor required for IgA class switching and production (185). Germinal centre CD4 T cells 
that are involved in the T-dependant mechanism are Foxp3 + Tregs (186), T-follicular helper cells 
(Tfh) (187) and Th17 cells (188).  
The maturation of GALT depends on the presence of commensal bacteria and their 
products; in germ-free mice, where IgA production is impaired although B cells are present in the 
lamina propria (111). The relationship between microbiota and immune cells in GALT is bi-
directional with both host and commensal bacteria cells contributing to immune homeostasis. 
Further, microbiota can promote Tfh-cell generation in the germinal centre of PP and T cell 
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dependent IgA generation and secretion (189). The importance of this synergism of host immune 
cells and commensal bacteria in gut lumen was elegantly shown in a study from Kawamoto et al. 
2014 (186). They reported that differentiation of Foxp3+ T cells into Tfh cells was necessary for 
the IgA production in mouse germinal centres and that the amount and quality of IgAs had a direct 
impact on the diversity and phylogenetic structure of bacterial communities (186). The microbiota 
can promote Tfh cells generation in the germinal centre of PP and T cell dependent IgA generation 
and secretion (189). Findings of Kawamoto et al. 2014 showed that balanced commensal 
populations induced activation of Foxp3+ T cells and IgAs production which together controled 
diversification of stimulatory bacterial species in the lumen (186). This cross-talk between 
commensal bacteria and host immune cells provides a self-regulatory loop that maintains 
important immune balance and health in the intestine (190). It is an interesting biological 
mechanism that does not seek to eliminate existing bacteria to achieve sterile environment, in 
contrast it evolved to maintain coexistence of microbiota and epithelial and immune cells.  
The T-cell-independent activation of IgA producing plasma cells depends on the local 
production of host cells cytokines and membrane components, commensal bacterial signals and 
nutritional chemicals from intestinal lumen (178). TGFβ, a cytokine produced by multiple cells in 
the intestinal mucosa, is an important factor for IgA isotype switching. The intestinal epithelial 
cells, DCs and T cells produce TGFβ but it is currently not clear which cell type is the main source 
of TGFβ, in vivo (179). The importance of TGFβ in CSR was demonstrated in in vivo studies where 
mice deficient for the TGFβ receptor, TβRII, had almost complete loss of IgA (191). The effect of 
TGFβ on IgA isotype switching is aided by IL-2, IL-4, IL-5, IL-6 and IL-10 secretion from 
different intestinal cell populations (132). Further, two cytokines important in regulating CSR are 
B-cell activating factor of TNF family (BAFF) and A proliferation-inducing ligand (APRIL) (132). 
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APRIL is secreted from epithelial cells, DCs, monocytes, macrophages and activated T cells while 
BAFF is secreted from epithelial cells, DCs and monocytes (132). The B cells express receptors 
for these cytokines and when bound by them, initiate CSR and maturation into IgA-secreting 
plasma cells. The DCs activated by microbial antigens produce nitric oxide which stimulates 
expression of TβRII and receptors for APRIL and BAFF on B cells leading to increased CSR 
(192). Commensal bacteria also can stimulate IgA responses indirectly through activation of TLRs 
on epithelial and DCs or directly through their fermentation products in the intestinal lumen. 
Commensal bacteria-derived short acid fat acids (SCFA) were reported to influence antibody 
responses, in vitro and in vivo (193). SCFA production by commensal bacteria depends on the 
amount of dietary fibers in animal food. Mice that had low SCFA production due to low dietary 
fiber intake or mice that lacked commensal bacteria had abrogated homeostatic and pathogen-
specific antibody responses (193). The addition of dietary fibers and SCFAs increased intestinal 
IgA and IgG responses and promoted pathogen-specific response in case of Citrobacter rodentium 
infection (193). The number of IgA+ cells in both small and large intestines were increased in mice 
fed dietary fibers (194). The results from this study shed light on the complex relationship between 
nutritional composition, commensal bacteria and host immune system, which all contribute to 
maintaining immune homeostasis and protection against enteric pathogens. Although this study 
used a mouse model, the results from this study could be extrapolated with confidence to humans 
or pigs due to the conserved biological functions of SCFA across animal species (195).  
The importance of dietary signals in the induction of IgA production is further emphasized 
by the role of retinoic acid in intestinal immune homeostasis. Retinoic acid is a metabolite of 
dietary vitamin A and is produced by intestinal epithelial and DCs. DCs generate retinoic acid 
from vitamin A due to expression of retinal dehydrogenase, RALDH2, and retinoic acid secreted 
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by epithelial cells influence DCs gut imprinting (171). Retinoic acid produced by DCs induces the 
expression of α4β7 integrin and CCR9 on T and B cells in MLN (172). In vitro assays showed that 
retinoic acid induces IgA class switching and IgA production (170) while in vivo experiments 
showed that mice with B cells unresponsive to retinoic acid had significantly less IgA+ B cells in 
germinal centres PPs and reduced IgA+ plasma cells in the small intestine (196). Retinoic acid can 
work in concert with IL-6 produced by DCs and to induce the generation and homing of IgA 
producing B cells from MLN to the gut (170). Even when administered as a supplement in a 
subcutaneous (s.c.) vaccine to mice, the presence of retinoic acid-induced immune responses in 
the small intestine by promoted the gut-homing capacity on T-cells and IgA+ plasma cells in 
inguinal LNs (197). Finally, s.c. immunization with retinoic acid in mice induced a strong immune 
response in the small intestine that protected mice from cholera toxin-induced diarrhea and 
diminished bacterial loads in PPs after oral infection with Salmonella (197). Thus, inclusion of 
retinoic acid as a vaccine component induced a specific immune response (i.e. secretion of antigen-
specific IgA and induced homing of lymphocytes to the small intestine) and may be an effective 
new vaccine strategies against enteric pathogens or a new tool for modulating the immune response 
in case of auto-immune diseases in humans (197). Further research is needed to determine the 
immune properties induced by retinoic acid in different animal species, as well as the dose needed 
for a safe and effective vaccine.  
Activated intestinal plasma cells play important functions in maintaining gut homeostasis 
and protecting against infections mediated by secretion of IgA and cytokines. Secreted IgA 
protects mucosa by the immune exclusion of antigen/pathogen, by regulating antigen/pathogen 
transport and uptake and providing regulation via binding to IgA receptors (198). Due to its high 
degree of glycosylation, IgAs are protected from rapid cleavage which allows to trap antigens in 
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the mucus layer for a relatively long period of time (199). For example, protection against cholera 
toxin (CT), a product of Vibrio cholerae is mediated primarily by sIgA antibodies that block toxin 
attachment to the epithelial cell receptor monosialotetrahexosylganglioside (GM1) (180). 
Furthermore, should an IgA-coated pathogen contacts an epithelial or adaptive immune cell, it may 
initiate crosslinking and activate innate and adaptive immune cells. For example, IgA binds to  
FcαRI (CD89), pIgR, Fcα/μR, transferrin receptor (CD71), Galectin-1 (which is expressed on cells 
involved in regulation of innate and adaptive immune response in the intestine), and the M cell 
IgA receptor (199). The IgA attachment to pathogen surface or to secreted pathogen products 
engage FcαRI present on neutrophils, monocytes, eosinophils, and some macrophages and DCs to 
induce phagocytosis, promote cytokine release, activation of reactive oxygen species and trigger 
antibody-dependent cell-mediated cytotoxicity (199). Interestingly, IgA-producing plasma cells 
influence composition and diversification of intestinal commensal bacteria (200, 186) . An in vivo 
study showed that 24-74% of commensal bacteria in the feces of healthy humans are coated with 
IgA, significantly more than with IgG or IgM (201). A more recent study in children found that 
children with intestinal dysbiosis such as coeliac disease have a skewed commensal bacteria 
population and reduced IgA-coated bacteria compared to healthy individuals (202). The plethora 
of immune functions of sIgA in mucosal tissues indicates its importance in protection against 
microbial pathogens and at the same time its key role in maintaining the mucosal immune 
homeostasis and balance between commensal bacteria and nutrients present in the intestinal lumen.  
IgA+ plasma cells secrete inducible nitric oxide synthase (iNOS) and TNFα which are 
important for IgA production and gut homeostasis at steady state and after challenge with a gut-
tropic pathogen (198). The study from Fritz et al  showed that B cell-derived iNOS and TNFα play 
an important function in the generation of IgA+ plasma cells (203). iNOS is an intracellular enzyme 
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that works as a catalyst in a reaction which utilizes nutritional L-Arginine to produce nitric oxide 
and L-citrulline (204). Nitric oxide is an important regulator of cellular metabolism, inflammatory 
cytokine production, survival and chemotactic signals (198). iNOS activation and nitric oxide 
production is required for differentiation of Th17 and Treg cells (205, 206) and it controls 
expansion of activated CD4+ Th1, Th2, Th17 -type T cell pools as well as CD8+ cells in lymph 
nodes (207, 208, 209). B cells only produce TNFα after they have first been activated by antigen 
and then activated by CD40L presented on Th2-type T cells (210). It was also reported that TLR1/2 
activation of CD27+ memory B cells produces TNFα, GM-CSF, and G-CSF (211) and TLR1/2, 
TLR7, and TLR9 stimulate CD19+ B cells to produce cytokines IL-1α, IL-1β, IL-6, TNF-α, IL-
13, and IL-10, and chemokines MIP-1α, MIP-1β, MCP-1, IP-10, and IL-8 (211). Activated B cell 
and plasma cell-secreted cytokines exert important immune regulatory roles on the mucosal 
environment and they are crucial components of the local immune system for protection against 
pathogens. 
 
1.3.3.2 Adaptive cell-mediated immunity in the intestine 
Adaptive cell-mediated immunity is mediated by T cells present in GALT including the 
intestinal epithelium. T-cells are differentiated by the expressed surface receptors CD4+ and CD8+ 
cells. CD4+ T cells can be distinguished into distinct subsets by their distinct effector function and 
cytokine secretion in response to the antigen presented on APCs or cytokines secreted in the 
intestinal epithelial environment. They play multiple roles in immune protection against intestinal 
pathogens and they play an important role in maintaining gut homeostasis in an environment rich 
in food and commensal antigens. Failure of T cells to maintain one of these functions due to genetic 
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alterations or as an aberrant response to infection can lead to inflammatory disease and damage to 
epithelial tissue in GALT.    
CD4-expressing helper T (TH) cells and CD8-expressing cytotoxic cells originate from the 
thymus as precursors without a defined effector function (212). T-lymphocytes have a unique T 
cell receptors (TCR) on their surface. The  pool of TCRs are such that they can recognize an almost 
unlimited number of antigens but only one TCR is present on each T cell. CD4 helper T cells (TH) 
recognize antigens presented in major histocompatibility complexes class II (MHCII) after 
processing by APCs (212). CD4+ TH cells further differentiate into effector cells with specific 
functions in TH1, TH2, and TH17 immunity with cellular plasticity in intestinal tissue (213). CD4+ 
regulatory Foxp3 expressing T cells (Tregs) are a subset of T cells that play a major factor in 
immune regulation and tolerance and a high proportion of these subsets reside in intestinal lamina 
propria (178). CD8 expressing cytotoxic T cells recognize antigens presented in MHCI on host 
cells, deriving from viral or intracellular bacterial pathogens that infected host cells. When CD8+ T 
cells engage with MHCI presenting intracellular antigen, they are activated and they differentiate 
into effector cells which results in the production of IFNγ or they have cytotoxic activity directed 
towards infected cells. 
The gut epithelium is home to an abundant population of CD8+ T cells located in between 
epithelial cells or dispersed in underlying tissue (190). The CD8+ T-cells are distinguished by 
expression of αβ or γδ TCRs, which determines their specific localization and role in the intestinal 
immune system (214). The γδ T-cells are intraepithelial lymphocytes (IELs) while αβ T-cells are 
located in the lamina propria. Subsets of γδ T-cells are present in low numbers in the circulation 
but they are abundant in epithelial tissues and constitute between 10–100% of T-cells in the 
epidermis of the skin and the epithelial tissues in gastrointestinal tract (215). They play an 
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important role in maintaining epithelial barrier, regeneration of epithelium, homeostasis and 
providing a balance between commensal tolerance and pathogen clearance (215).  
Human and mice subtypes of γδ T-cells are well characterized and two nomenclature are 
used today, the German and Heilig & Tonegawa nomenclature (215). The murine γδ T-cell subsets 
are characterized by Vγ whereas human γδ T-cell subsets are distinguished by Vδ usage (215). A 
porcine subpopulation of  γδ T-cells express CD2 and in combination with CD8α three different 
subsets can be defined as CD2+CD8α+, CD2+CD8α- and CD2-CD8α-  (214). The development of 
γδ T-cells in mice starts in the thymus during the embryonic stage and they migrate to the intestine 
before birth as influenced by the expression of CCR9 (which is the receptor for CCL25) and α4β7 
(which is the integrin which binds MAdCAM-1 receptor) (215). Secretion of cytokines in local 
tissue has an important effect on IELs maturation and function. Mice deficient in IL-7 or IL-7R in 
thymic tissue lack γδ T-cells implying the importance of this cytokine and receptor on γδ T-cell 
generation (216, 217). Also, IL-15 deficient and IL-15R-deficient mice have no Vγ5+ IEL residing 
in intestinal epithelium which implies that intestinal epithelial cell-derived IL-15 plays an 
important role in proper localization and tissue tropism of γδ T-cells (218).  
The intestinal γδ T-cells are nested between two epithelial cells such that they are able to 
monitor and react to the signals coming from enterocytes or bacteria from the lumen. They are 
motile and can move between epithelial cells to actively surveying the environment (215). It has 
been reported that activated γδ T-cells maintain epithelial homeostasis and tissue repair by 
secreting keratinocyte growth factor 1 (KGF-1), which induces proliferation of epithelial cells in 
crypts (219). The importance of γδ T cells in epithelial homeostasis and repair was shown in a 
study with mice model of chemically induced colitis with dextran sodium sulfate (DSS) (220). 
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DSS in TCRδ−/− or KGF-1-deficient (KGF1−/−) mice had increased tissue damage and the repair 
of damaged epithelium was significantly reduced compared to the wild-type (WT) mice (220).  
The intraepithelial γδ T-cells play a major role in limiting access of luminal pathogens and 
commensals to the subepithelial tissue. Due to their intraepithelial and basolateral location, they 
can sense invading microbes and effectively communicate with epithelial cells and other immune 
cells to clear the infection. Small intestinal γδ T-cells express cytolytic proteins such as Granzyme 
A and B, suggesting a potent cytotoxic effect against pathogens and infected cells (221), but other 
studies reported that porcine γδ T-cells do not express perforin (222). Early in vitro experiments 
found that small intestinal γδ IEL express Th-1 type T-cell markers and upon ligand binding, they 
destroy target cells by cytolysis (223). A major finding in a study by Ismail et al. 2011was that γδ 
IEL responded to invasion by resident pathobionts, and exogenous overt pathogens (224). Further, 
they established that bacterial stimulation of γδ IEL was indirect, and required activation of 
MyD88 signaling in neighboring epithelial cells (224). Salmonella Typhimurium invaded 
epithelial cells and induced neighboring γδ IEL to express innate antibacterial effectors such as 
lectin RegIIIγ (224). The activation of γδ IEL provided critical antibacterial protection of the 
mucosal surface, especially during the first hours following S. Typhimurium exposure thus 
suggesting an important role of γδ IEL at the inception of the immune response (224). This study 
did not reveal whether antibacterial factors such as RegIIIγ and RegIIIβ were the main protective 
molecules that directly inhibited bacterial epithelial penetration or whether cytolytic functions of 
IELs were responsible for the removal of S. Typhimurium infected epithelial cells (224). 
Activated IELs in the skin and/or gut can generate significant amounts of biologically 
active soluble mediators, including granzymes, cytokines, and chemotactic factors, thus enhancing 
the immune response (225). In response to viral infection, IELs respond with the secretion of IFNγ 
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and cytotoxic activity specifically against virus-infected cells in culture (226, 227). Activated IEL 
induce the upregulation of IFN-stimulated genes (ISGs) and antiviral response in intestinal 
epithelial cells in vitro, which was linked to the production of type I, II and III IFNs (225). Also, 
epithelial cells were more impervious to virus infection in vitro when supernatants from activated 
IEL were present (225). When activated T cells induced ISGs in the villus epithelium in mice, it 
correlated with significantly increased resistance to murine norovirus (MNV) within 40 h of 
gastrointestinal infection (225). These findings support the notion that IELs are a bridge between 
innate and adaptive immunity, which facilitate the important transfer of signals from the lumen to 
the lamina propria while maintaining epithelial integrity and protection against pathogens. These 
cells are conserved from fish to humans and have a limited diversity of receptors thus exhibiting 
some innate immune traits. Although lacking receptor diversity, γδ T-cells are able to react to 
stress signals from epithelial cells and conserved PAMPs to induce a protective immune response 
against extracellular and intracellular pathogens. Further research is needed to elucidate all 
molecular mechanisms that contribute to the multiple protective functions of γδ T-cells. 
In addition to the above-presented roles of intestinal γδ T cells in maintaining gut barrier 
and protection against different pathogen, one surprising role of IELs emerged from studies of 
intestinal inflammation. It was reported that IELs are important regulators of inflammation and 
that in different murine models for IBD, celiac disease and colitis these cells suppressed 
inflammation and the cytotoxic effect of αβ T-cells (228). In the murine model of intestinal 
inflammation and colitis, γδ T cells deficient animals had increased levels of IFNγ in the intestinal 
epithelium and aggravated intestinal inflammation (228). These data confirm previous findings 
where the transfer of γδ IEL from WT to TCRδ−/− mice resulted in reduced colitis due to increased 
TGFβ1 production by intestinal IELs, decreased IFNγ expression and protection against 
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inflammation (229). Findings in a murine model of intestinal inflammation correlate to human 
patients with celiac disease where a CD8+ TCR γδ+ NKG2A+  subset of gut γδ T-cells dampened 
the pro-inflammatory (IFNγ) and cytotoxic (Granzyme B) potential of αβ intestinal T-cells (230). 
This anti-inflammatory effect of γδ T-cells was partially mediated through the production of 
TGFβ1 after HLA-E binding to on enterocytes and/or TCRαβ+ IELs (230). These results further 
emphasize the important homeostatic role of IELs in intestinal immunity.  
Currently, three different effector CD4 populations are described based on the specific 
cytokine secreted (231). Th1-type T-cells produce IFNγ cytokine, Th2-type T cells produce IL-4, 
IL-5, and IL-13 (232) and Th-17-type T cell cells produce IL-17. The Th1-type T-cells are 
involved in the eradication of intracellular pathogens such as intracellular bacteria, viruses, and 
some protozoa. They are activated by type I interferons (IFNα, IFNβ) and type II interferon (IFNγ) 
with successive activation of the signal transducer of activated T-cells, STAT-1 and STAT-4 (233). 
This signal cascade induces T-box transcription factor expressed in T cells (T-bet) and IFNγ (231). 
IFNγ is a strong activator of innate immune cells such as macrophages and an inducer of class-
switch recombination of B cells to immunoglobulin IgG isotypes that opsonize microbes for 
enhanced uptake by phagocytes (234). Differentiated Th1-type T cells express surface molecules 
CCR1, CCR5, and CXCR3, which helps them reach sites of inflammation (231). 
The Th2-type T-cells secrete cytokines IL-4, IL-5, and IL-13. IL-4 leads to production of 
IgE antibodies that activate basophils and mast cells for granule release, IL-5 increases eosinophil 
mobilization and IL-13 increases mucous production and hypermotility (234). The effector Th2-
type T cell cytokine secretion facilitates enhanced elimination of parasitic infections, such as 
helminths from intestinal mucosa. When WT mice were infected with Schistosoma mansoni eggs, 
intestinal DCs were engaged and promoted a Th2-type T cell response (235). NF-κB1 expression 
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within DC induced production of IL-4, IL-5, and IL-13 in the draining lymph node of WT mice, 
while NF-κB1−/− mice did not express Th2-type T cell cytokines and developed a polarized 
antigen-specific IFNγ response (235). The importance of signals from invading parasites on the 
Th2-type T cell response in humans is shown in the findings that Th2-type T cells are almost absent 
from intestine from people living in countries with good sanitation with limited exposure to 
helminths (231).   
Th17-type T-cells were discovered as a subset of effector CD4 cells that play an important 
role in mucosal immune regulation and protection. They play a pivotal factor in many 
inflammatory and autoimmune diseases that can have devastating effects on mucosal tissues. 
Th17-type T-cells are characterized by the production of the IL-17 family cytokines, IL-17A and 
IL-17F (236) which induce neutrophil production by regulating the expression of G-CSF and IL-
8 on innate immune cells and epithelial cells (237). Th17-type T-cells also produce IL-22 and GM-
CSF (237). IL-22 belongs to the IL-10 cytokine family that facilitate maintenance of epithelial 
barrier integrity in gut, lung, and skin, and GM-SCF promotes the enhanced production of 
granulocytes and monocytes in bone marrow (234). Differentiation of Th17-type T cells from 
naïve CD4+ cells is induced by co-stimulation with TGFβ in mice (238) or IL-1β in humans, as 
well as  IL-6 (239), IL-23 and local molecular signals such as nitric oxide (205). Th17-type T-cells 
are present in great numbers in intestinal tissue and are the dominant adaptive immune cells that 
respond to extracellular bacteria and fungi (240). Interestingly, germ-free mice do not have CD4+ 
Th17-type T-cells in the intestine and IL-7 and IL-22 secreting Th17-type T cells are induced with 
the introduction of SFB in the intestine (241). SFB-colonized mice had increased expression of 
genes associated with inflammation and anti-microbial defenses which resulted in improved 
resistance to the murine intestinal pathogen C. rodentium (241). A recent study revealed that a 
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central role in regulating the relationship between SFB and Th17-type T cell is facilitated by IL-
17RA, a receptor on epithelial cells (242). Mice deficient for IL-17RA had increased SFB numbers 
due to decreased expression of α-defensins, Pigr, and Nox1 (242). Also, IL-17RA-deficient mice 
had a significantly lower concentration of sIgA in the intestinal lumen which may suggest that IL-
17RA is required for expression of pIgR and IgA secretion to intestinal lumen (242). The 
regulation of pIgR by Th17-type T-cells was also reported in association with mucosal immune 
protection against intestinal parasite Giardia (243). Furthermore, when experimental autoimmune 
encephalomyelitis was induced in IL-17R signaling-deficient mice, they exhibited increased 
intestinal Csf2 expression and elevated systemic GM-CSF cytokine concentrations, which resulted 
in exacerbation of autoimmune disease (242). Experimental data in mice regarding immune cross-
talk between SFB and Th17-type T-cells and immune regulation cannot be easily extrapolated to 
humans due to the relative absence of SFB in the human intestine. It seems rational to speculate 
that in human intestine, other species of commensal bacteria have the same regulatory role as SFB 
in mice due to the high prevalence of Th17-type T-cells in the human intestine. Indeed, studies 
where human fecal matter was transplanted into germ-free mice, revealed that human commensal 
bacteria, E. coli, and Bifidobacterium, were able to induce a Th17-type T response in mice (244, 
245). Induction of Th17-type T-cells was initiated by close adhesion of commensal bacteria to the 
surface of epithelial cells (245). This was also supported by the findings that majority Th17-type 
T-cells, but not other T-cells, identify specific antigens expressed by SFB in mice (209). This 
recognition is dependent on MHCII expression of the antigen by CD11C+ (246) and monocyte-
derived macrophages (247). Upon activation of specific RORγt+ CD4+ T cells, they receive a signal 
from epithelial cells reacting to SFB adhesion. Attached SFB induce epithelial cells to produce 
serum amyloid A (SAA) and ROS which promote IL-17 production and Th17-type T-cells homing 
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to the small intestine (245, 248). This epithelial response is further enhanced by IL-23-dependent 
IL-22 production by the ILC3, and IL-1β production from lamina propria CD11C+ which 
altogether results in amplification of local IL-17 production by Th17-type T cells (245, 248). This 
complex mechanism of Th17-type T-cell immune response activation, mutual dependence of 
commensal bacteria and multiple cells and molecular signals in intestinal tissue presents a 
challenge regarding intestinal inflammatory diseases. It appears that the Th17-type T-cell pathway 
is central in the underlying mechanism behind immune-mediated intestinal inflammatory diseases.   
If not controlled by regulatory immune mechanism, the activation of effector subtypes of 
CD4+ T-cells in intestine would lead to continuous inflammation and destruction of intestinal 
tissue. The important regulators of innate and adaptive immune cells and inflammation are T regs. 
Tregs cells are characterized by expression of CD4, CD25, FoxP3 and they constitute 10-20% of 
all CD4+ cells and 20-40% of all CD4+ cells in colon (178, 249). The proportion of FoxP3+ T 
cells compared to effector CD4+ cells is higher in the intestine than in other tissues, which suggest 
their importance in regulating immunity and inflammation in intestinal lamina propria and mucosa 
(178). Recent studies revealed the existence of two subsets of FoxP3+ CD4+ T cells in mice, 
thymically-derived natural (n)Treg cells that co-express neuropilin 1 (NRP1) and Helios and 
peripherally induced (p)Treg cells (or iTreg) which are NRP1-  Helios- Foxp3+ (178, 250). These 
two Treg -type T cell subtypes differ not only in marker expression and induced localization but 
they also have some unique characteristics. The nTreg cells are induced in thymus with the 
engagement of TCR and presence of TGFβ and IL-2 with self-antigen specificity and cell contact-
dependent mechanism of suppression (251). The pTregs are induced naïve T-cells in secondary 
lymphoid organs or inflamed tissue which acquires FoxP3 expression with co-stimulation of 
CTLA-4 and cytokines TGFβ, IL-2 and retinoic acid which are abundant in intestinal tissue (252, 
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251). They recognize self and foreign antigens and facilitate immune suppression with secreted 
cytokines (251). These pTregs are further distinguished by the expression of RORγt on FoxP3+ 
RORγt+, which are more prevalent in the colon, and FoxP3+ RORγt- which are dominant FoxP3+ 
T cell subset in the small intestine (250, 253). Their affinity for a specific region of the intestine 
may represent their specific function in the regulation of the intestinal immune system. 
FoxP3+RORγt+ pTregs are closely connected to the presence of microbiota in colon and germ-free 
mice or antibiotic-treated mice have reduced numbers of FoxP3+ RORγt+ pTregs (194, 250, 253). 
FoxP3+ RORγt- cells are more prevalent in the small intestine and mice fed with antigen free food 
have significantly decreased numbers of these cells in the small intestine, which suggest that 
antigens promote clonal expansion of these cells (194). Also, deficiencies of FoxP3+RORγt+ 
pTregs result in increased intestinal Th2 (254), Th1, and Th17 type T cell responses (250), while 
deficiencies of FoxP3+RORγt- cells lead to greater immune reaction towards dietary antigens 
(194).  
The pTreg cells maintain the immune balance in intestinal tissue by suppressing immune 
responses and maintaining self-tolerance. Multiple mechanisms of pTreg suppression were 
reported from which the production of cytokines IL-10 and TGFβ, and direct contact suppression 
of DC were supported by most studies. IL-10 is responsible for inhibited expansion and function 
of conventional T cells, inhibition of activated macrophages and DCs, and inhibition of pathogenic 
Th17-type T cell responses (255, 256, 257). It specifically binds to IL-10R1 on many innate and 
immune cells (258). The importance of Treg derived IL-10 was examined in the study by Robtsov 
et al 2008. They showed that particular removal of IL-10R expression in Treg cells led to 
spontaneous colitis suggesting that Treg-derived IL-10 plays an important role in preventing 
inflammation at mucosal surfaces (157).  
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TGFβ is a regulatory cytokine that plays an important role in essential physiological 
processes such as embryogenesis, cell differentiation and immune response (259). The TGFβ 
family consists of three members, TGFβ1, TGFβ2, TGFβ3 with TGFβ1 being prevalent type in 
the immune system of mammals (260). It is produced in multiple cells as a latent form that needs 
to be proteolytically cleaved to become active after which it binds to TGF-type I and TGF-type II 
receptors (259). Binding to the receptors initiates phosphorylation of downstream targets and 
activates multiple signaling pathways (259). The central role in this signaling pathway is provided 
by action of SMAD transcription factor (the abbreviation refers to the homologies to the 
Caenorhabditis elegans SMA ("small" worm phenotype) and Drosophila MAD ("Mothers Against 
Decapentaplegic") family of genes), which binds to multiple transcription factors and results in 
diverse cellular responses (261). TGFβ is produced by a variety of innate and immune cells and 
has diverse roles in the regulation of immune response. Although TGFβ is produced by pTreg 
cells, it also has an important function in the transformation of naïve T cells in peripheral tissues 
into FoxP3+ pTreg cells (252). The effect of TGFβ on pTreg differentiation is further aided by T 
cell-secreted IL-2 (262). The induction of pTreg cells is particularly evident at intestinal mucosal 
sites where CD103+ GALT DCs play a major role in inducing that mechanism (259). The 
production of TGF-β and RA from CD103+ cells are prerequisite factors for conversion of naïve 
T cells to pTreg cells in the periphery (263). Other external signals, such as specific bacterial 
species or their products, can initiate pTreg cell differentiation in the intestinal mucosa. Clostridia 
species induce mucosal TGFβ and FoxP3+RORγt+ pTregs formation (264) and short chain fatty 
acids (SCFA), butyrate, and propionate, act directly on CD4+ cells or indirectly via DCs to secrete 
TGFβ and promote FoxP3+ generation in intestinal tissue (178). TGFβ secreted by the intestinal 
lamina propria pTreg cells is a major regulator of effector T-cell differentiation and effector 
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functions. It has a strong inhibitory effect on Th1-type and Th2-type T cell differentiation in vitro 
via downregulation of T-bet and GATA-3 expression (259). It also regulates differentiation of 
Th17-type T cells but it has a dual effect depending on cooperation with other cytokines. TGFβ 
alone promotes FoxP3 expression and pTreg cell differentiation from activated CD4+ cells but the 
addition of IL-6 and TGFβ together in T cell in vitro culture leads to differentiation of effector 
Th17 cells (265). These findings reveal how cytokines can have multiple and diverse roles in 
immune response depending on tissue-specific signals and external factors. Additionally, TGFβ 
plays an important role in CSR such that mice deficient for the TGFβ receptor TβRII have 
diminished IgA production (191). IgA isotype switching is induced in response to TGFβ in concert 
with other cytokines such as IL-2, IL-4, IL-5, IL-6, and IL-10 from different intestinal cell 
populations (132). This response again highlights how the effect of one cytokine is influenced in 
the context of multi-cytokine environment.  
As well as mediating suppression through cytokine secretion, pTreg cells also exert 
suppression of NK cells, DCs, macrophages, monocytes, neutrophils, T and B cells by direct 
contact (266). pTreg cells express CTLA4 and TIGIT (T cell immunoreceptor with Ig and ITIM 
domains) which directly act on DCs to inhibit expression of CD80 and CD86 which leads to IL-
10 secretion and suppression of effector T cells (267, 268). In return, DC antigen presentation and 
the local abundance of TGFβ, IL-2, and retinoic acid in intestinal lamina propria favours pTreg 
cell generation (251). There is a feedback regulatory loop between DCs and T reg wherein loss of 
DCs leads to a loss of Treg cells and/or the remaining Treg cells exhibit decreased Foxp3 
expression (269). DC-dependent depletion of Treg cells leads to increased number of effector T 
cells and the production of inflammatory cytokines, such as IFNγ and IL-17 (269). Furthermore, 
increasing number of DCs leads to increased number of Treg by a mechanism that requires MHCII 
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expression on DCs (269). This mutual dependence and regulation of Treg cells and DCs is a 
dominant mechanism in gut mucosal tissue. In vitro assays showed that lamina propria and MLN 
CD103+ DCs are able to promote the generation of CD4+FoxP3+ cells from naïve CD4+ cells by 
production of retinoic acid (263). On the contrary, CD103- DCs can convert naïve CD4+ cells to 
effector cells and induce secretion of pro-inflammatory cytokines (263). A study from Manoharan 
et al 2014 showed that DCs cells ability to regulate induction of Treg cells relies on TLR2 signaling 
via AKT activation of β-catenin/T cell factor 4 which induces expression of  IL-10 and 
retinaldehyde dehydrogenase 2, and suppresses expression of pro-inflammatory cytokines (270). 
Knock out of β-catenin gene from DCs induces Th17/Th1-type T cell generation in response to 
zymosan (270). This activation mechanism of β-catenin in DCs via TLR2 stimulation is suggested 
to be a mechanism of controling autoimmune inflammation (270). 
Additional mechanisms of Treg-induced suppression of effector cells and in regulation of 
inflammation have been reported. Treg cells express CD39 and CD73 (two ATP 
diphosphohydrolases) which degrade ATP to adenosine via an AMP intermediate (271). Also, 
Treg cells bind IL-2 in higher capacity and therefore can out-compete effector cells for this 
essential T cell activation cytokine (272). Discovery of the novel Ebi3–IL-12a heterodimeric 
cytokine, interleukin-35 (IL-35), revealed an additional tool for Treg dependent immune 
suppression as  ectopic expression of IL-35 can regulate activity on naive T cells and suppresses 
T-cell proliferation (273).   
Although immune suppression and self-tolerance is an essential process during steady state 
and tissue repair, increased activation of pTreg was reported in cases of chronic viral, bacterial and 
parasitic infections. It was found that Helicobacter pylori infection-induced activation of antigen-
specific CD4+CD25+ regulatory T-cells, which suppressed memory T-cells in the gastric and 
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duodenal mucosa (274). Higher numbers of CD4+FOXP3+T cells were found in areas of duodenal 
gastric metaplasia in the ulcer patients compared to duodenal gastric metaplasia of asymptomatic 
individuals and in healthy mucosa (275). Interestingly, pathogen-specific Treg cells were induced 
in response to chronic Listeria monocytogenes infection of mice but authors reported that L. 
monocytogenes infection selectively primed for proliferation, expansion and subsequent 
contraction of L. monocytogenes specific Foxp3- effector CD4+ cells (276). Additionally, this study 
found that the numbers of L. monocytogenes-specific Foxp3+CD4+ regulatory cells stayed 
unaltered (276). The authors concluded that selective priming and expansion of Foxp3- CD4 T 
cells is a distinctive characteristic for acute bacterial infection (276). Taken together, these studies 
indicate that there was pathogen-specific induction of a distinct subset of Treg cells which favours 
pathogen persistence.  
Each effector CD4+ subset is activated by antigen presentation by APCs. The local tissue-
specific cytokines present during APCs internalization of antigen leads to changes in the APC’s 
molecular signals, which manifest as secretions of specific cytokines that in turn influence CD4+ 
T cell differentiation. APC-derived cytokines induce transcriptional cascade that regulates specific 
effector T cell differentiation with their own characteristic cytokine signature profile. These CD4+ 
T cell-derived cytokines maintain the specific lineage self-preservation through positive feedback, 
and they regulate suppression of other lineages (231). Furthermore, effector CD4 T cell-derived 
cytokines enhance the activation and effect of specific innate immune cells responsible for the 
eradication of specific antigen. For example, Th1-type cell-derived cytokines induce 
monocytes/macrophage phagocytosis and inflammation to destroy intracellular pathogens or 
cancer cells; Th2-type cell-derived cytokines attract and activate eosinophils, basophils and mast 
cells to fight off parasites, and Th17-type T cells recruit neutrophils and enhance their killing effect 
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of extracellular bacteria and fungi (234). Although this is a widely accepted division of CD4+ 
lineages, recent research into their development, phenotype and functions revealed that CD4+ T 
helper cells may have plasticity which results in some phenotypically and functionally 
intermediate subtypes. It was reported that Candida albicans-specific Th17-type T cells produced 
IL-17 and IFNγ, but not IL-10, whereas Staphylococcus aureus-specific Th17-type T cells 
produced IL-17 and were able to produce IL-10 after re-stimulation (277). Cytokines IL-6, IL-23, 
and IL-1β produced by activated APCs promote Th17-type T cell differentiation as a response to 
both pathogens, but IL-1β secretion was crucial in C. albicans-induced Th17-type T cell 
differentiation to oppose the inhibitory activity of IL-12 and to prime IL-17/IFNγ double-
producing cells (277). Further, this study showed that IL-1β inhibited IL-10 production in 
differentiating and in memory Th17-type T-cells, whereas blockade of IL-1β in vivo led to 
increased IL-10 production by memory Th17-type T cells (277). This Th1/Th17-type T-cell 
plasticity plays an important role in the inception of inflammatory diseases in the intestine. The 
implication of intermediate Th lineage in colitis was studied using a Th17-type T-cell transfer 
model of colitis (278). This study found that IFNγ–deficient Th17-type T cells retained an IL-17A+ 
phenotype and were unable to induce colitis in recipients and that development of disease required 
the transition of a subset of Th17-type T-cells precursors to Th1-like T-cells (278). Both STAT4 
and T-bet were highly expressed, but not the IL-12 or IFNγ receptors. It was suggested that Th17-
type T-cells may induce signals for the development of pathogenic Th1-type T-cells from naïve 
precursors (278). From these result, authors concluded that Th17-type T-cells are important factors 
responsible for colitis pathogenesis acting in two ways: by directly transitioning to Th1-like T-
cells and by supporting the development of classic Th1-type T-cells (278).  
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As well as the above-explained role in inflammation and pathology, change of phenotype 
and cytokine secretion of Th17-Type T-cells has also been reported during immune homeostasis 
and suppression of inflammation. In a study using two new fate-mapping mouse models, authors 
showed that CD4 T-cells that formerly expressed IL-17A had the ability to change phenotype and 
become anti-inflammatory CD4 Treg cells (279). This change was depicted in a complete shift of 
transcriptional profile from Th17-type T-cells into regulatory T-cells with the important role of 
canonical TGFβ signaling and consequently of the aryl hydrocarbon receptor (AhR) in this 
conversion (279). This study showed an important mechanism of Th17-type T cells trans-
differentiation into regulatory cells, which led to the resolution of inflammation and restoration of 
immune homeostasis (279). 
 
1.3.4 Immune response to infection with L. intracellularis 
(Modified version of this chapter was used to write a review article “Immune 
response and protection against Lawsonia intracellularis infections in pigs”, Obradovic M. 
and Wilson L. H.; submitting to Veterinary Immunology and Immunopathology)  
L. intracellularis has two clinically distinct forms of the disease, PIA and PHE, which 
differ in severity, clinical symptoms, and ages of animals impacted by them. L. intracellularis 
infection induces distinct immune response with unique cellular and molecular immune patterns 
in the intestine, which are not fully elucidated. Generally, L. intracellularis infection leading to 
PIA promotes induction of a mild immune response with limited infiltration of B cells,  CD8+ and 
CD25+ T lymphocytes in the lamina propria of jejunum, ileum, and colon (Fig. 1.6A, C) (13, 3). 
In pigs that have the hemorrhagic PHE form of the disease, the cellular response is greater but still 
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show moderate infiltration of CD8+ and CD25+ T lymphocytes into lamina propria (Fig.1.6B, D) 
(13). IgA-bound L. intracellularis within intestinal epithelial cells are observed in both PIA and 
PHE (Fig.1.6) (13). Because L. intracellularis is the sole species responsible for both disease 
models without obvious differences in pathogenicity between isolated strains, it is reasonable to 
speculate that different clinical symptoms are due to factors related to the host animal that could 
range from genetic base of immunity of different breeds, age of animals, maturity of immune 
system at time of infection, presence of specific maternal antibodies, parity of sows, presence of 
specific commensal bacteria, nutrition, etc. Changes in immune response and gene expression in 
response to infection have been studied to decipher the complicated host-pathogen immune 
interactions, which impacts L. intracellularis pathogenesis.  
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Figure 1.6. Early mucosal immune response to L. intracellularis infection in PIA and PHE form of 
disease. Ileum of L. intracellularis experimentally infected piglet, PIA form of disease (A) and ileum 
from gilt with a field case of PHE from Saskatchewan (B). In PIA form of ileitis, microscopic changes 
appear as multiplication of immature cells (light blue cells), absence of goblet cells and disturbance of 
normal crypt cell differentiation (C). Mucosal IgA titers and cytokine production against L. intracellularis 
are delayed which may aid to bacterial spread into the lamina propria. At 5 days post-infection (dpi), 
bacteria were detected in lamina propria surrounding heavily infected crypts. After 11 dpi, significant 
numbers of L. intracellularis were detected in the cytoplasm of hyperplastic crypt epithelial cells and in 
the cytoplasm of mononuclear cells in the lamina propria. Innate and adaptive immune responses were 
delayed or very mild, possibly due to the suppression of immune response by bacteria. In PHE form of 
disease (D), inflammation and mucosal hemorrhages is major hallmark of this acute form of ileitis 
disease. Infiltration of macrophages and neutrophils with secretion of inflammatory cytokines into lamina 
propria lead to the characteristic symptoms of PHE and subsequent death of animal.  (Keys for cells on 
Fig 1.3) 
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The precise molecular mechanisms in the bacteria and the contributing environmental 
conditions needed for L. intracellularis invasion are still obscure. However, it is known that L. 
intracellularis can infect small intestinal epithelial cells in as few as 12 h post-infection, and it can 
form discrete foci of bacteria 36 h post-infection (158). At 5 dpi, bacteria were detected in lamina 
propria surrounding heavily infected crypts (Fig. 1.6C) (158). As the infection progresses, bacteria 
multiply inside crypts and by 8 dpi, multiple bacteria were detected in ileal crypt enterocytes and 
in the tip of villi without obvious signs of hyperproliferation of the epithelial cells or inflammation 
(7). In a study from MacIntyre et al 2003, two out of four infected 7 weeks old pigs showed crypt 
epithelial hyperplasia with evidence of neutrophil infiltration between crypt epithelial cells 7 dpi 
but without apparent inflammatory reaction in lamina propria (13). After 11 dpi, significant 
numbers of L. intracellularis were detected in the cytoplasm of hyperplastic crypts and in the 
cytoplasm of mononuclear cells in the lamina propria (Fig. 1.6C) (7). Interestingly, although 
bacteria had been detected in mononuclear cells of the lamina propria since day 5, no evidence of 
inflammation was obvious 11 dpi, indicating that innate and adaptive immune responses were 
delayed or very mild (158, 7). These studies indicate that in the acute phase of infection, L. 
intracellularis thrive in the small intestinal lumen, survive commensal competition, traverse the 
mucus barrier to infect their host cells and avoid the immediate effect of innate immune cells and 
cytokines during initial infection.  
L. intracellularis infection can lead to changes in serum cytokine expression over time. 
For instance, 5 week-old L. intracellularis seronegative pigs orally infected with 5.25 x 108 L. 
intracellularis showed increased serum TNF-α, IFNγ, and IL-6 after 5 dpi which peaked on 10 dpi 
for TNF-α and 20 dpi for IFNγ which remained elevated until 40 dpi, and which peaked on 20 dpi 
and 40 dpi for IL-6 peaked (280). In vivo infection studies were performed to gather data on 
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expression changes in genes that contribute to cell-mediated immunity (281). After 21 dpi, pigs 
enterocytes showed down-regulation of the gene coding for signaling lymphocytic activation 
molecule (SLAM7) (also known as CD2), which is required for T-cell activation (78). This study 
also reported the significant up-regulation of genes encoding MHC-I in infected enterocytes, which 
implies that the molecular mechanism of presentation of L. intracellularis antigens on the 
basolateral membrane of enterocytes was unaltered, and that the cells could present antigens for 
induction of adaptive cell-mediated immunity (78). Microarray and cytokine analysis of field cases 
of pigs with diarrhea showed limited gene expression and limited cytokine secretion in both sera 
and intestine which points to the conclusion that immune response was weakly induced (281). 
Interpretation of this study should be undertaken with caution due to the high prevalence of porcine 
circovirus 2 in intestinal samples which could skew the cytokine expression and interpretation of 
data.  
The root cause of the delayed immune response to L. intracellularis and modest infiltration 
of immune cells at the beginning of infection may lie in the unique way that L. intracellularis 
infects immature crypt epithelial cells. As explained in detail in Section 1.2.4, L. intracellularis 
promote cellular proliferation by altering the β-catenin/Wnt and Notch signaling pathways (84). 
Abundant β-catenin staining was detected in the cytosol and cytoplasmic membrane of crypts at 7 
and 14 days post infection compared to uninfected or resolving crypts (84). β-catenin activity in 
intestinal DCs and macrophages is an important regulator of intestinal homeostasis (282). TLR2-
activated DCs may induce activation of the β-catenin/T cell factor 4 (TCF4) pathway which may 
lead to  DCs production of retinoic acid and IL-10 thus inducing a regulatory state in the intestine 
and inhibiting Th1-type and Th17-type T cell responses (270). In the absence of β-catenin, 
activated Th1- and Th17-type T-cell responses induced uncontrolled inflammation and 
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autoimmunity as a response to zymosan (270). Elevated levels of β-catenin in crypt epithelial cell 
cytoplasm during L. intracellularis infection was not investigated in terms of DCs activation and 
immune response, but increased serum IL-10 from 5 to 10 dpi and TGFβ from 0 to 5 dpi was 
reported in a recent study of systemic cytokine response in pigs infected orally with a South Korean 
strain (280). Although this study examined serum cytokine levels that might not faithfully 
represent local immune response in the intestinal mucosa, a study from Nogueira et al 2013 
reported that a 10-times oral dose of Enterisol® (a commercially available inactivated L. 
intracellulairs vaccine) induced significantly higher levels of TGFβ and TNFα in mucosal 
scrapings compared to pigs administered the vaccine i.m. (283). This 10-times oral dose of 
avirulent vaccine completely protected animals from the avirulent challenge thus these cytokine 
levels may represent an optimal balance between inflammatory and immune suppressive cytokines 
needed to protect against L. intracellularis (283). Serum cytokine levels should be further 
investigated as possible correlates of protection for future vaccine development.  
 Although it has not been investigated directly, one molecular mechanism by which  L. 
intracellularis may initiate proliferation may be due to the β-catenin pathway-dependent activation 
of DCs which could lead to induction of an immune suppressive state in the first days of bacterial 
infection. This delayed or suppressed immune response may help the bacteria to survive, multiply 
and spread inside intestinal crypts. Further studies are needed to elucidate the relationship between 
β-catenin expression, lamina propria DC activation and immune regulation during L. 
intracellularis infection of enterocytes.  
L. intracellularis infection eventually leads to characteristic macroscopic and microscopic 
pathological changes and alterations of immune cell infiltration from 14 to 24 dpi (Fig. 1.7) (7, 13, 
283, 84). By 15 dpi, bacteria spread through small and large intestine with signs of diffused 
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immature epithelial cell hyperplasia in the ileum, cecum, proximal and spiral colon, and jejunum 
(7). During this time, bacterial antigens can be detected in crypt cells and the lamina propria in 
the ileum and jejunum, in the lumen and cytoplasm of crypt cells in the duodenum, proximal and 
spiral colon, cecum and rectum (7), as well as in the lymphoid nodules of submucosa of the 
proximal colon (7). These findings indicate that L. intracellularis were able to spread through the 
intestinal mucosa unrestrained from immune system and by 15 dpi, bacteria had been taken up by 
antigen presenting cells and macrophages in lamina propria (Fig. 1.7). Here they were presented 
to adaptive immune cells in lymphoid tissue, which initiated a specific adaptive immune response. 
These findings confirm previous studies where a significant increase of macrophages with bacteria 
antigen was detected in intraepithelial cells adjacent to heavily infected crypts at 14 dpi (Fig. 1.7) 
(13, 284). The involvement and activation of macrophages may explain the sudden increase in pro-
inflammatory cytokine around this time point reported in the study of systemic cytokine response 
in pigs infected with L. intracellularis (280). TNFα was the first cytokine to be elevated in response 
to L. intracellularis infection with an increase from 5 to 10 dpi, followed by elevated IFNγ and IL-
6 secretion from 10 to 20 dpi (280). These pro-inflammatory cytokines play an important role in 
activation of adaptive immune cells and specific protection against intestinal pathogens but, in a 
case of L. intracellularis infection, the cytokines could also provide a pro-inflammatory 
environment contributing to uncontrolled inflammation in intestinal mucosa and PHE form of the 
disease.  
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Figure 1.7. Mucosal immune response to L. intracellularis infection between 14 and 25 dpi in PIA 
form. The peak of infection corresponds to microscopic changes characterized by excessive proliferation 
of immature cells (light blue cells), absence of goblet cells (green cells in Fig. 1 and 2) and increased of 
numbers of macrophages (pink cells) and dendritic cells with ingested bacteria. The cytokine profile is 
dominated by increased secretion of IFNγ, TNFα and IL-6 while serum concentrations of IL-10, IL-4 and 
TGFβ are reduced. The local humoral immune response is activated and there is increase of secretion of 
specific IgA despite IL-10, IL-4 and TGFβ being reduced. The main source of IFNγ are CD8+ and 
CD4+CD8+ T cells with minor secretion from CD4-CD8- T cells. Towards the end of this period of peak 
of the infection, the regulatory arm of immune response is initiated, characterized by secretion of TGFβ at 
20 dpi and IL-8 and IL-10 at 25 dpi in serum.  
 
From 19-24 dpi, increased evidence of histopathology were evident, especially in the 
jejunum where some studies indicate mucosal necrosis (7). Interestingly, IFNγ and IL-6 cytokines 
in serum concentrations were increasing during the same period while anti-inflammatory cytokines 
IL-4 and TGFβ were decreased until day 20 or until day 25 for IL-10 (280). Furthermore, 
independent studies reported increasing IgA titres in intestinal lavages from 15 dpi, ranging from 
1:4 to 1:16 (7) and 1:4 to 1:64 (285). These data indicate that the adaptive immune system had 
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been activated to clear bacteria from the infected intestinal mucosa. Activation of the adaptive 
immune system is also obvious in ileocecal lymph nodes which showed prominent germinal centre 
and medullary cords filled with plasma cells from 5 to 24 dpi and increased IgA titres in mucosal 
scrapings between 15 to 29 dpi (7). Elevated IgA was present despite histological analysis showing 
reduced B cells numbers in lamina propria during the same period (13, 285, 7). Indeed, by 29 dpi 
most of the bacteria were cleared from intestinal epithelial cells and bacterial antigen was detected 
mostly in the cytoplasm of mononuclear cells in the lamina propria (7). From 35 to 42 dpi, no 
histological lesions or L. intracellularis antigen were detected in intestinal sections indicating 
clearance of bacterial infection and resolution of intestinal homeostasis (Fig. 1.8) (13, 7). Evidence 
of clearance of infection was also represented in serum cytokine concentrations. IFNγ levels had 
increased sharply from 10 to 20 dpi and stayed elevated from 20 to 35 dpi with a small increase 
on day 40 (280). At the site of infection, there was increased numbers of IFNγ producing cells 
detected by ELISpot from 9 to 91 dpi (48). IFNγ is an important cytokine for protection against 
intracellular pathogens and it may be a crucial factor that mediates protection against L. 
intracellularis infection. The significance of IFNγ for mediating protection against L. 
intracellularis was observed when IFNγ receptor knock-out mice failed to resolve infection after 
35 days whereas WT mice cleared infection after 21 days (286). IFNγ producing cells were CD8+ 
and CD4+CD8+ lymphocytes with a small percentage being CD4-CD8- (Fig. 1.8) (284). CD8+ and 
CD4+CD8+ lymphocytes have been reported as the main mediators of immune protection (287) 
but whether cytotoxic T cells, NK cells, or γδT cells are the main source of IFNγ is unclear.  
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Figure 1.8. Mucosal immune response at the resolution of L. intracellularis infection between 26 and 
42 dpi in PIA form. Resolution of infection is characterized by absence of histological lesions, clearing 
of bacteria and restoration of normal crypt differentiated cell population. Serum IFNγ levels are increased 
from 10 to 20 dpi and stayed elevated from 20 to 35 dpi with a small increase on day 40. Increased 
numbers of IFNγ producing cells are detected in the lamina propria, from 9 to 91 dpi. Serum 
concentration of TGFβ, IL-8 and IL-10 are increased. Relative to 14 dpi, total numbers of CD4+ and 
CD8+ cells are not statistically reduced at 42 dpi but there is evidence that there are significantly reduced 
numbers of CD8+ cells in the villous relative to the lamina propria. At resolution of infection at 42 dpi, 
there is a significant reduction in lamina proprial CD3+ cells. Successful resolution of infection and 
subsequent immune protection may depend on the balance between pro-inflammatory and regulatory 
cytokines, IFNγ, TGFβ, IL-10 and antigen-specific IgA titres and immune cells that are responsible for 
their secretion.   
 
At resolution of infection (approximately 42 dpi), there is a significant reduction in lamina 
propria of CD3+ cells (13). Relative to 14 dpi, total numbers of CD4+ and CD8+ cells were reduced 
slightly with no statistical significance compared to 42 dpi but significantly reduced numbers of 
CD8+ cells were evident in the villous relative to the lamina propria (Fig. 1.8)(13). Also, a 
significant reduction of B-cells in lamina propria was detected on day 14 compared to resolved 
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lesions on day 42 pi (13). MHCII staining revealed a reduction in overall amount of MHCII 
positive staining concentrated in the core of the villi and in the lamina propria after 42 dpi 
indicating reduced APCs in the lamina propria during resolution (13). These data indicate that the 
adaptive immune response was delayed up to at least 14 dpi, which may help bacterial 
multiplication and spread throughout the intestine.  
During the period of clearance of bacteria and resolution of gut homeostasis, pigs showed 
an increase in serum anti-inflammatory cytokines such TGFβ after 20 dpi and IL-10 and IL-8 25 
dpi (280). These cytokines play an important role in regulating immune homeostasis by limiting 
effect of pro-inflammatory cytokines and maintaining the intestinal epithelial barrier. Following 
the course of L. intracellularis infection through analyzing the cell population involved, mucosal 
IgA titres and cytokine production against L. intracellularis was delayed during the first 5 dpi 
which helps bacteria to spread and move into the lamina propria. Eventually, the adaptive immune 
system was primed by day 15 and both cellular  and mucosal humoral immunity, represented by 
IFNγ secretion cells and elevated IgA response, respectively, was activated which help clear 
bacteria by day 35. It appears that successful resolution of L. intracellularis infection requires 
adequate and timely activation of regulatory arm of the immune system, involving TGFβ and IL-
10. These cytokines suppress excessive inflammation, downregulate pro-inflammatory cytokines 
and cells and help in the recovery of epithelial intestinal integrity. If the inflammatory response 
was augmented due to increasing pro-inflammatory cytokine secretion or lack of regulatory 
cytokines or cells, L. intracellularis infection led to development of the severe, hemorrhagic form 
of PE, which often leads to acute clinical symptoms and high mortality rates.  
Numerous unresolved questions concerning immune response during the course of L. 
intracellularis infection remain. Although the involvement of serum and mucosal cytokines during 
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infection has been reported, the involvement of Th17-type T-cell immune response is still 
unknown. The Th17-type T-cell response is implicated during immune response against numerous 
enteric pathogens and has importance in regulating commensal bacteria in lumen and gut 
homeostasis but its role in immune response against L. intracellularis has not been fully elucidated. 
IFNγ is an important cytokine in cell-mediated immunity and it could be secreted by different cells 
in intestinal mucosa, not just CD4+ or CD8+ T cells. It was reported that IFNγ could be secreted 
by Th cell population that has a mixed Th1/Th17-type phenotype and therefore the Th1/Th17-type 
phenotype could be implicated in a pathogenic immune response and clinical outcome from 
disease. Further, because intestinal epithelial and innate immune cells express TLR2, 4 and 5 
(ligands of which are present on L. intracellularis), it must be determined experimentally whether 
the respective agonists impact the response to L. intracellularis infection or pathogenesis. 
Molecular mechanisms present in bacteria could play an important role in regulating host immune 
response but secreted or other molecular factors have not yet been reported. IgA plays important 
role in protection against enteric pathogens, regulation of commensal bacteria, and intestinal 
immune homeostasis. Although increased titres of IgA are present in the intestinal mucosa of L. 
intracellularis infected pigs from day 15 to 29 dpi, the extent of protection mediated by IgA is still 
unknown (285, 7) and needs to be clarified.  
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1.3.5 Immune protection against Lawsonia intracellularis infection 
(Modified version of this chapter was used to write review article “Immune response 
and protection against Lawsonia intracellularis infections in pigs”, Obradovic M. and Wilson 
L. H.; submitting to Veterinary Immunology and Immunopathology)  
There are two reported ways to achieve complete immune protection against L. 
intracellularis infection: re-inoculation of pigs with virulent bacteria 10 weeks after primary 
infection or vaccination of animals with live, avirulent vaccine or inactivated vaccine (288, 289, 
283, 287, 290). It was shown that pigs infected orally with 105 virulent or 1010 avirulent L. 
intracellularis developed PPE and resolve infection on their own (288). After 10 weeks, when pigs 
stopped shedding bacteria in their feces, animals were re-challenged orally with 1010 bacteria and 
clinical symptoms such as elevated titres of serum antibodies and fecal shedding were monitored 
(288). Re-challenged animals did not show signs of clinical disease characteristic for PPE nor was 
fecal shedding of bacteria detected by PCR; elevated serum IgG antibodies were detected in most 
of the re-challenged pigs (288). Thus, pigs previously infected with L. intracellularis were 
protected from subsequent challenge for at least 10 weeks with no clinical signs or bacterial 
shedding detected regardless of initial dose of bacteria (288).  
A more recent study using age-matched pigs in the experimental challenge confirmed these 
findings that prior infection protects against subsequent (289). Pigs infected with intestinal mucosa 
containing 1010 L. intracellularis by the oral route then treated with antibiotics followed by oral 
challenge with approximately 1010 L. intracellularis at day 49 after the first infection were referred 
to as re-challenged pigs. Pigs infected for the first time with 1010 L. intracellularis on day 49  were 
referred to as challenge control pigs. Uninfected and unchallenged pigs were also used as control 
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animals. Re-challenged pigs showed lack of fecal shedding of L. intracellularis, low levels of acute 
phase protein concentrations in serum and low levels of bacterial antigen in the intestinal mucosa 
comparable to the challenge control pigs. However, challenge control pigs shed L. intracellularis 
in feces and showed extensive L. intracellularis antigen within all layers of the intestinal mucosa, 
and significant acute phase protein response in serum after the experimental infection relative to 
uninfected control pigs (289). In the challenge control group, serum concentrations of C-reactive 
protein and haptoglobin were increased from 6 dpi, and increased serum concentrations of 
haptoglobin were generally observed 2–3 weeks after primary infection both at 5–6 and 12–13 
weeks of age (289). Re-challenged pigs had a significantly lower increase in haptoglobin and C-
reactive protein then what was observed in challenge control pigs, which may reflect the observed 
protection and lack of clinical disease in re-challenged pigs (289). Acute phase proteins are non-
specific indicators of disease and inflammation and theirs lower levels detected in re-challenged 
pigs may imply that adequate adaptive immune response was able to protect animals without 
eliciting a strong inflammatory response. This study is the first to report elevated acute phase 
proteins in response to L. intracellularis infection and should be investigated as a correlate of 
protection in future vaccine trials (289).  
The same group published the follow-up a study where they evaluated the cell-mediated 
and humoral immune responses in pigs following primary and secondary challenge exposure to L. 
intracellularis (284). They confirmed former findings that the previously infected pigs were 
protected against oral re-infection with bacteria (284). After a second exposure to L. 
intracellularis, animals did not show characteristic clinical symptoms of PE, bacteria were not 
detected in feces and there was a significant reduction in the pathology of intestinal mucosa 
compared to pigs only infected once (284). A second exposure to bacteria initiated stronger 
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memory cell-mediated immune response compared to the primarily infected pigs  and the dominant 
IFNγ producing cells were characterized as CD8+ and CD4+CD8+ double positive lymphocytes 
(284). Results of this study imply that protective immunity against L. intracellularis may be 
mediated by CD8+ effector cells and CD4+CD8+ double positive memory T-cells (284).  
Currently, there are two registered vaccines against L. intracellularis available to prevent 
of PE in pig farms. The first registered vaccine was an avirulent live bacteria developed by multiple 
consecutive passaging of the bacterial isolate B3903 in McCoy cells (291), (Enterisol®, Boehringer 
Ingelheim). The attenuation of virulence was achieved between 20 and 40 passages in vitro which 
is represented by attenuation and down-regulation of important genes responsible for virulence 
and cell metabolism in bacteria (74). The commercial vaccine administered orally to weaners and 
each dose is comprised of 105 bacteria (291). One study showed that after challenge with virulent 
bacteria, vaccinated pigs showed partial protection with a significant reduction in intestinal lesions, 
absence of clinical symptoms, and higher average daily gains compared to the unvaccinated 
control group (291). Although fecal shedding was reduced in the vaccinated group (47% and 40% 
reduction on day 35 and 42, respectively), vaccinated animals still shed bacteria in great numbers 
and therefore may be a source of transmission of L. intracellularis in naïve pigs (291). The 
potential reason for this partial immune protection by the oral vaccine may be due to the low dose 
recommended by the manufacturer that may not be sufficient to induce strong immune response 
when administered to animals in drinking water. Indeed, a study published by Nogueira et al 2013 
compared prescribing the recommended oral dose (104.9 TCID50) to 10-times oral (10
5.9 TCID50) 
and the recommended dose administered via the i.m. route (283). Pigs that received 10-times 
higher oral dose were protected after challenge to a higher level than animals that received the 
other doses (283). Pigs orally vaccinated with 10-times dose showed increased serum and mucosal 
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concentrations of IgM and IgG antibodies, increased TNF-α and TGFβ1 in the intestinal mucosa, 
and a trend towards higher levels of serum IFNγ and IL-6 on day 17 (283). Levels of serum IgG 
titres were increased between day 9 and day 17 for all vaccinated groups and those levels were 
similar for 1x dose oral and i.m. vaccinated animals (283). In contrast, serum and mucosal levels 
of IgA titres were below detection limits in all vaccinated groups (283). To test the protective 
properties of oral and i.m. vaccination against L. intracellularis, vaccinated and control animals 
were challenged orally with 25 ml of a suspension containing around 109 bacteria total (283). 
Vaccination with 1x oral dose induced modest serum and mucosal-scrapings IgG titres but 
vaccination with a 10-times dose resulted in higher titres of L. intracellularis specific IgG titres in 
the first two weeks after vaccine administration (283). After challenge, the control vaccinated 
animals had increased serum cytokines levels of IFNγ, IL-6, IL-10 and TNF-α from day 0 to day 
21 post-challenge and a significant increase in serum L. intracellularis-specific IgG and IgA (283). 
Although all vaccinated pigs in this trial had significantly reduced fecal shedding of L. 
intracellularis after virulent challenge compared to the non-vaccinated control group, animals 
vaccinated with 10-times dose shed significantly fewer bacteria in their feces and had less total 
percentage of ileum affected than the other two vaccinated groups (283). The observed immune 
protection of oral 10-times dose might be attributed to stronger priming of both cell-mediated and 
humoral immunity in intestinal mucosa than a 1x oral dose or 1x i.m. dose. Intramuscular 
administration of 1x dose of live avirulent vaccine was also able to provide protection from virulent 
challenge, as determined by reduced fecal shedding and intestinal pathology (283). This suggests 
that serum antibodies might play role in preventing entry of bacteria into the cells or by ADCC 
(283). The immune correlates of protection after virulent challenge could not be determined in this 
trial due to the high variability of serum cytokines levels of IFNγ, IL-6, IL-10, and TNF-α in 
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vaccinated and control pigs and the absence of correlation between cytokine levels and severity of 
clinical symptoms (283). 
A recent study explored immune correlates of protection by comparing immune responses 
and level of protection after a L. intracellularis challenge of orally vaccinated pigs and pigs 
previously infected with bacteria (287). Both humoral and cellular mediated immune response in 
vaccinated animals were low compared to animals infected with virulent bacteria. Oral vaccination 
with 105 bacteria per dose did not induce elevated antigen-specific IgG and IFNγ levels in serum 
which was in contrast to the previous study of Guedes and Gebhart were they reported 
seroconversion and increased levels of serum IFNγ after oral vaccination (287, 48). These data 
indicate that dose and/or strain dependent induction of immune responses might play a critical role 
in eliciting robust or modest immune responses (283).  
In the second part of the study by Riber et al. 2015, control, vaccinated, and primary 
infected animals were challenged with a virulent L. intracellularis strain (287). The vaccinated 
and control animals shed high levels of bacteria in their feces while no shed bacteria were detected 
in feces of primary infected animals (287). These results confirmed previous findings of 
incomplete protection and shedding of bacteria in animals vaccinated with the 105 oral vaccine 
dose (291, 283). In addition, re-challenged animals had significantly higher induction of antigen-
specific proliferation of CD4+CD8+ and CD8high CD4neg T cells compared to vaccinated group 
(287). Although the IFNγ response was increased in both vaccinated and control groups after 
challenge, vaccinated animals showed induced proliferation of IFNγ producing CD4+CD8neg T 
cells after challenge whereas CD8+ and CD4+CD8+ produced IFNγ after challenge in previously 
infected pigs (287).  
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This difference in the induction of cell-mediated immune response was suggested to be the 
main reason for different levels of protection observed between different groups. One the one hand, 
1x dose of oral vaccine was not sufficient to mount complete protection against virulent challenge 
and prevent bacterial shedding in feces. On the other hand, vaccinated animals showed no 
symptoms of PE, showed significantly less intestinal mucosal pathology and significantly higher 
weight gain than non-vaccinated animals after challenge with a virulent strain. Secondary exposure 
was sufficient and able to provide complete immune protection presumably due to activation of 
cellular immune response mediated by IFNγ producing CD4+CD8+ and CD8high CD4neg T-cells 
(287). These findings suggest activation of memory T-cell in intestinal mucosa that promptly react 
to L. intracellularis invasion and elicit a strong CMI. Further, differences in immune response 
between orally vaccinated and re-challenged pigs reported in several studies may exist due to a 
low dose of vaccine given in drinking water and due to loss of important immune stimulant 
antigens during attenuation of the vaccine strain (283, 287). Increases levels of intestinal IgG, IgM, 
IgA, TGFβ and IL-10 observed after challenge in animals that received the 10-times oral vaccine 
dose may contribute to the clearance of bacteria and promote resolution of infection (283). The 
local humoral immune response and elevated secretion of suppressive cytokines may play an 
important role in protection by controlling inflammation and promotion of restoration of the 
epithelial barrier. Taken together these data indicate that an ideal vaccine should be able to elicit 
balanced immune response where both cell-mediated and local humoral immunity should work in 
concert to eliminate L. intracellularis and control excessive inflammation.  
The second commercially available vaccine against L. intracellularis contains inactivated 
whole cell bacteria in an oil-in-water emulsion and adjuvant based on mineral oil and alpha-
tocopherol (Vitamin E) (290), (Porcilis Ileitis®, Merck Animal Health, Medison, NJ, USA). 
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Protection was assessed under field conditions when the vaccine was administered i.m. to 22-25 
days old pigs immediately prior to weaning (290). The major findings from this study were that 
the vaccine-induced significant serum antibody titres and upon subsequent challenge, vaccinated 
pigs showed a 15-fold reduced bacterial fecal shedding and bacterial burden and microscopic 
lesions in ileum relative to the control group (290). Vaccinated animals had preserved gut integrity 
and preserved goblet cells as detected by unaltered secretion of molecular marker MUC2 and 
positive Periodic Acid Schiff (PAS) staining (290). This study demonstrated that animals 
vaccinated i.m. with the inactivated vaccine showed reduced incidence of disease and severity of 
clinical symptoms of PE as well as reduced colonization and duration of fecal bacterial shedding 
in response to challenge (290). Studies need to be undertaken to determine whether the immune 
correlates of protection include induction of humoral immune response (283, 290).     
In modern pig husbandry, vaccination timing is crucial to achieving protection of the herd. 
Serological tests play important role in seroprofiling and timing of vaccination in naïve animals. 
Results showed that crucial period for infection risk is in the nursery and that optimal period for 
vaccination is between 5 and 8 weeks (292).  
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1.4 ANTIGEN SELECTION FOR SUBUNIT VACCINE DEVELOPMENT  
1.4.1 Bioinformatics and reverse vaccinology 
Vaccines are considered one of the most important public health measures in the prevention 
of both human and animal diseases. The conventional or classical development of vaccines relied 
on biochemical and microbiological methods of isolating, growing, attenuating or killing of 
pathogens and administration of pathogen with or without adjuvants to induce immune protection 
in animals or humans. These methods have changed little since their inception by Dr. Jenner in 
1796 (293), as many pathogens that could be cultivated in the laboratory and that had low antigen 
variability could trigger a protective humoral immune response (294, 293). One notable exception 
to this rule is a vaccine against human hepatitis B virus where the virus cannot be cultured in the 
lab but high titres of the virus can be isolated from infected persons and used to formulate the 
vaccine (295). Examples of successful and protective conventional vaccines include bacterial 
vaccines against tetanus, pertussis, viral-like polio, rabies, and others. Conventional vaccines 
succeeded in the eradication of one human disease, smallpox (296), and one animal disease, 
rinderpest (297). Polio has been very nearly eradicated where incidence has decreased more than 
99 % since the late 1980s (298). Despite this success, conventional design of vaccines has failed 
to develop effective vaccines for many important human and animal pathogens that display 
antigenic diversity, that cannot be cultured in vitro, that lack adequate animal models, and that 
require inducing cell-mediated or mucosal immunity to achieve immune protection (299). 
Development of sequencing technology and bioinformatics during the 1990’s made 
available new tools for exploring microorganisms, which were also applicable in vaccine 
development. Sequencing of the bacterial genome of Haemophilus influenzae in 1995 marked the 
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turning point in the methodology used to explore antigenic characteristics of microorganisms, 
which in subsequent years initiated advances in vaccine development (300). It then became 
possible to use information from genome sequencing coupled with bioinformatics analysis to 
screen for potential antigens present in microorganisms without requiring their cultivation or 
requiring time-consuming and laborious microbiological techniques to isolate and purify antigens 
in quantities adequate for vaccine formulation (301). This new antigen discovery methodology for 
vaccine design was named reverse vaccinology (301). 
The term reverse vaccinology was first proposed by Dr. Rappuoli who identified a process 
of antigen discovery using in silico analysis of pathogen genome sequences using bioinformatics 
and producing recombinant proteins that could be subsequently screened for antigenic and 
immunogenic properties (301). This method was appropriately named because antigen selection 
starts from the pathogen genome and not from an organism itself such as in conventional 
vaccinology. Reverse vaccinology allows for the screening of hundreds of proteins coded in the 
genome for their capability to induce an immune response and to produce antigens (302). The 
prime example of successful application of reverse vaccinology principles is the development of a 
vaccine against Neisseria meningitidis serogroup B (MenB). Conventional vaccinology was not 
able to develop a vaccine against MenB due to similarity of the MenB capsule polysaccharide with 
human polysialic acid. This high degree of similarity resulted in low immunogenicity, high 
variability of antigens across MenB strains, and poor cross-protection (303, 304). Sequencing of 
the complete genome of virulent MenB strain led to the identification of 2158 open reading frames 
(ORFs) (305). The search for new potential antigens of MenB started by screening the whole MenB 
genome and 570 ORFs were predicted to code for surface or secreted proteins (306). A total of 
350 ORFs were found suitable for cloning in Escherichia coli and recombinant proteins were 
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purified, tested for surface localization by FACS and ELISA analysis. The antigens were selected 
based on whether these recombinant proteins were recognized by antibodies and whether they 
could promote protective immunity (306). After completion of this selection process, 90 
previously unknown antigens were discovered, of which 28 were able to induce antibodies (Abs) 
that killed the bacteria (306). In contrast, previous studies using the conventional methodology to 
fraction bacterial extracts for vaccine antigen discovery yielded only 12 MenB surface antigens, 
of which only four induced antibodies with bactericidal activity (302). Five antigens identified by 
reverse vaccinology approach were selected for vaccine formulation: Neisseria antigen 1870 
(GNA1870; which is factor H–binding protein [fHBP]), GNA1994 (which is NadA), GNA2132 
(GenBank accession number NP_275117), GNA1030 (GenBank accession number AAF41429), 
GNA2091 (GenBank accession number NP_275079), and outer membrane vesicles (OMV) from 
the New Zealand MeNZB vaccine strain, which contains the immunogen PorA (307, 299). The 
final vaccine formulation consisted of a fHBP-GNA2091 fusion protein, a GNA2132-GNA1030 
fusion protein, NadA, and OMV and this vaccine which was registered under the name 4CMenB 
and acquired market authorization for the European Union in January 2013 (299, 298). The 
4CMenB vaccine was tested in clinical studies in European countries on a large number of children 
and results showed excellent immunogenicity, safety, and compatibility with pediatric vaccines 
given at the same age (308, 309). Promising results from clinical studies in Europe prompted 
approval of 4CMenB in other countries, including Australia, Canada, UK and USA (310). To 
achieve adequate protection and protective antibodies titres in children, different vaccination 
schedules and doses were proposed. The general conclusion was that infants should receive two to 
three doses before the end of their first year of life and one booster dose after the first year to keep 
protective antibodies titres high (310). Children between 2-10 years should receive two doses in 
 
 
102 
 
not less than 2 months intervals and adolescents and adults should receive 2 booster immunizations 
with the interval not less than one month (310). The 4CMenB vaccine was also successfully 
applied as a preventive measure during two outbreaks at Princeton and Santa Barbara Universities 
in the USA caused by two different clones of MenB (310). Development, clinical trials, successful 
implementation in vaccination schedules of 4CMenB and application for use as a preventive 
measure during outbreaks of meningococcal diseases have demonstrated the enormous potential 
of reverse vaccinology to provide a solution for prevention of bacterial diseases in humans.  
Reverse vaccinology has also been used to develop new vaccines against animal diseases 
such as contagious bovine pleuropneumonia (CBPP) caused by Mycoplasma mycoides subsp. 
mycoides (Mmm), an important disease in sub-Saharan African countries. Reverse vaccinology 
identified 66 candidate proteins that were ranked based on recognition by serum antibody titers 
from CBPP-positive cattle (311, 312). The best candidates were used as vaccines in animal 
challenge trial wherein groups of animals were immunized with five different proteins. Two 
groups of animals were protected from the Mmm challenge with one group showing complete 
clearance of the Mmm from lung samples (312). In a third group, there were a reduced number of 
reported animals with lung lesions and Mmm could not be cultured from lung samples (312). 
Although immunization with the recombinant proteins was able to protect animals after challenge, 
the study also reported that some combination of proteins used for immunization actually increased 
immune-related pathology after the challenge (312). These findings indicate the importance of 
adequate testing of vaccine recombinant protein candidates both in vitro and in vivo experiments 
to select antigens that can confer protective immunity.    
With the development of sequencing and bioinformatics, more data on microorganism 
genomes have become available which has led to a new branch of reverse vaccinology named pan-
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genomic analysis (313). The pan-genomic analysis compares genomes across all strains belonging 
to the certain specific phylogenetic clade. It defines two subsets of genomic repertoire, the core 
genome (i.e. genes shared across all strains of the clade) and dispensable genome (i.e. genes that 
are specific to subsets of strains) (298). This comparative analysis of the genomes applied to 
multiple pathogenic isolates of Streptococcus agalactiae led to the discovery of significant 
interspecies gene diversity and identification of bacterial proteins suitable for vaccine formulation 
to test for protection against multiple strains (313, 314). The comparative analysis of the complete 
genome sequences of eight S. agalactiae strains coupled with bioinformatics yielded 589 genes 
encoding proteins predicted to be expressed on the surface or secreted proteins (314). Of these 
proteins, 396 belonged to the core genome and 193 belonged to the indispensable genome (314). 
After 312 proteins were expressed in E. coli, soluble recombinant proteins were screened as 
suitable vaccine antigens for their ability to confer immune protection in the infant mice model of 
disease (314). After extensive testing, four proteins, one from the core genome and three from the 
dispensable genome were selected as vaccine candidates that could elicit protection against all 
eight circulating strains of S. agalactiae (314). The importance and utility of pan-genome approach 
were also proved in genome analysis of multiple strains of S. pneumoniae which led to the 
identification of genes that encode three previously unknown proteins that form subunits of two 
distinct pili (315). Antibodies raised against these proteins enabled the use of immune-electron 
microscopy to image bacteria and discovery of two types of pneumococcal pili (PI-1 and PI-2) 
(315). Pili are abundant and long filamentous structures protruding from the bacterial surface. 
Because different strains have different types of pili, the global genomic approach was successfully 
used to identify the frequencies of two types of pili and to suggest that a vaccine against multiple 
strains should be formulated to include antigens from both types of pili (316). Additional screening 
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for other vaccine antigen candidates conserved among different strains should be conducted in 
order to achieve comprehensive coverage of all circulating S. pneumococcal strains. The pan-
genomic approach offers great possibilities for screening potential vaccine candidates across 
multiple strains and selecting the best one based on conferred immune protection against all 
virulent strains in circulation.  
Although classical and structural vaccinology have not fulfilled the promise of developing 
protective vaccines against HIV-1, reverse vaccinology principles were successful in developing 
effective vaccines against some human and animal viral diseases. A vaccine against Hepatitis B 
virus registered for human use, RECOMVIVAX HB, is based on recombinant HBsAg protein 
produced in yeast cells and formulated with aluminum adjuvant (Merck. http//merck.com) (298). 
Recently, two vaccines against human papillomavirus (HPV) were approved by the US Food and 
Drug Administration (298)  made from different HPV recombinant proteins produced in yeast or 
insect cells formulated with immune enhancers and adjuvants (317). They show great safety and 
protection against HPV mediated cervical cancer (317). In veterinary medicine, a vaccine against 
West Nile virus registered for use in horses consists of a combination of existing canarypox 
vaccine with genes expressing two proteins from West Nile virus (318, 298). With the 
improvement of bioinformatics and a growing understanding of host-pathogen interactions, new 
vaccines and therapeutics against infectious or other diseases, such as cancer, autoimmune or 
neurodegenerative diseases, could be developed using reverse vaccinology methods.   
Application of reverse vaccinology methodology does not require growing pathogens in 
vitro and does not require inactivation or attenuation of the pathogen. Thus, vaccines developed 
by reverse vaccinology are safe and eliminate the risk of reversion to virulence which is a risk 
associated with live attenuated vaccines (298). By using bioinformatics, we can avoid regions of 
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the antigens which may be potentially toxic, allergy-causing or potentially oncogenic. Subunit 
vaccines developed by reverse vaccinology are economical and easily scalable which appeals to 
the pharmaceutical needs but also offers great efficacy and flexibility for Public Health system 
during infectious diseases outbreaks. Less than two decades of reverse vaccinology has resulted in 
important scientific discoveries and applicable vaccine solutions for a limited number of diseases. 
Future predicted development in bioinformatics and improved molecular techniques has overcome 
many previous vaccine development limitations and lead to development of new vaccines and 
immune therapeutics for a wide range of diseases that currently lack adequate prophylactic or 
therapeutic measures.     
Although reverse vaccinology has been applied successfully in the development of 
vaccines for bacterial and some viral diseases, both in humans and animals, this approach is not 
without its own limitations. Imperfect bioinformatics prediction programs and systemic validation 
including complicated and incomplete in-silico prediction of discontinuous epitopes, difficulties 
using in-silico approaches to predict how sequences translate to functional proteins and whether 
post-translation modifications on the recombinant proteins are critically required are all limitations 
to the reverse vaccinology approach. Other functional limitations are that there are only a small 
number of protein expression systems available to express the recombinant proteins, and each 
protein may have their own difficulties in expression and purification and solubilization of 
recombinant proteins with their natural conformation, which may be critical for immune 
recognition. Disease-specific difficulties may include challenges in comparing multiple isolates of 
pathogen species for multi-strain vaccine protection, incomplete knowledge on the impact of host-
pathogen interactions on protein conformation, and lack of known immune correlates of protection 
for certain diseases. Finally, genetic diversity of the host as well as challenges to discern the ideal 
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route of administration, challenges in overcoming mucosal tolerance for mucosally-administered 
vaccines and the choice of appropriate adjuvants all impact vaccine development that may not be 
overcome simply by using reverse vaccinology approaches (301, 306, 314, 319, 299, 302).  
In addition to reverse vaccinology and pan-genomic selection of antigens, certain bacterial 
proteins could be subjected to in-depth structural analysis by X-ray crystallography or other 
techniques to identify 3D structures. Knowledge of the 3D structure of proteins may lead to further 
advancement in the formulation of bacterial subunit vaccines by selecting antigens that can better 
mimic pathogenic protein shape. This approach was named structural vaccinology in the field of 
bacterial vaccines (320). A subunit vaccine formulated to include these proteins may prevent 
bacterial invasion and thus propagation of intracellular bacteria. Structural vaccinology has been 
expanded to identify HIV-1 proteins that could be used as vaccine against HIV (302). It 
investigated the structure of viral proteins and their importance in immune invasion and as possible 
targets for neutralizing antibodies (321). Although important information on protein and antibodies 
structure were gained, structural vaccinology in HIV-1 research did not lead to success in 
identification of neutralizing antibody targets that could be used in a vaccine  (302). The reasons 
for this failure may lie in viral capacity to evade immune responses during infection, the 
complicated nature of immune recognition and unknown immune correlates of protection for HIV-
1 infection. Structural vaccinology has been applied to both viral and host immune system protein 
structures that are involved during the HIV-1 infection and we anticipate new discoveries that 
could lead to effective HIV vaccines or therapies. Proteins expressed on the pathogen surface that 
are critically required for invasion of the host may be suitable vaccine targets. 
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1.4.2 2-D gel electrophoresis to identify proteins targeted by host immune system. 
2-DE is an efficient analytical tool for separation of complex proteins mixtures from tissue, 
mammalian and bacterial cells, as well as their secretions (322). The commonly used workflow 
for detection of proteins from complex mixtures includes sample preparation or extraction, protein 
separation by 2-DE, protein gel staining, identification, characterization, and quantitation of 
proteins with Electrospray ionization Liquid chromatography–mass spectrometry (ESI LC-
MS/MS) followed by virtual or experimental 2-DE protein database construction (323). The basic 
principle of 2-DE is the separation of proteins in two dimensions. The first dimension is the 
separation of proteins based on their isoelectric point (pI) and the second dimension is separation 
depending on molecular mass (MW) of proteins (322). Both separation steps must have very good 
resolution and can to resolve up to 5,000 protein spots with high degree of accuracy (324). A 
particular advantage of 2-DE analysis and separation power is the ability to visually detect protein 
post-translation and co-translation modifications, which are currently impossible to accurately 
predict using a genomic approach (322). To visualize the resolved protein spots, a gel is stained 
with Coomassie brilliant blue or silver nitrate (323). Coomassie staining is less sensitive (can 
detect ng levels) than silver staining (can detect pg levels) but it has better linearity, accuracy and 
is more compatible for downstream MS analysis (323). The use of formaldehyde as a reductant 
during the developing stage in silver staining could cross-link proteins, which hampers MS 
analysis (325). To overcome this problem, a formaldehyde-free silver staining was developed 
which enhanced compatibility with downstream MS applications (326). In addition to these 
commonly used stains, modern proteomics developed improved methods for protein detection with 
a high agreement with MS, such as using fluorescent stains and colloidal Coomassie blue (G250 
and R250) (327, 328, 329).  
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2-DE is a robust and proven technique that is compatible with other biochemical techniques 
(330) such as Western blot and MS and has been used to detect antigens from bacteria (331, 332), 
cancer cells (333) and fungi (334) that are recognized by the human immune system. The 
resolution and sensitivity of 2-DE is such that it has been used to analyze proteins that have not 
been characterized by other methods, such as nucleolus proteins or secreted proteins from myeloid 
cells secretome (335, 336, 337). Bacterial cells are excellent candidates for 2-DE analysis due to 
their lower complexity compared to mammalian cells which are an essential requirement for 
successful protein separation (330). However, limitations of 2-DE include difficulty in precise 
reproduction of gels and difficulties in separating proteins that are hydrophobic, very acidic or 
basic (322). To achieve highly reproducible gels, it may be advisable to lower the complexity of 
the sample by analyzing specific regions of the bacterial or secreted bacterial products. Bacterial 
culture growth conditions must be constant to avoid metabolic adaptations that could lead to a 
change in protein expression that could contribute to sample variability (330). The problem of low 
reproducibility of IEF was mitigated by the development of immobilized pH gradient (IPG). This 
commercially available pre-casted acrylamide gel matrix co-polymerized with a pH gradient on a 
plastic strip has many advantages over traditional ampholyte method (322). The main advantages 
are the capacity to circumvent cationic accumulation, production of better-focused protein without 
smearing, reduced cathodic drift, higher mechanical strength, higher protein loading capacity and 
commercial availability of different pH ranges and sizes of the IPG strips (322). With the 
improvement of IEF, improved staining of gel and downstream analysis such as MS and the use 
of image analysis software, the only bottleneck left in the 2-DE protocol is sample preparation. It 
is widely acknowledged that the major weakness of 2-DE protocol is the separation of hydrophobic 
and highly acidic proteins, especially low abundant, low molecular weight membrane proteins 
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(330). The problem emerges due to insufficient extraction and solubilization of hydrophobic or 
acidic proteins in IEF buffers (322) which has been somewhat improved with development of 
improved IEF compatible detergents (338, 339, 340, 341). Despite improved solubilization of 
membrane proteins with detergents, effective detection of membrane proteins still remains the 
greatest challenge for 2-DE analysis (330).       
WB analysis and MS add to the analytical power of 2-DE and allows accurate identification 
of targeted proteins. For example, 2-DE followed by MS lead to identification of 310 antigenic 
protein from Helicobacter pylori, 32 of which were bound by hyperimmune serum generated 
against H. pylori (342). Out of these 32 antibody targets, nine were newly identified antigens 
whereas 23 were previously confirmed antigens (342). Another study used 2-DE 
immunoproteomics to identify membrane antigens of uropathogenic E. coli expressed during 
urinary tract infection (343). This study identified 23 outer membrane antigens, together with a 
novel iron compound receptor and antigens that play  important roles in UPEC pathogenesis, such 
as ChuA, IroN, IreA, Iha, IutA, and FliC (343). 2-DE coupled with MS was used to identify 
interactions between membrane complexes of E. coli which yielded 31 proteins with some newly 
discovered interacting proteins (344). This approach identified bacterial outer envelope proteins, 
which can then be functionally proven to play a role in the bacterial membrane, highlighting the 
versatility of this method (344). The capabilities of 2-DE to identify important outer membrane 
proteins and potential antigens from Staphylococcus aureus (345), Streptococcus thermophilus 
(346), extraintestinal pathogenic E. coli (347) and other bacteria (331, 332). These studies 
exemplify the technical capabilities of 2-DE coupled with MS to identify important proteins in the 
outer membrane of pathogenic bacteria which could be selected as promising antigens for vaccine 
formulation.  
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We have adapted 2-DE to resolve L. intracellularis proteins to identify proteins recognized 
by antibodies from hyperimmune serum and to determine which of these immunogenic protein 
bind to host cells.  We predicted that proteins that fit these criteria may be neutralizing antibody 
targets which were then validated experimentally. 
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2. HYPOTHESIS AND OBJECTIVES 
2.1 Hypothesis 
We hypothesize that serum antibodies specific for L. intracellularis can be used to identify 
antigenic bacterial proteins suitable for subunit vaccine development. 
2.2 Objectives 
The main objective is to use functional biological assays to identify proteins in L. 
intracellularis which are the targets of neutralizing antibodies. The identified antigens can then be 
used in a subunit vaccine to promote strong neutralizing antibodies in pigs.  
Objective 1. Developing an assay approach using flow cytometry and qPCR to evaluate if 
antibodies against L. intracellularis can block L. intracellularis penetration of eukaryotic cells and 
subsequent growth, in vitro. 
Objective 2: Using modified 2-D electrophoresis and Mass Spectrometry to identify 
proteins unique to L. intracellularis that are recognized by rabbit hyperimmune serum. 
Objective 3: Perform in silico screening of identified proteins to predict which ones are 
expressed on the bacterial surface followed by cloning of selected proteins into E. coli to produce 
recombinant proteins.  
Objective 4: In vitro evaluation of inhibitory capabilities of sera against recombinant 
proteins on L. intracellularis penetration into porcine intestinal epithelial cells. Compare our 
approach to select Bioinformatics Platforms and evaluate recombinant antigen characteristics and 
potential to formulate subunit vaccine. 
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3. USE OF FLOW CYTOMETRY AND PCR ANALYSIS TO DETECT 5’-
CARBOXYFLUORESCEIN-STAINED OBLIGATE INTRACELLULAR BACTERIA 
LAWSONIA INTRACELLULARIS INVASION OF MCCOY CELLS 
(Journal of Microbiological Methods 126 (2016) 60–66, 
dx.doi.org/10.1016/j.mimet.2016.04.015) 
 
Relationship of this study to the dissertation 
L. intracellularis is obligate intracellular pathogen that has been difficult to precisely 
quantify during infection. Also, evaluation of neutralization properties of sera or other immune 
components on bacterial entrance into the cells have not been investigated completely due to the 
lack of adequate in vitro invasion and quantification assays. Thus in this study, we devise a method 
to quantify invasion of obligate intracellular bacteria, L. intracellularis, inside McCoy cells and a 
method to establish whether antibodies neutralize bacterial adherence or invasion of eukaryotic 
cells. The results of this study suggest that coupling CFSE-labeling of bacteria and qPCR analysis 
can be utilized to detect and quantify bacterial invasion and may be a useful tool for studying the 
invasion of eukaryotic cells by intracellular bacteria. 
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3.1 Introduction: 
L. intracellularis are obligate intracellular Gram-negative bacteria that cause an infectious 
enteric disease known as PE or ileitis. This bacterium is endemic in intensive swine herds all over 
the world (5). PE is a major cause of weight loss and mortality in pigs and represents a significant 
economic burden for the swine industry (6, 47) and it is an emerging pathogen in horses (348). In 
the 1970’s, G.H.K Lawson’s group identified bacteria in proliferative lesions in the pigs suffering 
from PE but it proved extremely challenging to isolate and characterize these bacteria (349). It was 
not until 1993 that the same group managed to isolate these bacteria, establish the in vitro growth 
conditions and confirm that these bacteria were responsible for this disease (31, 4). The bacteria 
were finally characterized and classified as L. intracellularis and their role in the disease was 
established through oral inoculation of pigs (350, 351). The isolation and in vitro cultivation of L. 
intracellularis is still difficult and studying these bacteria in laboratory and field condition is 
limited by current tools and techniques.  
It remains very challenging to detect, track and quantify obligate intracellular bacteria if 
antibodies are not available. Labeling extracellular bacteria with CFSE has been useful in tracking 
the presence and activity of environmental and food-borne microorganism (352, 353, 354, 355, 
356, 357, 358). CFSE staining proved a suitable method for identifying Chlamydia trachomatis 
elementary bodies in human monocytes (359). Because CFSE has minimal effects on bacterial 
adhesion, viability, and metabolic activity, and it is readily retained in bacteria for long periods, 
we predicted it may be useful for quantifying invasion or cellular association of L. intracellularis 
within its host cell. This work was undertaken to critically evaluate whether labeling L. 
intracellularis with CFSE can be used to develop an easy and effective high-throughput method 
to track and quantifying infected eukaryotic cells. Coupled with qPCR analysis and confocal 
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microscopy, we confirmed that the bacteria invaded the host cell and were not merely cell adherent. 
Use of fluorescence activated cell sorting (FACS) allowed for sorting of infected from non-
infected cells for further experimentation. To show that this approach was compatible with 
functional analysis, we introduced hyperimmune serum and measured the impact that antibodies 
had on bacterial invasion and growth. These simple techniques can be adapted for use with other 
obligate intracellular pathogens and are amenable to be used for a myriad of functional analysis.   
 
3.2 Material and methods 
 
3.2.1 Animals and hyperimmune serum.  
All animal experimental procedures were performed in accordance with the Procedures for 
Ethics Review of Animal Use Protocols and approved by the University Committee on Animal 
Care and Supply (UCACS), University of Saskatchewan.  
Two female New Zealand White rabbits (2-3 kg weight) were kept in isolation units in the 
Animal Care Unit of VIDO-InterVac. To generate rabbit hyperimmune serum, rabbits were 
injected via the intramuscular route with the Enterisol® vaccine (Boehringer Ingelheim, 
Burlington, ON) which is comprised of live avirulent L. intracellularis strain. The vaccine 
consisted of 20 mg of Enterisol® was dissolved in 500 μl of vaccine sterile diluent and 500 μl 
Incomplete Freund’s Adjuvant (Sigma-Aldrich, Oakville, ON). Each rabbit was vaccinated on day 
0, 21, and 42. Rabbit hyperimmune sera were collected via exsanguination following euthanasia 
of the rabbits (Euthanyl, Bimeda-MTC Animal Health INC., Cambridge ON, Canada) 60 days 
after the first vaccination. All blood samples were collected using Ethylenediaminetetraacetic acid 
 
 
115 
 
(EDTA) Vacutainers (BD Biosciences-Canada, Mississauga, ON) followed by centrifugation 
(2500 × g) before the serum was stored at −20 °C until use. 
 
3.2.2 Cell culture and bacterial propagation conditions.  
Mouse fibroblast cells (McCoy B, ATCC CRL-1696) were grown in Dulbecco's Modified 
Eagle Medium (DMEM; Life Technologies, Burlington, ON) with 10 % Fetal Bovine Serum (FBS; 
Gibco Life Technologies, Burlington, ON) in a humidified incubator in an atmosphere of 5 % CO2 
and 95 % air at 37 oC in media with 10 μg/ml gentamycin (Bio Basic Canada Inc., Markham, ON) 
and 1 % L-Glutamine (Gibco #25030-081). Cells were passaged two times per week in 1:5 ratio 
in Corning 75 cm2 cell culture flasks.  
Prior to infection with L. intracellularis, cells were cultured in their respective medium 
without FBS or gentamycin for 24 h at 37 ̊C in a mixture of gases (10 % hydrogen, 10 % carbon 
dioxide and 80 % nitrogen gas) in zip lock bags (99). Cells were then co-cultured with L. 
intracellularis (from the Boehringer-Ingelheim’s Enterisol® avirulent live vaccine suspended in 
vaccine sterile diluent as directed) at a MOI of 0.1 with a cell density of 1 x 105 cells per well. The 
number of avirulent L. intracellularis in the vaccine was calculated based on data published by 
Guedes et al. (48), that one milliliter of the Enterisol® vaccine contains 5.3 x 105 organisms. 
 
3.2.3 CFSE-labelling procedure for L. intracellularis and Flow Cytometric Analysis. 
The CellTrace™ CFSE Cell Proliferation Kit for flow cytometry (C34554, Molecular Probes, Life 
Technologies) was used to stain live avirulent L. intracellularis with CFSE according to 
manufacturer’s instructions. The CFDA-SE form is non-fluorescent and passes through cell 
membranes of prokaryotic and eukaryotic cells. Once inside cells, CFDA-SE is converted to 
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fluorescent CFSE which is well-retained within the bacteria, even after several days in a cell 
culture environment (360). L. intracellularis from Enterisol® vaccine were rehydrated with 1 ml 
of vaccine sterile diluent then centrifuged at 6,000 x g for 5 min and suspended in 500 μl of PBS 
(Gibco Life Technologies, # 20012-027). The bacteria were incubated with 1 μl of 5 mM CFSE in 
500 μl of PBS and incubated at 37 oC for 10 min. Next, 500 μl of FBS (Gibco Life Technologies) 
was added and the samples were incubated for an additional 15 min at room temperature to quench 
the CFSE reaction. The CFSE-stained bacteria were then washed three times with PBS and 
centrifuged at 6,000 x g for 5 min, to remove excess dye. CFSE-labeled bacteria were re-suspended 
in DMEM for infection of McCoy cells.  
To ensure that the CFSE was retained in the bacteria and did not leak into the culture 
supernatant resulting in staining of the eukaryotic cells, we adapted the following procedure from 
Vander Top et al (361). Briefly, CFSE-stained bacteria were suspended in tissue-culture cell-
specific media as indicated above for 1 h at 37 oC. CFSE-bacteria were removed by centrifugation 
at 6,000 x g for 5 min and the remaining supernatant was incubated with 0.1x106 McCoy cells at 
37 oC for 1 hr. After this time, the cells were centrifuged and then suspended in PBS plus 2% FBS.  
Flow cytometric analysis was performed using a BD FACS Caliburtm flow cytometer (BD 
Biosciences). We detected CFSE fluorescence in the FL1 channel, with gating being selected based 
on uninfected, unstained McCoy cells as our negative control cells. Flow cytometer results were 
analyzed in Kaluza software (Beckman-Coulter).  
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3.2.4 Cellular penetration assays.  
To assess the penetration of bacteria into the cells, CFSE-stained live-avirulent L. 
intracellularis were used to infect McCoy cells that were plated 24 h previously at a density of 
(0.1 x 106 cells/per well/24 well plate). An MOI of 0.1 CFSE-stained L. intracellularis was used 
to infect each well. During the infection, the McCoy were cultured in their respective media 
without FBS and gentamycin for 24 hr at 37  ̊C in mixture of gases (10% hydrogen, 10% carbon 
dioxide and 80% nitrogen gas) in ziplock bags (99). After 24 hr of incubation, cells were 
trypsinized and collected for flow cytometric analysis. 
 
3.2.5 Neutralization assays.  
Rabbit serum was complement-inactivated with heating 56 ̊C for 30 min. The 
Bicinchoninic acid (BCA) analysis (Pierce BCA Protein Assay Kit, #23225, Thermo Scientific) 
was performed to quantify protein concentration. Protein concentration of pooled rabbit serum 
from vaccinated animals was 108.5 mg/ml. Protein concentration of pooled rabbit serum from 
control non-immunized animals was 53.8 mg/ml.  
The CFSE-stained avirulent L. intracellularis were incubated in media without FBS or 
gentamycin for 60 min at room temperature in 1.5 ml Eppendorf tubes with increasing volume of 
complement-inactivated rabbit serum (ratio of bacteria to serum was 1:0.1, 1:1 or 1:2 as indicated). 
As detailed above, McCoy cells previously seeded onto a 24 well plate were infected with CFSE-
stained bacteria (MOI 0.1) bound by rabbit antibodies. The cells and bacteria were left to incubate 
24 hr at 37 ̊C in zip lock bags filled with ma ixture of gases detailed above. After 24 hr, cells were 
trypsinized and collected for analysis by flow cytometry. 
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3.2.6 PCR analysis to detect L. intracellularis-specific DNA in the neutralization 
assay.  
McCoy cells were seeded to an MOI of 0.1 bacteria with or without pre-incubation with 
rabbit serum detailed above. After 1, 3 or 5 days, cells were trypsinized and resuspended in DMEM 
Complete media containing 10% FBS (Gibco Life Technologies) to arrest the trypsin reaction. 
Cells were pelleted by centrifugation at 500 x g for 10 minutes. The pellet was suspended in NaOH 
buffer (25 mM NaOH, 0.2 mM EDTA) and heated for 95 ̊C for 1 hr to rupture the cells and release 
the DNA from the nucleus. HCl (40 mM Tris-HCl, pH 5.5) was added to neutralize the solution. 
Primers designed against amino acid ABC transporter substrate-binding protein (GlnH, Locus 
LI0754) from the L. intracellularis PHE/MN1-00 genome (Forward: 5’-
GGTTAGTCGTTGCCCATGATA-3’, Reverse: 5’-CTGCGATATGCTCCCATAGTT-3’) were 
used to quantify genome copy number. Quantitative real time PCR (qPCR) was conducted using 
Kapa Syber Green Mastermix (Kapa Biosystems, Wilmington, MA) with data collected using a 
Step One Real-Time PCR System (Applied Biosystems by Life Technologies).  
 
3.2.7 FACS, cytospin, and fluorescent confocal microscopy.  
McCoy cells were seeded into T-75 tissue culture flask (1x106 cells per flask) in DMEM 
with 10% FBS (Gibco Life Technologies) with 50 μg/ml gentamycin (Bio Basic Canada, Inc.) and 
1% L-glutamine (25030-081; Gibco Life Technologies) in a humidified incubator (5% CO2 and 
95% air  at 37
oC). After one day of growth and around 50% confluency, cell growth medium was 
replaced with medium without antibiotics and FBS, cells were infected at a MOI 0.1 or CFSE-
labelled L. intracellularis and the flasks were incubated as detailed above. After 24h after infection 
cells were trypsinized, centrifuged at 500 x g for 10 minutes and resuspended in FACS sorting 
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buffer (PBS, 1mM EDTA, 25mM HEPES pH 7.0, 1% FBS heat inactivated, filtered through a 0.2 
mm filter and stored at 4 oC). Cells were sorted into CFSE- and CFSE+ on a MoFlo sorter (Beckman 
Coulter, Indianapolis, IN) (362).  CFSE- and CFSE+ cells were stained with PKH26 as per 
manufacturer’s instructions (Mini26-1kt, Sigma). PKH26 stained cells, 10,000 per fraction, were 
collected on microscope slides using Cytospin 4 (Thermo Fisher Scientific) at 1,000 rpm for 3 
min, dried and protected with ProLong Gold antifade reagent with DAPI (Molecular probes, Life 
Technologies) before covering with cover slips. Fluorescent microscopy was performed after 24 h 
using Leica SP8 confocal microscope (Leica Mycrosystems Inc., Concord, ON, Canada).   
 
3.2.8 Western blot analysis  
Whole cell L. intracellularis proteins or McCoy cell proteins were subjected to 10% SDS-
PAGE gel and analysed by WB using rabbit serum from animals vaccinated against avirulent L. 
intracellularis or rabbit serum before immunization (negative control). 
Proteins were transferred by a semi-dry transfer protocol to a nitrocellulose membrane 
(BIO-RAD, 162-0094) using Bio-Rad Trans-Blot SD Semi-Dry transfer cell (10 V for 30 min) and 
then WB analysis was performed using hyperimmune serum (1:500; obtained from rabbits 
immunized with whole bacteria) or rabbit serum before immunization (negative control) as 
primary antibodies. Anti-rabbit IR 800 antibody (1 µg/ml; Li-COR, Lincoln, NE, USA) was used 
as secondary antibody. The membrane was scanned with Odyssey scanner (Li-COR®) in the IR 
700 and IR 800 channels.  
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3.2.9 Statistical Analysis.  
One way ANOVA with Kruskal-Wallis test was used to compare flow cytometry and 
qPCR data and medians were compared using Dunn’s test. All statistical analyses and graphing 
were performed using GraphPad Prism 5 software (GraphPad Software, San Diego, CA). 
Differences were considered significant if p<0.05. 
 
3.3 Results and Discussion 
 
3.3.1 Detection of CFSE-stained L. intracellularis in eukaryotic cells using flow 
cytometric analysis.   
L. intracellularis is an intracellular bacterium 0.1 to 0.3 μm in width and 0.7 to 2.0 μm in 
length (1), which is sufficiently large to be detected using flow cytometric analysis We stained L. 
intracellularis with lipid-permeable fluorescent molecule carboxyfluoroscein diacetate (CFDA)-
succinimidyl ester (CFDA-SE). Once inside bacteria or eukaryotic cell, the diacetate groups are 
cleaved leaving fluorescent carboxyfluoroscein. Fuller et al., showed that CFSE efficiently stained 
Gram positive and Gram-negative bacteria without causing undesirable effects on cell adhesion or 
viability (355). 
Unstained and CFSE-stained L. intracellularis were subjected to flow cytometric analysis. 
A representative forward (FSC-H) and side scatter (SSC-H) dot plot and the gating of viable cells 
areshown in Figure 3.1. The side-scatter on the y-axis is an indicator of the cellular 
granularity/complexity of L. intracellularis and the forward-scatter is an indicator of size. 
Unstained bacteria were introduced to the flow cytometer; events within Gate A are live, unstained 
L. intracellularis (Fig 3.1A) which indicates that these bacteria are indeed of sufficient size and 
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complexity to be quantified using flow cytometry. The population indicated by the arrow (Fig 
3.1A) represent dead bacteria or cellular debris, which were not included in the gate and therefore 
excluded from further analysis. Next, CFSE-stained bacteria were introduced to the flow cytometer 
and an identical gate was used to quantify the percentage of events (i.e. the percentage of bacteria) 
that share similar same size and complexity as was observed in the unstained bacteria (Fig 3.1B). 
As expected, we did not see a shift in the percentage of events outside of Gate A, which confirms 
that the CFSE stain does not radically impact bacterial size or structure complexity. Because the 
CFSE-staining procedure has multiple washes, any cellular debris have been washed away from 
the live bacteria, which explain why the population indicated by the arrow in fig. 3.1A is not 
present in fig. 3.1B. We measured fluorescence in the FL1-H channel along the y-axis to detect 
CFSE and the results are shown in figures 3.1C and 3.1D. A gate was drawn above the background 
fluorescence of the unstained bacteria (Fig. 1C) and this identical gate is then used to measure 
fluorescence of the CFSE-bacteria (Fig 3.1D).  As expected for this negative control, only 
negligible fluorescent events are detected in the unstained bacteria (0.31%; Fig. 3.1C). When the 
identical gate was introduced to the CFSE-stained L. intracellularis, we observed that 99.36% of 
the bacteria were fluorescent in the FL1-H channel (Fig 3.1D). These results indicate that we can 
detect L. intracellularis using flow cytometric analysis and that our CFSE staining procedure was 
efficient in staining the majority of bacteria.  
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Figure 3.1 Flow cytometry analysis of avirulent L. intracellualris non-stained forward/side scatter 
plot (A), CFSE stained forward/side scatter plot (B), non-stained forward scatter/FL1 channel plot (C) and 
CFSE stained forward scatter/FL1 channel plot (D). Experiment was done three times.  
 
3.3.2 Quantification of invasion or cellular association of CFSE-labelled L. 
intracellularis into McCoy cells  
McCoy cells are routinely used for L. intracellularis propagation and growth in laboratory 
and industrial environments (363) and therefore we used flow cytometry to assess invasion and/or 
cellular adherence of L. intracellularis with McCoy cells. Figure 3.2A shows the flow cytometric 
gating strategy for live McCoy cells. Because McCoy cells are collected using trypsin and 
centrifugation (explained in detail in Materials and Methods) any free bacteria, not associated with 
the cells were removed and Gate A includes only viable McCoy cells. Figure 3.2B shows the 
fluorescence for mock-infected McCoy cells which served as a negative control and, as expected, 
showed negligible fluorescent events (0.4%) in FL1-H gate. These data confirm that McCoy cells 
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are not auto-fluorescent in this channel. Also, as another negative control, we analyzed McCoy 
cells infected with non-stained a-virulent bacteria gated with same parameters as previous. Again 
our control showed negligible fluorescent events (0.4%) in the FL1-H gate (data not shown). 
McCoy cells incubated with a MOI of 0.1 CFSE-stained bacteria showed that 21.4 % of the McCoy 
cells were fluorescent indicating invasion by and/or cellular association with CFSE-stained 
bacteria (Fig. 3.2C). McCoy cells incubated with a MOI of 0.3 CSFE-bacteria showed that 50.4 % 
of McCoy cells were invaded by or associated with CFSE-bacteria (Fig 3.2D). In all subsequent 
experiments, a MOI of 0.1 CFSE-stained bacteria were used to infect McCoy cells. The average 
percentage of McCoy cells infected with CFSE-stained bacteria was 19.5% +/- 5.2 (Fig 3.2E). 
Next, we confirmed that the CFSE dye was retained inside L. intracellularis and that our 
results were not compromised by CFSE leaking out of the bacterial cells and staining McCoy cells. 
The CFSE-labeled bacteria were suspended in cell media for 1 h at 37 oC and then the bacteria 
were removed by centrifugation (361). McCoy cells were then cultured in this medium that had 
previously contained the CFSE-stained bacteria with the idea being that any CFSE that had leaked 
out of the bacteria could penetrate the McCoy cells. We observed that despite being cultured in a 
medium which previously contained CFSE-stained bacteria, the McCoy cells showed negligible 
fluorescence in the FL-1 channel (0.3%; Fig 3.2F) confirming that the CFSE stain did not leak 
from the bacteria and stain the eukaryotic McCoy cells.  
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Figure 3.2 Flow cytometry analysis: gating strategy on live McCoy cells forward/side scatter plot (A), 
gating strategy on live McCoy cells forward scatter/FL1 channel plot (B), McCoy cells infected with CFSE 
labeled L. intracellularis MOI 0.1 (C), McCoy cells infected with CFSE labeled L. intracellularis MOI 0.3 
(D), multiple biological replicates are shown on one graph (E) and McCoy cells incubated in CFSE-
bacterial supernatant forward scatter/FL1 channel plot (F). 
 
 
We concluded that flow cytometry can be used to quantify fluorescence attributable to 
CFSE-stained bacteria in solution (Fig 3.1) or after invasion or adherence to McCoy cells (Fig 
3.2). Because the CFSE stain did not leak from the bacteria and the gating is specific for McCoy 
cells (i.e. it will not include any free CFSE-stained bacteria), fluorescence in FL1-H detected in 
McCoy cells must be attributed to CFSE-stained bacteria that are adherent to or have invaded the 
McCoy cells.  
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3.3.3 Establish bacterial invasion of McCoy cells using PCR analysis and fluorescent 
microscopy. 
Because L. intracellularis are obligate intracellular bacteria, they can only replicate if they 
have invaded a susceptible eukaryotic cell. Thus if the qPCR analysis indicates that McCoy cells 
infected with bacteria show increased bacterial DNA over time, we indirectly establish that the 
growing bacteria are intracellular. We infected McCoy cells with L. intracellularis (MOI 0.1) and 
performed qPCR analysis on McCoy cells 1, 3 and 5 days after infection (Fig 3.3). As expected, 
mock-infected McCoy cells showed no increase in bacterial DNA over time. However, after 
McCoy cells were incubated with L. intracellularis for 1, 3 and 5 days, we observed a significant 
increase in fold change of bacterial DNA relative to the bacterial DNA present on day 1 ( (p<0.05 
and p<0.001, respectively). For each biological replicate, we observed growth over time (indicated 
by lines joining data points). We conclude that because the fold change in bacterial DNA is 
increasing over time, these obligate intracellular bacteria have invaded the McCoy cells and are 
growing.  
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Figure 3.3 qPCR analysis of McCoy cells and McCoy cells infected with avirulent L. intracellularis 
Day 1, Day 3 and Day 5. Fold change of bacterial DNA relative to the bacterial DNA present on day 1 ((*) 
day 3 p<0.05 and (***) day 5 p<0.001). Data present five independent experiments for each time point.  
 
We next used fluorescent confocal microscopy to directly confirm that L. intracellularis 
invaded the eukaryotic cells and were not merely adherent to their surface. We incubated McCoy 
cells with CFSE-stained bacteria for 24 h as indicated above but this time we performed fluorescent 
activated cell sorting (FACS) which allowed us to physically separate the fluorescent McCoy cells 
(i.e. the cells that were invaded by the CFSE+ bacteria) from the non-fluorescent McCoy cells (i.e. 
McCoy cells that were not invaded by the labeled bacteria). We plated the uninfected (data not 
shown) and infected McCoy cells on microscope slides and stained the cells with DAPI to 
fluorescently label the nuclei (bright white colour in the first panel of figure 3.4 and indicated by 
blue colour; in the last panel). Also, we stained the cell membrane with PKH26 which is shown as 
grey and white in the second panel and red in the last panel of figure 3.4. The CFSE+ bacteria are 
present as bright white spots in the 3rd panel of figure 3.4 and green in the last panel of Figure 4. 
The uninfected McCoy cells did not show green fluorescence which confirms that the cells are not 
autofluorescent and that they are negative for CFSE+ bacteria (data not shown). The infected 
McCoy cells have green scattered flecks or inclusions in the cytosol and are not co-localized with 
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the DAPI or PKH26 stain. These images confirm that the bacteria have invaded the McCoy cells 
and not adherent to the cell membranes nor are they localized to the nucleus.  
 
Figure 3.4 Fluorescent confocal microscopy of infected McCoy cells. McCoy cells sorted for CFSE 
positive signal (green), cytospinned and stained with PKH26 (red) and DAPI (blue).   
 
3.3.4 Neutralization assay to assess whether serum antibodies blocked bacteria 
invasion of McCoy cells. 
To determine whether humoral immunity could contribute to immune protection, we 
investigated the potential impact that serum antibodies had on the invasion of L. intracellularis 
into McCoy cells and the bacterial growth. The role of antibody-mediated immunity to mediate 
protection against intracellular microorganisms is still a debated topic (364). Pigs with PE 
consistently show an accumulation of IgA within ileal epithelial cells (349, 13, 365) and there is 
some evidence that serum antibodies may be sufficient to generate protective immunity against L. 
intracellularis (366). Others have shown that antibodies may mediate their protective immunity 
against PE partly by coating the bacteria so that once they are within the enterocytes, the antibody-
pathogen complex could undergo proteasomal degradation via antibody-dependent intracellular 
neutralization (ADIN) (367).  
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We repeatedly immunized rabbits with the Enterisol® vaccine (consisting of 105 L. 
intracellularis) and obtained their serum after 60 days. To confirm that the antibodies in the 
hyperimmune serum have specificity for L. intracellularis, we performed total protein isolation 
from L. intracellularis, McCoy cells (which are known to be present in the vaccine strain) as well 
as McCoy cells infected with L. intracellularis. We subjected the total proteins to SDS-PAGE 
electrophoresis, transferred the proteins to a membrane and hybridized the membrane with 
hyperimmune serum or control rabbit serum (Fig. 3.5). Lane 1 shows fractionated bacteria and 
McCoy cells. Antibodies in the hyperimmune serum bound to many proteins in this lane. Lane 2 
shows fractionated McCoys cells and serum from the immunized rabbits failed to bind McCoy cell 
proteins. Lane 3 shows fractionated bacteria and McCoy cells hybridized with control rabbit serum 
and no proteins were bound. Thus, we are confident that the rabbit hyperimmune serum has 
antibodies specific for L. intracellularis.  
 
 
Figure 3.5 Western blot analysis of L. intracellularis protein fractions from whole cell isolation 
method: 1- total protein isolation samples from a-virulent L. intracellularis detected using positive rabbit 
serum; 2- total protein isolation from McCoy cells detected using positive rabbit serum, 3- Total protein 
isolation from avirulent L. intracellularis detected with negative rabbit serum. Anti-rabbit antibodies were 
detected with an IRDye 800 nm conjugated goat-anti-rabbit antibody.  
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To investigate whether CFSE-labelling of bacteria can be used in conjunction with 
functional assays, we investigated whether antibodies in hyperimmune serum could impact 
bacterial invasion and/or bacterial growth. Flow cytometry was performed on the McCoy cells 
infected with bacteria alone or with CFSE-stained bacteria pre-incubated with 1/10th volume 
(1:0.1 volume), an equal volume (1:1) or twice the volume (1:2) rabbit hyperimmune serum to 
bacteria. The CFSE-stained bacteria were then introduced to cultures of McCoy cells. As expected, 
McCoy cells cultured alone were negative for fluorescence (Fig 3.6A) and McCoy cells cultured 
in the presence of CFSE-stained bacteria showed that approximately 17.1% of cells were 
fluorescent (i.e. infected). When 1:0.1 volume of rabbit serum was incubated with the bacteria 
prior to infection, we observed that approximately 27.8% of cells were fluorescent. When the 
volume of rabbit serum incubated with the bacteria prior to infection was increased to 1:1 or 1:2, 
we observed approximately 38.4% and 40.4% fluorescent cells, respectively. Significantly more 
CFSE-stained bacteria pre-incubated with 1:1 rabbit hyperimmune serum invaded the McCoy cells 
(p<0.05) relative to the bacteria not preincubated with the serum. In contrast, when we incubated 
the CFSE-bacteria with negative rabbit immune serum, we did not observe increased events in 
FL1-H (19.3%) (Fig 3.6B). These results indicate that rabbit anti-L. intracellularis antibodies in 
positive rabbit serum enhanced bacterial invasion of McCoy cells.  
Finally, we performed qPCR analysis to establish whether pre-incubating bacteria with 
rabbit hyperimmune serum impacted bacterial replication. As detailed in figure 3.6, the qPCR 
analysis was performed 1, 3 or 5 dpi of McCoy cells with L. intracellularis alone or pre-incubated 
with rabbit hyperimmune serum (Fig. 3.6C). After 5 days, bacteria incubated with McCoy cells in 
the absence of rabbit serum showed significantly increased fold change in bacterial DNA relative 
to day 1 (p<0.001). When 1:1 or 1:2 volume of rabbit serum was preincubated with the bacteria, 
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we observed significantly more bacterial DNA present after 5 days ((p<0.01), (p<0.05), 
respectively). These data indicate that the bacteria were replicating inside McCoy cells despite pre-
incubation with rabbit antibodies.  
 
Figure 3.6 Flow cytometry and qPCR data from neutralization assay with increasing volume of 
positive serum. Multiple flow cytometry data (n=4) from neutralization assay with increasing volume of 
positive rabbit serum (A), forward scatter/FL1 channel plot of McCoy cells infected with CFSE labeled L. 
intracellularis (B) and qPCR analysis of McCoy cells, McCoy cells infected with avirulent L. 
intracellularis and McCoy cells infected with avirulent L. intracellularis incubated with rabbit serum Day 
1, Day 3 and Day 5 (C). Fold change of bacterial DNA relative to the bacterial DNA present on day 1 
bacteria alone ((***) p<0.001, (**) p<0.01 and (*) p<0.05). 
 
Using these techniques, we determined that rabbit hyperimmune serum antibodies promote 
bacterial invasion into McCoy cells.  
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3.4 Conclusions: 
The present data show that CFSE fluorescent dye can stain Gram-negative L. 
intracellularis, that the CFSE fluorescent stain is stable and retained inside the bacteria, and it does 
not significantly affect bacterial viability and growth. Using flow cytometric analysis, we showed 
that CFSE-stained L. intracellularis infected McCoy cells in culture in an oxygen-reduced gas 
environment (Fig 3.2). Benefits to using CFSE labeling of obligate intracellular microorganism 
are numerous. CFSE staining of bacteria is cheap and easy to perform and CFSE-stained bacteria 
can be detected inside the host cells without fixation and permeabilization of the eukaryotic cells. 
Unlike antibodies that bind to bacterial surface proteins which may be important for adhesion or 
invasion, CFDA-SE stain is permeable to the lipid bilayer and therefore does not bind surface 
proteins. CFSE-stained bacteria can be sorted from uninfected eukaryotic cells via cell sorting 
without the use of antibodies or beads bound to the surface that may impact function. Sorting can 
be used to establish eukaryotic and/or bacterial differential gene and protein expression and other 
changes in cellular events during adhesion and infection. By coupling qPCR analysis with 
fluorescent microscopy, we confirmed that the bacterial invaded the host cell were replicating and 
were not merely cell adherent. CFSE-staining of bacteria was compatible with functional analysis 
and rabbit hyperimmune serum promoted bacterial uptake and growth. These simple techniques 
can be adapted for use with other obligate intracellular pathogens and are amenable to be used for 
a myriad of functional analysis.  
Student contribution: M.O. performed the flow cytometric analysis, established the 
growth conditions for avirulent L. intracellularis in the tissue culture cell lines, tissue culture 
analysis, PCR, neutralization assay, microscopy experiments, designed experiments and assisted 
in the writing of the manuscript.  
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4. IMMUNOPROTEOMIC ANALYSIS OF LAWSONIA INTRACELLULARIS 
IDENTIFIES CANDIDATE NEUTRALIZING ANTIBODY TARGETS FOR USE IN 
SUBUNIT VACCINE DEVELOPMENT  
(Submitted for a provisional patent application and to Veterinary Microbiology for 
publication) 
Relationship of this study to the dissertation 
Due to its obligate intracellular nature, characterization of L. intracellularis antigens and 
proteins involved in host-pathogen interaction and immune recognition have not been elucidated 
using conventional microbiological techniques. In this study, we utilized 2-dimensional gel 
electrophoresis coupled with Western-immunoblotting, mass spectrometry, and bioinformatics to 
identify proteins on the surface of bacterium that interacts in vitro with pig intestinal cells (IPEC-
1) and that have immunogenic properties. Using this methodology we were able to detect 11 
immunogenic bacterial proteins from which four were predicted to be expressed on the outer 
membrane. Recombinant proteins were produced from E. coli, purified using affinity 
chromatography. Western blot analysis determined that these recombinant proteins were 
immunogenic as they were recognized by porcine hyperimmune serum specific for whole 
Lawsonia lysate. In chapter 3 we described the use of CFSE stained L. intracellularis for 
evaluating anti L. intracellularis sera neutralization properties. This neutralization assay was 
applied to evaluate neutralization properties of rabbit hyperimmune sera generated against vaccine 
strain of L. intracellularis and sera specific for each recombinant protein. Our results indicate that 
each recombinant protein is a potential neutralizing antibody target and candidate for subunit 
vaccine formulation.   
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4.1 Introduction 
 Attachment of L. intracellularis to enterocytes is an important step in bacterial infection 
but the mechanism by which these bacteria interact with the host cells has not yet been determined 
(3). Proteins which comprise the Type III secretion system (T3SS), a common secretion system 
found in many enteroinvasive pathogens that plays the role in invasion and suppression of innate 
defenses, has been detected in three Lawsonia isolates (368). These T3SS proteins and other 
uncharacterized bacterial proteins that facilitate contact with enterocytes are potentially important 
immunogens as they are expressed on the surface and therefore accessible to the host immune 
system. Establishing that these proteins are important for attachment has been hampered by the 
obligate intracellular growth requirement of L. intracellularis and by difficulties of removing 
eukaryotic host cell proteins from sample preparation. Modern proteomic analysis coupled with a 
fully sequenced and partially annotated L. intracellularis genome offers the means to identify 
potential antigens. For example, the L. intracellularis autotransporter protein (LatA) was detected 
by Watson et al 2011 using mass spectrometry (MS) and bioinformatics (103). The same group 
applied shotgun proteomic analysis to identify 19 unique proteins during in vitro infection of which 
two proteins, LI0841, and LI0902, were shown to have antigenic properties (104). The success 
and efficacy of proteomic analysis to detect yet uncharacterized L. intracellularis proteins 
prompted us to perform 2-dimensional gel electrophoresis (2-DE) coupled with WB analysis to 
identify antigens that could be detected by hyperimmune serum and be used towards the 
formulation of neutralizing subunit vaccine. 
2-DE is an efficient analytical tool for separation of complex proteins mixtures from tissue, 
mammalian and bacterial cells, and secretions (322). 2-DE is a robust and confident technique with 
the advantage of being compatible with other biochemical techniques (330). For instance, 2-DE 
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coupled with WB and MS has been used to detect antigens from bacteria (331, 332), cancer cells 
(333) and fungi (334) that are recognized by the human immune system. Bacterial cells are good 
candidates for 2-DE analysis due to their lower complexity compared to mammalian cells, which 
is an essential requirement for successful protein separation (330). A downstream application such 
as WB and MS add to the analytical power of 2-DE and allows efficient identification of targeted 
proteins.    
To detect L. intracellularis immunogenic proteins that play a role in adherence or invasion, 
we combined the separation power of 2-DE with WB and MS. The resulting target genes were 
then cloned, and proteins expressed and evaluated for their immunoreactivity and capacity to 
interfere with bacterial-host interactions under competitive conditions. Our analysis revealed 11 
unique L. intracellularis proteins and further bioinformatics analysis and flow cytometry assay 
indicated that four were predicted to be possible vaccine targets.  
 
4.2 Materials and methods 
4.2.1 Cell culture conditions 
Undifferentiated porcine intestinal epithelial cell lines (IPEC-1), which were derived from 
the jejunum and ileum of unsuckled one day old piglets (369), were cultured and maintained in 
DMEM/ F-12 (SH30271.01; HyClone, Thermo Fisher Scientific, San Jose, CA, USA) with 5% 
Fetal bovine serum (FBS) (Sigma-Aldrich, Oakville, ON, Canada), penicillin/streptomycin (Gibco 
5000 units/ml Penicillin, 5000 μg/ml Streptomycin), insulin (10 μg/ml), transferrin (5.5 μg/ml), 
selenium (5 ng/ml) (ITS; Sigma-Aldrich) and 5 ng/ml of epidermal growth factor (Sigma-Aldrich). 
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Cells were kept in a humidified incubator in an atmosphere of 5% CO2 and 95% air at 37 
oC and 
passaged two times per week at 1:5 ratio in Corning® 75 cm2 cell culture flasks. IPEC-1 cells used 
for L. intracellularis infection and neutralization assays were grown as indicated above but in the 
absence of antibiotics.       
 
4.2.2 L. intracellularis protein sample preparation 
L. intracellularis pellets prepared from infected McCoy cells (detailed in (4)) were  
suspended in RIPA buffer (0.05 M Tris pH 8, Bio Basic Canada INC, Markham. ON, Canada); 
0.15 M NaCl (Bio Basic Canada INC.); 0.10% SDS, (Bio Basic Canada INC.); 1% Deoxycholic 
acid, (VWR-Amresco, Dublin, Ireland); 1% Nonidet P40 substitute (Sigma-Aldrich); distilled 
water) complete with 0.1 M phenylmethylsulfonyl fluoride (PMSF) (Sigma-Aldrich) in 
isopropanol (Sigma-Aldrich). The sample was freeze/thawed three times to rupture the bacterial 
cells and the mixture was centrifuged at 10,000 x g for 10 min. Bacterial proteins were then 
precipitated from the supernatant with ice-cold acetone. The mixture was vortexed and stored in -
20 °C for 1 h then the incubation mixture was centrifuged 14 000 x g for 10 min. The supernatant 
was carefully discarded and the pellet dried before resuspending with NaHCO3 buffer and 
quantifying by BCA analysis following the manufacturer’s instructions (Pierce, Thermo Fisher 
Scientific).  
The L. intracellularis proteins were labeled with Cy5 dye (GE Healthcare Life Sciences-
Amersham Biosciences, Mississauga, ON, Canada) in a dye/protein molar ratio of 8:1, following 
the manufacturer’s recommended protocols. The mixture was incubated for 4 h at room 
temperature in the dark. Unbound dye was removed by size filtration using 3000 MWCO 15 ml 
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filters (Millipore, Etobicoke, ON, Canada) with four additional washes with ultra-pure water. The 
final concentration of Cy5-labelled L. intracellularis proteins was determined by BCA assay 
(Pierce) prior to 2-DE.  
 
4.2.3 Binding of Cy5-labeled L. intracellularis proteins to IPEC cells 
IPEC-1 cells were grown to confluence in T-75 flasks trypsinized and washed three times 
with antibiotic and FBS-free IPEC medium. Next, 1x106 IPEC cells were incubated with 700 μg 
of Cy5-labeled bacterial proteins for 3 h with gentle mixing on nutator at 4 oC. Cells were 
centrifuged as indicated above and the unbound L. intracellularis proteins were removed with the 
supernatant. The IPEC-1 cells and bound L. intracellularis proteins were then suspended in RIPA 
buffer with PMSF (Sigma-Aldrich) and subjected to repeated freeze/thaws as indicated above. 
IPEC-1 proteins and Cy5-labeled adherent L. intracellularis proteins were then subjected to 2-DE. 
 
4.2.4 Two dimensional gel electrophoresis 
Proteins from lysed IPEC-1 cells and bound Cye-5 labeled L. intracellularis (250 μg used 
for the analytical gels and 600 μg for preparation gels) were solubilized in rehydration buffer 
overnight (9 M urea, 2% 3-[(3-Cholamidopropyl)dimethylammonio]-1-propanesulfonate hydrate 
(CHAPS, Fisher BioReagents), 1% DL-Dithiothreitol (DTT , Promega, Madison, WI, USA), 2% 
pharmalyte 5-8 (GE Healthcare), 0.002% bromophenol blue (BioRad, Hercules, CA, USA) and 
were loaded onto an IPG strip (Immobiline tm DryStrip, pH 4-7, 13 cm, GE Healthcare). The strips 
were individually subjected to IEF using the IPGphor device (GE Healthcare-Amersham 
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Biosciences) following the stepwise protocol (150 V step and hold for 3h, 300 V step and hold 
1200 Vh, 1000 V gradient for 3900Vh, 8000 V gradient for 13500 Vh and 8000 V step and hold 
for 25000 Vh). After IEF, both IPG strips were stored at -80 oC. The IPG strips with isoelectric 
focused proteins were thawed at room temperature and equilibrated with SDS equilibration buffer 
with 1% DTT (Dithiothreitol) (6 M urea, 75 mM Tris-HCl pH 8.8, 29.3% glycerol, 2% SDS and 
0.002% bromophenol blue) for 15 min at room temperature followed by washing with SDS 
equilibration buffer with 2.5 % Iodoacetamide (GE Healthcare) for 15 min. After equilibration, 
strips were placed over SDS gels and covered with sealing solution (0.5% agarose in 1x SDS 
running buffer). Second dimension electrophoresis was performed using BIO-RAD protean® II xi 
Cell Apparatus and two medium sizes, 10 % SDS PAGE gels. Electrophoresis was performed 
using 90 V constant voltage for 16 h with constant water cooling of apparatus (Bio-Rad Power 
pack 200).  
 
4.2.5 Western blot analysis and silver staining  
Proteins on the analytical gel were transferred with semi-dry transfer to a nitrocellulose 
membrane (BIO-RAD, 162-0094) using Bio-Rad Trans-Blot® SD Semi-Dry transfer cell (15 V for 
60 min) and then Western blot analysis was performed using rabbit hyperimmune serum (1:500; 
obtained from rabbits i.m immunized with avirulent vaccine strain) as primary antibodies. Anti-
rabbit IR 800 antibody (1µg/ml; Li-COR®, Lincoln, NE, USA) was used as secondary antibody. 
The membrane was scanned with Odyssey scanner (Li-COR) in the IR 700 and IR 800 channels. 
IR800-stained proteins indicate bacterial proteins with affinity for IPEC-1 cells and bound by 
rabbit serum against whole bacteria (See Figure 4.1 A).  
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For the preparative gel, L. intracellularis proteins were stained with Silver stain kit, 
(PROTSIL-1-KT, Sigma Aldrich) according to manufacturer’s protocol and this gel was reserved 
for excising gel spots for MS analysis (See Figure 4.1 B).  
 
4.2.6 Preparation of samples for Mass Spectrometry  
Silver-stained proteins on the preparative gel which correspond to IR-800 labeled proteins 
detected by WB analysis were excised from the gel using a sterile 3 mm diameter biopsy punch to 
avoid contamination of gel samples with environmental proteins. Gel plugs were collected and 
stored in ultrapure water at -20 °C. Gel plug samples (annotated as 1.4, 2.3, 3.1, 3.2 and 4 (Fig. 
4.1 B)) were sent to Plateforme Proteomique Centre de Recherché du CHU de Québec CHUL, 
Québec, Canada for MS analysis.  
 
4.2.7 Tryptic digestion 
Protein digestion and MS analyses were performed by the Proteomics Platform of the CHU 
de Québec Research Centre (Quebec, Canada). Excised gel pieces were placed in 96-well plates 
and then washed with water followed by tryptic digestion performed using a liquid handling robot 
(MultiProbe, Perkin Elmer) according to the manufacturer’s specifications. Briefly, proteins were 
reduced with 10 mM DTT and alkylated with 55 mM iodoacetamide. Trypsin digestion was 
performed using 126 nM of modified porcine trypsin (Sequencing grade, Promega, Madison, WI) 
at 37°C for 18 h. Digestion products were extracted using 1% formic acid, 2% acetonitrile followed 
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by 1% formic acid, 50% acetonitrile. The recovered extracts were pooled, vacuum centrifuge dried 
and then resuspended into 12 µl of 0.1% formic acid and 5 µl were analyzed by MS.  
 
4.2.8 Mass spectrometry 
Peptide samples were injected and separated by online reversed-phase (RP) nanoscale 
capillary liquid chromatography (nanoLC) and analyzed by electrospray mass spectrometry (ESI 
MS/MS). The experiments were performed with a Dionex UltiMate 3000 nanoRSLC 
chromatography system (Thermo Fisher Scientific / Dionex Softron GmbH, Germering, Germany) 
connected to an Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific,) driving with 
Orbitrap Fusion Tune Application 2.0 and equipped with a nanoelectrospray ion source. Peptides 
were trapped at 20 μl/min in loading solvent (2% acetonitrile, 0.05% TFA) on a 5mm x 300 μm 
C18 pepmap cartridge pre-column (Thermo Fisher Scientific / Dionex Softron GmbH, Germering, 
Germany) during 5 min. Then, the pre-column was switch online with a self-made 50 cm x 75µm 
internal diameter separation column packed with ReproSil-Pur C18-AQ 3-μm resin (Dr. Maisch 
HPLC GmbH, Ammerbuch-Entringen, Germany) and the peptides were eluted with a linear 
gradient from 5-40% solvent B (A: 0,1% formic acid, B: 80% acetonitrile, 0.1% formic acid) in 
30 min at 300 nL/min. Mass spectra data were acquired using a data-dependent acquisition mode 
using Thermo XCalibur software version 3.0.63. Full scan mass spectra (350 to 1800m/z) were 
acquired in the orbitrap using an AGC target of 4e5, a maximum injection time of 50 ms and a 
resolution of 120 000. Internal calibration using lock mass on the m/z 445.12003 siloxane ion was 
used. Each MS scan was followed by the acquisition of fragmentation MS/MS spectra of the most 
intense ions for a total cycle time of 3 seconds (top speed mode). The selected ions were isolated 
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using the quadrupole analyzer in a window of 1.6 m/z and fragmented by Higher Energy Collision-
induced Dissociation (HCD) with 35% of collision energy. The resulting fragments were detected 
by the linear ion trap in rapid scan rate with an AGC target of 1e4 and a maximum injection time 
of 50 ms.  Dynamic exclusion of previously fragmented peptides was set for a period of 20 sec and 
a tolerance of 10 ppm. 
 
4.2.9 Database searching 
All MS/MS samples were analyzed using Mascot (Matrix Science, London, UK; version 
2.5.1). The mascot was set up to search the TAX_Desulfovibrio_CI_194924_20160714 database 
(unknown version, 104802 entries) assuming digestion with trypsin. The mascot was searched with 
a fragment ion mass tolerance of 0.60 Da and a parent ion tolerance of 10.0 PPM. 
Carbamidomethyl of cysteine was specified in Mascot as a fixed modification. Deamidated 
asparagine and glutamine and oxidation of methionine were specified in Mascot as variable 
modifications. Two missed cleavages were allowed. 
4.2.10 Criteria for protein identification   
The Scaffold (version Scaffold_4.7.5, Proteome Software Inc., Portland, OR) was used to 
validate MS/MS based peptide and protein identifications. Peptide identifications were accepted 
if they could be established at greater than 95.0% probability by the Peptide Prophet algorithm 
(370) with Scaffold delta-mass correction. Protein identifications were accepted if they could be 
established at greater than 95.0% probability and contained at least two identified peptides. Protein 
probabilities were assigned by the Protein Prophet algorithm (371). Proteins that contain similar 
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peptides and could not be differentiated based on MS/MS analysis alone were grouped to satisfy 
the principles of parsimony.   
 
4.2.11 Bioinformatics analysis of proteins 
Amino acid sequences from peptides identified by mass spectrometry were submitted to 
the BLAST algorithm (372) to identify corresponding proteins. Prediction of functional domains 
and motifs was performed using UniProt (https://www.uniprot.org) and Pfam 
(http://pfam.xfam.org) and proteins are listed in Table 2. To compute physical and chemical 
parameters of MS/MS detected proteins, protein sequences were submitted to the ExPasy 
ProtParam tool (https://web.expasy.org/protparam) (373). To predict presence of B-cell epitopes, 
sequences were submitted to BepiPred-2.0, a web server for sequence-based B-cell epitope 
prediction (http://tools.iedb.org/bcell/) (374).  
 
4.2.12 Molecular cloning  
Bacterial genomic DNA from avirulent L. intracellularis N343 was isolated using 
GenElutetm Bacterial Genomic DNA Kit, (Sigma-Aldrich) following manufacturer’s protocol. 
PCR amplification of open reading frames was performed using Phusion® High-Fidelity PCR kit, 
(NEB, Ipswich, MA, USA). Primers with cleavage sites for in-frame cloning with the N-terminal 
His-tag contained within the expression vector pET30a are listed in Table 4.1; these were based 
on the genomic sequence of L. intracellularis (PHE/MN1-00). DNA was gel purified, cut with the 
appropriate restriction enzymes (either BamHI/XhoI or NcoI/XhoI) and ligated into pET30a using 
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T4 DNA Ligase (NEB, New England Biolabs). The resulting constructs were transformed into 
competent Dh5α E. coli using standard procedures (375). Plasmid DNA were isolated from the 
bacteria using the Presto Mini plasmid kit (Genaid, New Taipei City, Taiwan). The cloned 
sequences and vector insertion were validated by DNA sequencing and restriction digests (data 
not shown) 
 
4.2.13 Expression and purification of recombinant proteins 
Recombinant proteins were expressed in LOBSTR-BL21 (DE3) pRosetta2 E. coli after 
transformation with the plasmids. E. coli grown grown to mid-exponential phase (OD = 0.6) in 
2xYT medium was induced by the addition of IPTG to 0.5 mM. Incubation was continued for 16 
h at 16 °C with shaking at 200 rpm. Bacteria were harvested by centrifugation and suspended in 
urea lysis buffer (8 M urea, 50 mM NaHPO4, 300 mM NaCl) followed by sonication to lyse 
bacterial cells. The lysate was centrifuged at 20,000 x g for 15 min to remove insoluble material. 
Recombinant His-tagged proteins were purified from the supernatants using the His60 Superflow 
Resin (Clontech, Takara Bio USA, Inc., Mountain View, CA, USA) equilibrated with urea lysis 
buffer.  Proteins were purified in accordance with the manufacturer’s protocol and eluted proteins 
were dialyzed in PBS. Recombinant proteins were subjected to SDS-PAGE (rLI1153 10% SDS 
gel, rFlagellin LI0710 12 % SDS gel, rLI0649 8% SDS gel, and rLI0169 10% SDS gel), and 
analyzed by Western blot using pigs sera from animals with clinical symptoms of PHE.  
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Table 4.1. Bacterial isolates, plasmids and primers used in this study 
 
 
Isolate  Description Origin 
   
   
Avirulent  
L intracellularis  
     Vaccine strain Live vaccine 
 Dh5α     E. coli cloning host   
LOBSTR-
BL21(DE3) 
pRosetta2 
E. coli expression host Kerafast 
   
Plasmid   
pET30a IPTG inducible, T7 expression vector, C-terminal 6xHis tag Novagen 
Primers Sequence 5’ to 3’ Restriction 
site 
Flag-F GACGGATCCTCTCTTGTCATTAATAACAACCTGATGG BamHI 
Flag-R GAGCTCGAGTTAGCCAATAAGTTGCTGAGCC XhoI 
LI1153-F GAGGGATCCGCTAATGTTAGTGGAATCCCTGC BamHI 
LI1153-R GAGCTCGAGTTATTGTATATTATTTTCATCTGGTTGTAGTG XhoI 
LI0649-F TCCCATGGCTGAGGCTGTTGAACACTTTG NcoI 
LI0649-R GGCTCGAGTTAGAATCTATAAGTAGCTCCTACC XhoI 
LI0169-F CGCCATGGACAGTGATGAGGACCTTAGTACAG NcoI 
LI0169-R AGCTCGAGTAGGAATCCACCACTGATCAAG XhoI 
 
 
 
4.2.14 Animals and generation of immune serum 
All animal experimental procedures were performed in accordance with the Procedures for 
Ethics Review of Animal Use Protocols and approved by the University Committee on Animal 
Care and Supply (UCACS), University of Saskatchewan.  
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Rabbit serum against whole cell L. intracellularis was generated as reported in Obradovic 
et al  (376). To obtain hyperimmune serum specific for each recombinant protein of interest, four 
female New Zealand White rabbits (2-3 kg weight) were kept in isolation units in the Animal Care 
Unit of VIDO-InterVac. Rabbits were injected via the subcutaneous route with the inoculum 
consisting of 100 μg of recombinant protein for the first immunization and 50 μg of the same 
recombinant protein for two booster injections. For all injections, recombinant proteins were 
dissolved suspended in 500 μl sterile PBS and mixed with 500 μl sterile Incomplete Freund’s 
adjuvant (Sigma-Aldrich) to 1 ml final volume and the vaccines were administered subcutaneously 
at 4 injection spots with 250 μl of inoculum per site. Each rabbit received just one of the four 
recombinant proteins on day 0, 20, and 40. Rabbit immune sera were collected via exsanguination 
following euthanasia of the rabbits (Euthanyl, Bimeda-MTC Animal Health INC., Cambridge ON, 
Canada) 60 days after the first vaccination. All blood samples were collected and centrifuged (2500 
× g) then sera were stored at −20 °C until use.  
 
4.2.15 Removal of antibodies against LPS from rabbit immune serum  
To remove any LPS-specific antibodies from sera, we incubated 10000 EU/ml LPS from 
E. coli 055:B5 (Sigma-Aldrich) per ml of each rabbit serum for 1 h at room temperature to allow 
serum anti-LPS antibodies to bound. After one hour of incubation, the endotoxin removing gel 
(Pierce High-Capacity Endotoxin removing Gel, Thermo Scientific) was used according to the 
manufacturer’s protocol, to remove LPS and LPS-bound antibodies from rabbit sera. The Flow-
through fractions before and after elution of LPS were collected and subjected to WB to test the 
efficacy of the clearing procedure. WB was performed on LPS (Lipopolysaccharide from E. coli 
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055:B5, Sigma) as a control, whole cell L. intracellularis extract, and all 4 recombinant proteins. 
Detection was performed using LPS-cleared rabbit serum in 1:500 dilution as primary antibody 
and anti-rabbit IR 800 antibody (1µg/ml; Li-COR) as secondary antibody (Figure 4.5 B, C).   
 
4.2.16 Neutralization assay 
To determine the effect of recombinant L. intracellularis protein-specific sera on the 
penetration of bacteria into IPEC cells, we performed neutralization assay using CFSE-stained 
bacteria, as previously described (376). Briefly, CFSE was used to stain avirulent L. intracellularis 
and stained bacteria were incubated with low (500 μg/ml), medium (1000 μg/ml) and high (2000 
μg/ml) complement-inactivated LPS-free rabbit hyperimmune serum for 1 h at room temperature. 
Bacteria bound with serum antibodies were used to infect 105 IPEC-1 cells in 24 well plates 
(Corning) incubated in a tri-gas environment (10% hydrogen, 10% carbon dioxide and 80% 
nitrogen gas (Praxair Canada Inc., Mississauga, ON, Canada)) in zip lock bags at 37 °C (99). After 
4 h incubation, cells were trypsinized then centrifuged at 500 x g for 5 min to remove medium and 
unbound bacteria. The cells were then suspended in PBS (Gibco Life Technologies) with 2 % FBS 
(Gibco Life Technologies) and analyzed by flow cytometer. This assay was repeated 4 times 
independently to obtain biological replicates. Flow cytometric analysis was performed using a BD 
FACS Calibur™ flow cytometer (BD Biosciences, Mississauga, ON, Canada). CFSE fluorescence 
was detected in the FL1 channel with gating selected based on uninfected IPEC-1 cells (negative 
control) and IPEC-1 cells infected with CFSE labeled bacteria (positive control). Thirty thousand 
events were acquired per sample and flow cytometer results were analyzed in Kaluza software 
(Beckman-Coulter, Indianapolis, Indiana, USA). The percent inhibition was calculated using the 
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following formula: Percent inhibition = (1- % of fluorescence of CFSE bacteria incubated with 
serum / % of fluorescence of CFSE bacteria (control)) x 100.  
 
4.2.17 Statistical analysis: 
The Shapiro-Wilk normality test was used to determine whether data follows a Gaussian 
distribution. One way ordinary ANOVA test was used to compare means of values of percentage 
of inhibition of each serum. All statistical analyses and graphing were performed using GraphPad 
Prism 5 software (GraphPad Software, San Diego, CA). Differences were considered significant 
if p <0.05. 
 
4.3 Results and Discussion 
4.3.1 Identification of bacterial proteins that interact with IPEC cells as putative 
antigens 
In the present work, we utilized 2-DE coupled with WB analysis and MS/MS to identify 
L. intracellularis proteins that interact with IPEC-1 cell’s surface proteins and are recognized by 
rabbit hyperimmune serum. On the WB, Cy-labeled L. intracellularis proteins appear as red spots 
(Fig 4.1A) whereas the green/yellow spots indicated that these proteins were also bound by rabbit 
antibodies and are therefore immunogenic. Characteristic accumulation of the abundant albumin 
protein was observed in the region from 75 kDa to 100 kDa which was also confirmed by MS/MS 
analysis (data not shown). Despite three washes with serum-free medium, contaminating albumin 
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was consistently present and attempts to remove albumin from the samples failed. However, 
despite the presence of albumin, low MW proteins separated well and we were able to visualize 
both red and green spots indicating Cy-labeled L. intracellularis proteins alone and bound by 
antibodies. Using the WB (Fig 4.1A) as a template, we isolated the corresponding spots in the 
silver-stained preparative gel (indicated by a red circle in Fig 4.1B). These proteins/spots were 
excised from the gel and subjected to MS/MS analysis.  
 
 
 
Figure 4.1. Protein separation by 2-Dimensional electrophoresis and selection of spots for mass 
spectrometry. Proteins were subjected to isoelectric focusing using IPG strip 4-7 (horizontal plane) 
followed by SDS-PAGE using 10% SDS-PAGE gel (vertical plane). Molecular weight markers are 
indicated (kD). A) Proteins were transferred to a nitrocellulose membrane and incubated with rabbit 
hyperimmune serum as primary antibody (1:500) and anti-rabbit IR800 secondary antibody (1:10,000).  
Proteins visible in IR700 channel are red and indicate all Cye-5 labeled bacterial proteins. The proteins 
visible in IR800 channel are yellow/green and indicate proteins bound by rabbit antibodies. B) The identical 
gel was stained with PROTSil-1 silver stain kit. Position and numbering of gel spots are indicated by red 
circles. Gel plug samples 1.4, 2.3, 3.1, 3.2 and 4 were sent to Plateforme proteomic Centre de recherché du 
CHU de Québec CHUL, Québec, Canada for Mass Spectrometry analysis.  
 
Bioinformatics analysis of MS/MS detected proteins by UniProt and PFAM revealed 11 
unique bacterial proteins identified by MS (Table 4.2). Four of the indicated proteins were 
4  7 4  7 
B) A) 
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predicted to be expressed and localized to the outer membrane of bacteria and these were selected 
for further analysis. These proteins were identified as Flagellin (FliC, LI0710), putative outer 
protein N (LI1153), ABC dipeptide transport system (LI0169), and a previously described 
autotransporter LatA (LI0649) (103). The selected proteins were analyzed with BepiPred-2.0, a 
web server analysis tool for sequence-based B-cell epitope prediction (374). All four protein 
sequences were predicted to have significant presence of B-cell epitopes thus suggesting their 
potential immunogenicity in-vivo (Fig 4.2). Among the 11 proteins detected in our study, proteins 
Chaperonin GroeL (LI0625) and 5’-nucleotidase/2’, 3’ cyclic phosphodiesterase (LI1171) were 
also reported previously using a shotgun proteomic approach which increased our confidence in 
our approach (104).  
 
Figure 4.2. B-cell epitope prediction of four L. intracellularis proteins. Protein sequences were 
submitted to BepiPred-2.0 analysis tool to predict B-cell epitops. LI0710 (A), LI1153 (B), LI0169 (C) and 
LI0649 (D). Yellow peaks represent parts of protein sequence with high score (above the threshold) and 
green peaks represent parts of protein sequence with low score (bellow the threshold) for predicted presence 
of B-cell epitope.     
 
 
149 
 
Flagellin (LI0710, FliC; NCBI-protein: CAJ54764; UniProt: Q1MQG3, MW 31kDa, PI 
5.97 ExPasy) is a subunit protein that polymerizes to form flagella and plays an important role in 
bacteria locomotion and chemotaxis. Flagellum was observed as a bacterial cell structure of L. 
intracellularis by Lawson and Gebhart (6). Recently, a L. intracellularis recombinant protein 
similar to flagellin (LI0710) (identified as  flagellar associated protein, LFliC,  LI0570) was shown 
to be immunogenic and to induce expression of IL-8 in HEK-Blue™-hTLR5 cells in a TLR5-
specific manner (105). The flagellin LI0710 and the putative protein LI0570 (NCBI-proteinID: 
CAJ54624; UniProt: Q1MQV3) share 79.8% amino acid sequence similarity with highly 
conserved domains although they are coded by distinct regions on the bacterial genome. The gene 
encoding LI0710 resides between 894,199 and 895,080 nt, whereas LI0570 resides between 
701,958 and 702,842 nt of the bacterial chromosome. The flagellin LI0710 has 293 amino acids 
and consists of a PF00669 (PFAM) domain between amino acids 5 to 141 and a PF00700 (PFAM) 
domain between amino acids 208-291.  
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Table 4.2. L. intracellularis proteins detected by mass spectrometry  
 
 
PHE/MN1-
00 
Locus tag 
 NCBI PHE/MN1-00 
annotation 
Spot  Sequence  
coverage 
% 
# Peptides  
identified 
Probability 
% 
MW (kDa)/PI  
(ExPasy) 
        
        
LI0710   Flagellin, FliC 2.3 36 9 100 31/5.97 
LI0649  Autotransporter      4     4 4 100 91.86/4.81 
LI0169  ABC type dipeptide 
transport system 
4 4 2 100 63.615/6.52 
LI1153  Putative outer protein N 3.1 7 2 100 44/4.62 
LI0786  DNA polymerase III 
subunit beta 
3.2 13 6 100 43.622/4.70 
LI1171  5’nucliotidase/2’3’ cyclic 
phosphodiesterase 
4 11 5 100 62.294/5.71 
LI0608  Cysteine-tRNA ligase  4 5 2 100 55.492/5.55 
LIO726  S-adenosylmethionine 
synthase 
     2.3     6     2 100   44.352/5.41 
LI0823  Xaa-Pro aminopeptidase 
 
     2.3     5     2 100   40.953/5.6 
LI0625  60 kDa chaperon, groL      3.2     5     2 100   58.641/5.63 
LI0794  ATP-dependant Clp 
protease proteolytic 
subunit  
1.4 21 4 100 23.465/4.73 
 
Flagellin is a TLR5 agonist that plays an important role in the immune recognition of 
Gram-negative bacteria. For example immunization of mice by the systemic route with Yersinia 
pseudotuberculosis-derived Flagellin triggered protection in mice orally infected with Y. 
pseudotuberculosis, likely through the activation of TLR5 receptors on intestinal epithelial cells 
and CD103+ DCs in the lamina propria (377). These mice showed increased secretion of flagellin-
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specific IgA antibodies in the intestinal mucosa (168) which likely played a  primary role in 
protection. Due to its dual antigen and adjuvant nature, we predict that L. intracellularis flagellin 
LI0710 may be an ideal subunit vaccine candidate antigen. 
The LI1153 protein, annotated as a putative outer protein N (NCBI-protein: CAJ55207; 
UniProt: Q1MP70; MW 44 kDa; PI 4.62, ExPasy) is a part of the T3SS system. The LI1153 protein 
consists of two prominent domains with important functions during invasion into eukaryotic cells. 
The HrpJ domain, positioned between 63-222 amino acids, PF07201 (PFAM) and TyeA domain 
positioned between 299-378 amino acids, PF09059 (PFAM). The HrpJ domain is predicted to be 
part of the T3SS and related proteins include SsaL and InvE invasion protein from Salmonella 
Typhimurium which are involved in host-pathogen interaction (378) and invasion (379), 
respectively. A related E. coli protein, SepL, plays a crucial role in the infection of 
enterohemorrhagic E. coli and has a potential role in the secretion of EspA, EspD, and EspB (380). 
The TyeA domain was identified in Yersinia spp. and it plays an essential role in controlling the 
secretion of effector proteins, YopE and Yop H (but not YopM, YopO, and YopP) into eukaryotic 
cells (381). TyeA is localized at the bacterial surface and together with YopD and YopN 
contributes to a translocation-control apparatus within the T3SS (381). These secretion regulator 
proteins have been described as “gate-keepers” in major Gram-negative bacterial species and their 
deletion leads to decreased secretion of translocon proteins or increased secretion of effector 
proteins (382). Alberdi et al 2009 determined that one part of L. intracellularis T3SS was 
positioned between 660,438 nt and 661,754 nt in bacterial genome and that the second part of 
T3SS has positioned approximately 800 kbp distant from their reported region between 1,413,348 
nt and 1,414,535 nt (368). We predict that the LI1153 protein, annotated as Putative Outer protein 
N, corresponds to the predicted second part of the L. intracellularis T3SS and has a role in 
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controlling the secretion of effector proteins into host cells. Further structural and functional 
studies are needed to elucidate the interactions of LI1153 with T3SS effector proteins of L. 
intracellularis but given our observation of an interaction between this protein and target cells, we 
believe the protein is likely to play a role in invasion and attachment of the bacteria to small 
intestine enterocytes. 
LI0169, OppA (NCBI-proteinID: CAJ54225; UniProt: Q1MS01; MW 63.5 kDa and PI 
6.59, ExPasy) is coded by the gene oppA and is predicted to be expressed on the bacterial 
membrane as part of the ABC transporter complex. In bacteria, the ABC transporter complex plays 
a central role in the uptake of sugars, amino acids, metals, growth factors, ions and other solutes 
across the cell membrane (383). The LI0169 protein consists of the transmembrane helical domain 
(12-34 aa), a periplasmic domain (98-456 aa, PF00496) and an ATP-binding coiled domain (476-
496 aa) at the intracellular face of the membrane that together forms a central pore. It transports 
di- and tripeptides in an ATP-dependent manner (384).   
The protein LI0649 (NCBI-protein ID: CAJ54703; UniProt: Q1MQM4; 91.861 kDa, pI 
4.81, ; ExPasy) has been identified previously as the autotransporter protein LatA (103). Using an 
approach similar to ours involving WB analysis coupled with MS, Watson et al, 2011 determined 
that LatA was recognized by pig hyperimmune serum thus representing a potential target for use 
in immunodiagnostics. The reoccurrence of this protein in our results, further validates the addition 
of 2-DE, confirms that LatA is immunogenic as it is bound by rabbit anti-L. intracellularis 
hyperimmune serum and has a role in bacterial-host interactions. The LatA protein had a predicted 
molecular mass of 91.2kDa (as determined by ExPasy) but the corresponding protein was 60 kDa 
in our 2-DE SDS-PAGE gel suggesting that cleavage of the protein may have occurred. This 
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protein is immunogenic and represents a good candidate for making recombinant protein and 
formulate subunit vaccine.  
 
4.3.2 In vitro evaluation of recombinant protein antigenic properties  
The bioinformatics analysis of these four proteins predicted to be localized to the bacterial 
surface and therefore they are potentially accessible to host antibodies. We selected these proteins 
for expression in E. coli and further analysis. Recombinant proteins were expressed into LOBSTR-
BL21 (DE3) pRosetta2 E. coli. SDS-PAGE analysis and Coomassie staining (Fig 4.3A) confirmed 
that rLI1153 (44 kDa; Lane 1), rLI710 Flagellin (32 kDa; Lane 2), rLI0649 (92 kDa; Lane 3), 
rLI0169 (64 kDa; Lane 4) were expressed at their predicted molecular masses. To confirm that 
these recombinant proteins were immunogenic in pigs, we pooled serum from pigs diagnosed with 
PE from a L. intracellularis endemic farm and used the sera in a WB analysis. All four recombinant 
proteins were recognized by sera from PE-infected pigs (Fig 4.3B; rLI1153 (44 kDa; Lane 1), 
rLI0710 FliC (32 kDa; Lane 2), rLI0649 (92 kDa; Lane 3), rLI0169 (64 kDa; Land 4)). This 
indicates that these recombinant proteins remained immunogenic and demonstrates the relevance 
of using rabbit serum to detect antigens for causative agent of PPE. The rLI0649 protein was 
weakly recognized by sera from PE-infected pigs in the WB possibly due to the fact that pig sera 
were pooled from only 5 infected animals from one farm. Previously studies showed that the pig 
sera against L. intracellularis from different animals have variable intensity of binding to 
recombinant proteins, rLI0649 (103) or rLscQ (368), possibly due to the differences in immune 
response against bacteria or infectious doses of bacteria infecting each animal. 
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Figure 4.3. Coomassie stained gels with Ni purified recombinant proteins and Western blot analysis. 
Marker lanes are indicated by M and sizes in kd are indicated. A) Lane 1:  rLI1153 44kDa (10 % SDS gel), 
Lane 2:  rLI0710 fliC 32kDa (12 % SDS gel), Lane 3: rLI0649 92kDa (8 % SDS gel), Lane 4: rLI0169 
64kDa (10 % SDS gel). B) Recognition of purified recombinant proteins by sera pooled from pigs with 
clinical symptoms of PHE (1:500). Anti-pig IR 800 (1:10000) was used as the secondary antibody. Arrows 
indicate predicted MW or recombinant proteins. Lane 1: rLI1153 44kDa, Lane 2: rLI0710 31kDa, Lane 3: 
LI0649 92kDa, Lane 4:LI0169 64kDa. C) Western Blot analysis of recombinant proteins. For all blots, 
recombinant proteins were recognized by antigen-specific IgG purified form rabbits immunized with 
recombinant proteins (1:500) followed by the secondary anti-rabbit IR800 antibody (1:10,000). Rabbit sera 
were generated against recombinant protein LI1153 44kDa (Lane 1), recombinant protein LI0710 fliC (MW 
32kDa) (Lane 2), recombinant protein LI0649 (MW 92kDa) (Lane 3); and recombinant protein LIi0169 
(MW 64kDa) (Lane 4).  
A) 
 
B) 
C) 
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To test the immunogenic potential of each of the 4 recombinant proteins, we vaccinated 
rabbits with the recombinant proteins to generate hyperimmune serum specific for each protein 
target. Hyperimmune serum was then used in WB analysis and visualized with anti-rabbit 
secondary IR800. Fig 4.3C, lane 1 shows recombinant LI1153 bound by rabbit hyperimmune sera 
(from a rabbit vaccinated against recombinant LI1153). The band at approximately 100 kDa and 
the smaller bands at 35 kDa are E. coli proteins present after Ni-affinity column purification.  
Lane 2 shows the recombinant LI0710 Flagellin (32 kDa) bound by rabbit hyperimmune 
sera (from a rabbit vaccinated against recombinant flagellin). Lane 3 shows the recombinant 
LI0649 protein (92 kDa) bound by rabbit hyperimmune sera (from a rabbit vaccinated against 
recombinant LI0649). Finally, lane 4 shows recombinant LI0169 (64 kDa) bound by rabbit 
hyperimmune sera (from a rabbit vaccinated against recombinant LI0169). Serum from 
unimmunized rabbits did not recognize any of our four recombinant proteins (Fig. 4.4). Our results 
indicate that the recombinant proteins were recognized by rabbit hyperimmune sera thus indicating 
their immunogenic properties.  
 
Figure 4.4. Western blot of recombinant proteins probed with precleared negative sera (sera before 
immunization). Putative protein N LI1153 (Lane 1), rFlagellin LI0710 (Lane 2), rLI0649 (Lane 3) and 
rLI0169 (Lane 4) were probed with pooled rabbit negative sera (1:500) that had been pre-cleared to remove 
anti-LPS antibodies. Secondary anti-rabbit IR800 (1:10000) used as negative control. Lane M, molecular 
weight marker.   
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 4.3.3 In vitro evaluation of proteins antigenic properties using flow cytometry 
We performed a neutralization assay (methodology optimized in Obradovic et al 2016 
(376) to quantify the level of inhibition that antigen-specific antibodies had on preventing 
penetration of CFSE-labelled avirulent L. intracellularis into eukaryotic cells (Fig. 4.6). The 
following sera were tested at low (500 μg/ml), medium (1000 μg/ml) and high (2000 μg/ml) 
concentrations: rabbit sera before immunization, rabbit sera against whole avirulent bacteria and 
rabbit hyperimmune serum specific for rLI0169, rLI0649, rLI0710 FliC, or rLI1153. A MOI of 
0.1 of CFSE stained L. intracellularis remained constant in all the assays. As our negative control 
sera, we pooled the sera from rabbits prior to immunization for hyperimmune serum generation. 
Because others have shown that a negative mouse serum showed 48% to 59% inhibition of L. 
intracellularis invasion, likely due to the presence of anti-LPS antibodies present prior to 
generation of hyperimmune serum (385), we tested whether negative rabbit serum was capable of 
binding to LPS. We observed that rabbit negative serum did bind to one band with a molecular 
mass between 20 and 25 kDa (Fig. 4.5A) which corresponds to the molecular weight of LPS (27). 
Therefore, we removed anti-LPS antibodies from all sera prior to performing the neutralization 
assays. WB analysis of sera pre- and post-incubation with LPS to remove LPS binding antibodies 
is shown in figure 4.5.   
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Figure 4.5. Removal of LPS-specific antibodies from sera: Western blot analysis of whole L. 
intracellularis bacteria detected with negative control rabbit sera (sera before immunization with 
recombinant proteins), protein marker M, whole L. intracellularis  bacteria (lane 1), (A); WB with negative 
sera after specific antibodies removal, LPS and whole L. intracellularis bacteria (lane 2) (B); WB with sera 
generated against whole avirulent L. intracellularis after specific antibodies removal, LPS, L. 
intracellularis (lane 3), WB with sera generated against recombinant proteins: LPS, rLI0169 (lane 4), 
rLI0649 (lane 5), rLI0710/fliC (lane 6) and rLI1153 lane 7 (C).  Rabbit sera were used in 1:500 to detect 
proteins within L. intracellularis, primary antibody targets were detected with secondary anti-rabbit IgG 
1:10000 IR 800. 
The gate in flow cytometry analysis was based on percentages of fluorescence detected in 
FL-1 channel (Gate B from representative biological replicate shown in Figure 4.6) for IPEC-1 
cells alone (Fig 4.6A) and IPEC-1 cells infected with CFSE-stained L. intracellularis (Fig 4.6.B). 
As expected, IPEC-1 cells alone had negligible positive fluorescence events (mean value of 0.20% 
fluorescence in FL1 channel; Fig 4.6A) and IPEC-1 cells infected with CFSE-stained L. 
intracellularis showed a mean value of 8.86% fluorescence in FL1 channel, 4 hours post-infection 
(Fig 4.6B). The percentage of positive events in FL1 channel when CFSE-stained L. intracellularis 
was incubated with 2000 μg/ml of serum from a rabbit immunized with whole bacteria was 
reduced to 2.29% (Fig 4.6C). Figure 4.7 shows the percentage of inhibition of L. intracellularis 
invasion of IPEC-1 cells in the presence of serum antibodies. We observed that pre-incubation of 
CFSE-L. intracellularis with low (500 μg/ml), medium (1000 μg/ml) and high (2000 μg/ml) 
concentrations of negative control sera showed 46.7% (±7.9), 58.9% (±8), 65.7% (±5.7) inhibition. 
This inhibition by negative control serum is not unexpected as others have shown that rabbit 
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polyclonal sera prepared against E. coli and other negative control serum obtained prior to 
generation of L. intracellularis hyperimmune sera inhibited L. intracellularis penetration of 
cultured rat enterocytes (IEC-18) (385).  
 
 
 
Figure 4.6. Representative dot blots and gating for flow cytometry analysis:  A) gates on live IPEC-1 
cells forward scatter/CFSE plot, 0.22% of fluorescent events, B) IPEC-1 cells infected with CFSE- labeled 
L. intracellularis MOI 0.1, 8.86% of fluorescent events, C) IPEC-1 cells infected with CFSE- labeled L. 
intracellularis MOI 0.1 incubated with 2000 μg/ml of positive serum from rabbits vaccinated against whole 
bacteria, 2.29% of fluorescent events (C). Plots represent one of four biological replicates for all sera 
purified from LPS antibodies to obtain mean values and calculate the level of inhibition. Thirty thousand 
events were acquired for each sample. 
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Figure 4.7. Inhibitory effect of rabbit serums on CFSE labeled avirulent L. intracellularis penetration 
in IPEC-1 cells: negative control sera (sera obtained prior to immunization and pooled), anti-L. 
intracellularis sera (serum from rabbits immunized with whole avirulent bacteria), sera from rabbits 
immunized with recombinant proteins: anti-rLI0169, anti-rLI0649, anti-rLI0710 FliC, anti-rLI1153; serum 
concentrations used in assay 500 μg/ml (A); 1000 μg/ml (B) and 2000 μg/ml (C). All sera were cleared 
from antibodies against LPS. Percent inhibition = (1- % of fluorescence of CFSE bacteria incubated with 
serum / % of fluorescence of CFSE bacteria (control)) x 100. Data presented for 4 biological replicates. 
The bar shows the standard deviation of mean value of 4 biological replicates. ((***) p<0.001, (**) p<0.01 
and (*) p<0.05, (ns) not significant.  
 
We used rabbit hyperimmune generated against whole L. intracellularis as our positive 
control serum and results indicated that CFSE-labeled L. intracellularis incubated with low (500 
μg/ml), medium (1000 μg/ml) and high (2000 μg/ml) serum resulted in 64.8% (±5.7), 73.4% (±4.7) 
and 79.88% (±5.9) inhibition of infection (Figure 4.7 A-C). Relative to the negative control sera, 
a positive control serum inhibited significantly more cellular adhesion/ penetration at low (p<0.05; 
Fig 4.7A), medium (p<0.01; Fig 4.5B) and high (p<0.001; Fig 4.7C) sera concentrations indicating 
that anti-L. intracellularis antibodies were neutralizing. To discern whether antibodies specific for 
rLI0169, rLI0649, rLI0710 and rLI153 blocked bacterial adherence/penetration into IPEC-1 cells, 
we pre-incubated the CFSE-stained L. intracellularis with 500 μg/ml (Fig 4.7A), 1000 μg/ml (Fig 
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4.7B) and 2000 μg/ml (Fig 4.7C) hyperimmune sera specific for each recombinant protein. At the 
lowest concertation of hyperimmune sera (Fig 4.7A), anti-rLI0169 showed 68.7% ±5.9 inhibition, 
anti-rLI0649 showed 64% ±9.0 inhibition, anti-rLI0710/FliC showed 69.5% ±5.2 inhibition, and 
anti-rLI1153 showed 60.4% ±11.8 inhibition. With the exception of anti-rLI1153, all 3 
hyperimmune sera showed significantly higher percent inhibition relative to the negative control 
serum (p<0.01, p<0.05, p<0.01, respectively). When the medium and high concentration of each 
antisera was used, statistically significant reduction of bacteria entrance into IPEC-1 cells was 
achieved relative to the corresponding dose of control serum: anti-rLI0169 (p<0.01 Fig 4.7B, 
p<0,001 Fig 4.7C), anti-rLI0649 (p<0.01 Fig 4.7B, p<0.001 Fig 4.7C), anti-rLI0710/FliC (p<0.01 
Fig 4.7B; p<0.001 Fig 4.7C), and anti-rLI1153 (p<0.01 Fig 4.7B; p<0.01 Fig 4.7C). We can 
conclude that sera antibodies specific for each recombinant proteins showed the comparable 
inhibitory effect to that observed with the positive rabbit serum against whole bacteria and that the 
inhibitory effect of all sera increased with increased serum concentration. The results from 
recombinant serum neutralization assay suggest that use of recombinant proteins as antigens in 
subunit vaccine formulation may generate neutralizing antibodies capable of inhibiting L. 
intracellularis penetration and infection.  
 
Because L. intracellularis is an obligate intracellular bacteria, the cellular immune 
response is assumed to play the major role in protection against virulent bacteria (284, 285), 
however, the humoral immune response may also play an important role in protecting against L. 
intracellularis infection. IgG antibodies against intracellular bacteria could bridge humoral and 
cellular immunity by targeting of intracellular pathogens to lysosomes through antibody-FcR-
mediated stimulation of the host cells (386), protection against intracellular bacteria by an Fc 
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receptor-mediated lysosomal targeting (387) and modulation of cytokine secretion (388). Also, 
IgA antibodies play an important role in protection against enteric pathogens. Accumulation of 
IgA bound to L. intracellularis inside enterocytes and lamina propria was reported previously 
(365) and L. intracellularis specific IgA were detected in intestinal lavage of pigs 3 weeks after 
experimental infection (285). Results from a vaccine trial where animals were vaccinated orally 
and challenged with virulent L. intracellularis suggested that protection was associated with 
mucosal cytokine and specific IgG and IgA responses and that systemic antibody response were 
boosted following challenge (283). In this study, we demonstrate that sera generated against 
recombinant proteins inhibited L. intracellularis invasion of IPEC-1 cells in vitro. Although this 
study was designed to identify proteins capable of generating a humoral response, it does not 
preclude the capacity of these proteins to elicit a cellular immune response and thus further 
investigation in this area is warranted.   
A subunit vaccine comprised of Flagellin alone or coupled with these 3 other antigens may 
induce a specific protective immune response against L. intracellularis in intestinal mucosa of pigs 
and should be investigated further.  
In conclusion, we have used functional 2-DE and WB analysis coupled with MS to identify 
potential antigens for an L. intracellularis subunit vaccine in pigs. Because the commercially 
available L. intracellularis vaccines are dependent on the growth of this obligate intracellular 
pathogen, production may be limited and time-consuming. A subunit vaccine has the advantage 
that recombinant antigen production can be performed in E. coli which is a safe, rapid and a cheap 
alternative to a vaccine that requires growing, attenuating and inactivating L. intracellularis. 
Flagellin has adjuvant and antigenic properties that induce a specific immune response in intestinal 
mucosa of mice thus subsequent vaccine with all four recombinant proteins may not require 
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additional adjuvants to provide protection against the intestinal pathogen. Extensive in vivo studies 
will need to be performed to ensure that such a quadrivalent subunit vaccine is effective in 
generating protective long-term immunity. However, an effective subunit vaccine against L. 
intracellularis may present the industry with an effective and economically attractive vaccine to 
use in high-security pig barns.   
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5. GENERAL DISCUSSION AND CONCLUSIONS 
5.1 General discussion 
L. intracellularis has been detected in swine herds all over the world with high prevalence 
among intensive production systems (5). Clinical symptoms range from weight loss and diarrhea 
to profuse bleeding and mortality, which imposes a significant economic burden for the swine 
industry (6, 48). L. intracellularis has been detected in many mammals and ratite birds but has 
emerged as important pathogen in horses in recent years (2). Rodents shed L. intracellularis in 
their feces and present a possibly important route of transmission for pigs and horses. Treatment 
and prevention of PPE rely on applying hygiene measures, antibiotic treatments and vaccination. 
Currently, two vaccines are registered for prevention of PPE in pigs. Enterisol® is formulated with 
a live avirulent strain of Lawsonia attenuated by extensive passaging in cell culture, and the 
Porcilis® is formulated with a killed bacterin. Both vaccines rely on bacterial growth in cell culture, 
which has its drawbacks and limitations. Further, immune protection achieved from these vaccines 
in the field has not always been obtained, thus indicating the need for new effective vaccine. We 
set out to explore the possibility of the development of a subunit vaccine formulated from 
recombinant proteins that induces neutralizing antibodies in the host immune system. This type of 
vaccine formulation may be a welcomed vaccine alternative for the industry.    
The obligate intracellular nature makes it a challenge to culture L. intracellularis which 
has been an obstacle for studying these bacteria in laboratory and field conditions. Due to limited 
tools and techniques currently available, it remains challenging to detect, track and quantify these 
obligate intracellular bacteria. Thus developing new high through put assays based on accurate 
quantitative methods, such as flow cytometry and qPCR, offer important tool to explore L. 
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intracellularis pathogenesis. The bacterial components and mechanism that facilitate attachment 
of bacteria to enterocytes has not yet been fully determined (3), and the bacterial proteins that 
facilitate invasion of intestinal epithelial cells are perspective immunogens. The goal of this thesis 
was to identify and use these immunogenic proteins to develop recombinant protein vaccine which 
could present new options for prevention of PPE that is a safe, effective and attractive vaccine 
option for both the pig industry and pharmaceutical companies. Also, this research details the 
development of new quantitative methodology to track intracellular bacterial infection and 
evaluation of inhibitory effects of immune sera on bacterial penetration as the means to identify 
neutralizing antibody targets for use in vaccine development. 
The first part of the research outlined in this thesis focused on development of functional 
assays as a useful tool in evaluating intracellular bacterial penetration and the role of serum 
antibodies in inhibiting that penetration and infection or eukaryotic cells. Previously, others 
showed that CFSE may be useful to label extracellular bacteria to detect the presence and activity 
of environmental and food-borne microorganism (352, 353, 354, 355, 356, 357, 358). We adapted 
this approach to label L. intracellularis and to use flow cytometry to quantify invasion or cellular 
association of L. intracellularis within its host cell. CFSE dye has staining properties that allow 
tracking of bacteria with no negative effects on bacterial adhesion, viability, and metabolic activity 
which helps us compensate for the restriction in use of standard molecular and microbiological 
techniques to analyze L. intracellularis-eukaryotic cell interactions. In light of L. intracellularis 
research, CFSE staining has additional advantages due to the obligate intracellular nature of 
bacteria and obvious restriction in use of standard molecular and microbiological techniques to 
analyze the host-pathogen interactions. Using this approach, we confirmed that the CFSE dye is 
retained in the bacteria and does not leak to the surrounding media or eukaryotic cytoplasm. Using 
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flow cytometry to detect. CFSE-stained L. intracellularis showed improved accuracy over 
standard L. intracellularis enumeration methods, which often show significant discrepancy 
between different laboratories and require use of specific monoclonal antibodies.  
CFSE-stained L .intracellularis were used to adhere to or infect McCoy cells. To confirm 
bacterial invasion, qPCR analysis was applied. qPCR analysis confirmed that the bacteria invaded 
the host cell and were able to grow in course of 5 days which was represented as increase of 
bacterial DNA compared to the non-infected cell control and to the day 1 and day 3 of infection. 
In addition fluorescence-activated cell sorting (FACS) was used to sort infected from non-infected 
cells for further analysis and confocal microscopy revealed CFSE stained bacteria in apical part of 
eukaryotic cell cytoplasm surrounding the nucleus. Next, experiments were executed to evaluate 
whether this approach was compatible with functional analysis. Rabbit hyperimmune serum 
generated against whole L. intracellularis was evaluated for its capability to inhibit entrance of 
bacteria inside McCoy cells. Interestingly instead of blocking bacterial invasion of the cells, rabbit 
serum enhanced the entrance of L. intracellularis into McCoy cells which was detected both with 
flow cytometry and qPCR analysis. When the same assay was applied using IPEC-1 cells, porcine 
intestinal epithelial cell line, rabbit serum against L. intracellularis was able to significantly reduce 
bacterial penetration into IPEC-1 cells (Fig 4.6 and 4.7). The increase of bacterial invasion of 
McCoy cells in presence of positive rabbit serum is not receptor-mediated and may be due to the 
fibroblast nature of McCoy cells that can engulf antibody-coated bacteria. Although this cell line 
was found to be optimal for L. intracellularis propagation both in the laboratory and in industrial 
settings, our results indicate that it is not adequate for use in functional assay due to the different 
mechanism of bacterial invasion. Further, others showed differential expression of cell cycle and 
cell differentiation genes of McCoy cells infected with L. intracellularis but no proliferative 
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changes or cell cycle alterations were observed microscopically (83). Marked difference between 
in vivo infection of enterocytes and in vitro infection of McCoy cells may indicate that functional 
assays could not be faithfully reproduced in McCoy cells although they did help prove the validity 
of CFSE bacterial staining to quantify bacterial invasion of eukaryotic cells. This approach can be 
adapted for use with facultative intracellular pathogens such as Neisseria gonorrhea infection of 
ME-180 cells (389) and are amenable to be used with L. intracellularis infection of for a functional 
analysis in IPEC-1 cells which are more suitable in vitro model for L. intracellularis infection.    
The obligate intracellular nature of L. intracellularis has imposed difficulties in exploring 
the bacterial components involved in attachment and molecular mechanisms during infection. 
Immunogenic proteins that play a role in adherence or invasion are not completely characterized 
and functionally determined. Others have shown that proteins which comprise the Type III 
secretion system (T3SS) autotransporter proteins (LatA), LI0841, and LI0902 were characterized 
and shown to have immunogenic properties (368, 103, 104). In the second part of this thesis, the 
separation power of 2-DE coupled with WB and MS was utilized to detect other uncharacterized 
bacterial proteins that are localized to the surface localization, that play a role in infection and are 
immunogens. Using these immunoproteomic techniques, we identified antigens that could be 
produced as recombinant proteins and utilized in the formulation of effective subunit vaccine. We 
applied immunoproteomics which yielded 11 unique L. intracellularis proteins (Table 4.2). 
Bioinformatics analysis indicated that four proteins were expressed on the surface of bacteria and 
have role in pathogenesis. These proteins were identified as flagellin (FliC, LI0710), Putative outer 
protein N (LI1153), ABC dipeptide transport system (LI0169) and autotransporter LatA (LI0649). 
Among the 11 proteins detected in this study, proteins chaperonin GroeL (LI0625) and 5’-
nucleotidase/2’, 3’ cyclic phosphodiesterase (LI1171) were also reported previously using a shot-
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gun proteomic approach (104). Due to their predicted surface localization, possible roles in 
pathogenesis and adequate biochemical properties. The flagellin LI0710, LI1153, LI0169 and 
LI0649 proteins were selected to be cloned, expressed and purified as recombinant proteins. All 
four recombinant proteins were recognized by sera from PE-infected pigs which indicates that 
these recombinant proteins remained immunogenic (4.3 B). That being said, we have to 
acknowledge the limitation of using pooled sera from animals during active infection with L. 
intracellularis. Sera from convalescent animals could have an additional pool of protective 
antibodies with increased neutralizing or ADCC characteristics. Future experiments should be 
conducted to compare the capabilities of the sera from actively infected and convalescent animals 
to recognize L. intracellularis proteins and to test the neutralizing characteristics of serum 
antibodies on bacterial penetration, in vitro.   
Interestingly, rLI0169 (OppA) was recognized by the pig sera from field cases of PE, 
indicating that although it has a periplasmic region, this protein is expressed during L. 
intracellularis infection and it is targeted by specific antibodies. OppA is conserved among many 
bacteria species and these results correspond to reported antigenicity and surface exposure of 
OppA in Streptococcus suis serotype 2 (390). Beyond transporting oligopeptides, Opp transporters 
are known to have important roles in pathogenesis of different bacterial species (391). They are 
important factors in adhesion to the host cell in Corynebacterium pseudotuberculosis infections 
(392), survival of Listeria monocytogenes inside macrophages (393), and they are expressed 
during bacteraemia in mouse model of Staphylococcus aureus infection (394). To evaluate their 
potential to induce immune response, each recombinant protein was used to vaccinate rabbits and 
acquire immune serum. Sera against each recombinant protein was able to recognize 
corresponding recombinant protein thus indicating their ability to induce immune humoral immune 
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response when administered as part of an i.m vaccine (4.3 C). Finally, rabbit sera specific for each 
recombinant proteins succeeded in blocking penetration of L. intracellularis into IPEC-1 cells 
indicating that they are potentially neutralization antigens.  
Despite two commercial vaccine based on attenuated live or inactivated whole bacteria 
currently available to vaccinate  pig herds against L. intracellularis, there is still room for progress 
in development of vaccines based on different principles. Subunit vaccines with specific bacterial 
antigens could be an acceptable alternative vaccine for both pig producers and animal health 
companies because they trigger immunity to select bacterial antigens without the risk of reversion 
to virulence. They are also comparatively cheap to produce because unlike inactivated and killed 
vaccines, a subunit L. intracellularis vaccines does not require the bacteria to be propagated in 
eukaryotic cells which is costly. Most importantly, the commercially available vaccines do not 
allow one to differentiate between infected and vaccinated animals (DIVA). DIVA vaccines, also 
known as marker vaccines, have been developed to prevent important swine infectious diseases, 
like Aujeszky’s disease, Actinobacillus pleuropneumoniae and Classical Swine fever (395, 396, 
397). These vaccines were formulated as live-modified vaccines that lack one or more antigens 
that are present in wild virulent type thus providing the ability to distinguish between vaccinated 
and infected animals based on immunological testing. The obligate intracellular nature of L. 
intracellularis limits the use of molecular techniques to genetically modify this organism to 
express or lack expression of distinctive proteins. The solution to this problem could be 
development of a DIVA subunit vaccine against L. intracellularis based on use of select 
immunogenic bacterial proteins. For example, one could test for immune response to vaccine 
subunit antigens as well as an immunogenic protein present on L. intracellularis that is not 
included in the vaccine. Vaccinated animals and infected animals would all have antibodies against 
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the vaccine antigens but only animals that were infected with L. intracellularis would have titres 
for the immunogenic protein absent from the vaccine. The development of DIVA vaccines have 
important benefits for pig producers and large animal veterinarians, as they can be used to limit 
the number of animals culled during an outbreak. Further, the pig industry has ever growing 
economic pressure and profits are impacted by international trade competition and emergence of 
new infectious diseases, such as PEDV or African swine fever (398, 399) . Science and technology 
to develop a subunit DIVA vaccine against L. intracellularis can help provide a safe and effective 
yet affordable vaccine that does not negatively impact trade. Because infected animals can shed L. 
intracellularis for up to 12 weeks (48), pigs testing positive for serum antibodies against L. 
intracellularis may be prevented for entering a barn for fear of transmission of disease. L. 
intracellularis DIVA vaccines could impact sale of replacement stock or movement of animals to 
different barns. However, if a DIVA vaccine allows the purchasing barn to have confidence that 
the animals were not infected but were vaccinated, then these animals can be purchased knowing 
that they pose no risk of transmission of disease to unvaccinated new herd mates. DIVA 
vaccination would help large animal veterinarians to monitor health status of the herd more 
accurately and to advise rational use of antibiotics. From the public health perspective, application 
of DIVA vaccines against L. intracellularis is important preventive measure due to possible 
reduced and more targeted administration of antibiotics to only infected animals and not the whole 
herd. With the emergence of antimicrobial resistant pathogens and expanding global trade, there 
are increased regulatory pressures to limit the usage of antibiotics in livestock industry. DIVA 
vaccines against L. intracellularis provide possible effective solution to pig producers for 
controlling PE and at the same time acceptable preventive measure from the public health 
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perspective. Although challenges in controlling L. intracellularis remain, we can expect new 
advancements in vaccine development in near future with benefits to all shareholders in industry.  
In summary, this study has been able to develop new methodology as a tool to investigate 
host-intracellular bacteria interactions in vitro and identified important L. intracellularis proteins 
involved in infection. Functional assay established that antibodies specific for each recombinant 
proteins neutralized bacterial invasion, in vitro. In future work, in vivo experiments should be 
conducted to analyze immune response and evaluate potential protection against pathogenic 
challenge of vaccine formulated from these four proteins. This Ph.D. thesis laid the foundation for 
future experiments and development of safe, effective, protective and economical vaccine against 
L. intracellularis.   
 
5.2 General conclusions 
In conclusion, this work developed in vitro methodology as a selection process to identify and L. 
intracellularis proteins as suitable subunit vaccine candidates. Functional assays based on CFSE-
staining of bacteria and application of flow cytometry were successfully developed to quantify 
infection of different cell lines and evaluation of effect of specific serum antibodies against L. 
intracellularis on bacterial penetration into eukaryotic cells. Using 2DE and WB analysis coupled 
with MS, eleven L. intracellularis proteins were identified from which four showed potential to 
be suitable recombinant antigens for formulation of L. intracellularis subunit vaccine in pigs. In 
vitro neutralization assay based on flow cytometry indicated that rabbit hyperimmune sera 
generated against the vaccine strain of L. intracellularis and rabbit sera specific for each 
recombinant protein showed an inhibitory effect on the attachment and penetration of live, 
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avirulent L. intracellularis into eukaryotic cells. Results from this in vitro study demonstrated a 
means to efficiently and economically select potential vaccine antigens prior to in vivo studies thus 
enabling us to narrow down the number of antigens tested in future live vaccine trials. In future, 
in vivo studies will need to be conducted to evaluate that such a quadrivalent subunit vaccine is 
effective in generating protective long term immunity which will benefit the pig industry. 
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APPENDIX 
     A.1 Isolation of pathogenic L. intracellularis from infected gut tissue from two PHE 
field cases in Canada  
      A.1.1 Introduction 
           In this chapter, we present data on the procedure to isolate and propagate pathogenic L. 
intracellularis from the intestine of two confirmed cases of PHE. One gut sample originated from 
gilt from a pig farm in Ontario (received in 2014) and one from a gilt previously vaccinated with 
Enterisol® vaccine from a farm in southern Saskatchewan (received in January 2018). Both cases 
were confirmed PHE disease with a typical hemorrhagic form of PE with intestinal lumen filled 
with blood. Both animals succumbed to the disease and intestinal samples were collected and sent 
to our lab. Isolation and in vitro growth of  L. intracellularis in McCoy cells from infected intestine 
was performed according to (4). To monitor infection and passaging of bacteria in McCoy cells, 
we used specific anti-Lawsonia antibody staining detected with flow cytometry. Standard IFAT to 
quantify infection depends on manual counting of serial dilutions of infected McCoy cells or free 
bacteria and can be subjective, with great differences between laboratories and even personal 
among the same lab. As an alternative approach, we used flow cytometry and qPCR to monitor 
the infection of McCoy cells, in vitro. In addition, intestinal homogenate prepared from two cases 
of PHE were successfully used to infect pigs indicating that the bacteria were infectious.  
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A.1.2 Materials and methods 
       A.1.2.1 Pathogenic Lawsonia intracellularis isolation from infected gut tissue 
Preparation of gut homogenate and isolation of L. intracellularis from infected porcine 
intestines were performed according to (4) and explained in detail in Section 1.2.4.  
New L. intracellularis isolate stocks were used to infect McCoy cells to start in vitro 
growth. Monitoring of bacteria passaging was done utilizing flow cytometry and presence of 
bacterial DNA confirmed with qPCR analysis.  
 
A.1.2.2 Cell culture conditions and infection of McCoy cells with L. intracellularis  
McCoy were grown as reported in (4, (376). For the purpose of propagating L. 
intracellularis, McCoy cells were seeded at a concentration of 0.2x 106 per T-25 flask. Medium 
for cell infection with L. intracellularis was Dulbecco's Modified Eagle Medium (DMEM) with 7 
% FBS with the addition of vancomycin (100 μg/ml) and amphotericin B (2.0 μg/ml) (4). Frozen 
aliquots of the gut filtrate and avirulent bacteria were thawed in a water bath on 37°C and diluted 
in DMEM-7% FBS at ratios 1:10 and 1:20 and added to a 30% confluent monolayer of McCoy 
cells. The flasks with infected McCoy cells were placed at 37°C in Zip-lock bags filled with a 
mixture of gases 10% hydrogen, 10% CO2 and balanced with nitrogen (99). After 3 h, gentamicin 
(50 μg/ml) was added to the infected cultures. 
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A.1.2.3 Passage of infection  
Cell lysis was acheived by exposing infected McCoy cells to 0.2% KCl for 5 min and then 
0.1 % KCl for 20-30 min at 37 oC. Hypotonic solution was evacuated and 10 ml of DMEM-7% 
FBS per T-75 or 3 ml per T-25 flask was added, the cells were scraped with a cell scraper and 
removed to a 50 ml tube. Cells were lysed by passing the suspension repeatedly more than 6 times 
through a 11/2 inch 20-gauge needle in 10 ml or 5 ml syringes. To remove nuclei and cell debris, 
suspension was centrifuged 150 x g for 5 min. The supernatant was removed and cells collected 
by centrifugation at 6000xg for 10 min. The pellet was suspended in SPG with 0% FBS and stored 
at -80 oC. For passaging, 1:10 of the total volume from one T-25 flask was used to infect next 
McCoy cells that were growth to 30% confluency.      
 
A.1.2.4 Flow cytometry analysis.  
Infected McCoy cells in T-25 flasks were collected for flow cytometry analysis seven days 
after infection, on the same day when lysing and passaging was done to new T-25 flasks. Controls 
included non-infected cells, non-infected cells stained with primary and secondary antibody, and 
non-infected cells stained with isotype control antibodies. The McCoy cells infected with the 
vaccine strain of L. intracellularis served as the positive control. Infected McCoy cells were 
collected by trypsinization using 5% Trypsin then washed with PBS + 10% FBS, centrifuged at 
500 x g for 10 min and this process was repeated twice. Cells were transferred to 96 well plate 
(Nunclon round bottom wells) and treated with 70% methanol for 5 min at room temperature for 
cell permeabilization followed by washing with washing buffer (PBS, 0.1% sodium azide, 0.5% 
BSA). Cells were then incubated for 1 h at room temperature with commercial primary antibody, 
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mouse anti-Lawsonia IgG2b specific antibody (concentration 1:200), 10 μl per well (BIOX, 
Belgium) or mouse isotype (Chrompure Mouse IgG, Jackson Immuno Research Laboratories, PA, 
USA). After 1 h of incubation, cells were washed twice with washing buffer (675 x g for 10min) 
followed by incubation with secondary APC labeled goat anti-mouse IgG2b antibody (Southern 
Biotech) for 30 min at room temperature in the dark. After washing twice in washing buffer, the 
cells were resuspended in PBS + 2% FBS and analyzed with a flow cytometer (26). Flow 
cytometric analysis was performed using a BD FACS Caliburtm flow cytometer (BD Biosciences). 
We detected fluorescence in the FL4 channel, with gating being selected based on uninfected 
McCoy cells as our negative control cells. Flow cytometer results were analyzed in Kaluza 
software (Beckman-Coulter).  
 
A.1.2.5 qPCR analysis to detect L. intracellularis specific DNA  
McCoy cells were seeded into a T-25 flask with a density of 0.2 x 106 per flask. Bacteria 
lysate from passages was then introduced to the wells and flask with growth medium for bacteria 
as described before (4). Cells were trypsinized and suspended in DMEM complete media 
containing 10% FBS to arrest the trypsin reaction. Cells were pelleted by centrifugation at 500 x 
g for 10 minutes. The pellet was suspended in NaOH (25 mM NaOH, 0.2 mM EDTA) and heated 
for 95 oC for 1 h to rupture the cells and release the DNA from the nucleus. HCl (40 mM Tris-
HCl, pH 5.5) was added to neutralize the solution. The two types of primers were used, one specific 
for LI0754 (L. intracellularis PHE/MN1-00: LI0754 gene) for qPCR reaction with 50x Kapa Syber 
Green Fast Rox High kit from Kapa Biosystems, and other 16 S primers 
(CCGGCTTTGGGTAAAACCA) for qPCR reaction with TaqMan probe (TAMRA TaqMan 
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probe, AB). Results were analyzed by Step One Real-Time PCR System (Applied Biosystems, by 
Life Technologies), Excel (Microsoft) and Prism (GraphPad) software. 
 
A.1.2.6 Infection of piglets with isolated pathogenic L. intracellularis. 
Two separate experiments were conducted to test the infectious potential of intestinal 
homogenate originated from infected gilts. The first experiment was performed on sixty-day old 
piglets with intestinal homogenate from the first case of PHE received in 2014. The second 
experiment was performed on thirty-day old piglets with intestinal homogenate received in 2018. 
Piglets were infected with intestinal homogenate with 108 to 109 bacteria orally. After 22 days, 
piglets were euthanized and blood, fecal, and intestinal samples were collected. For the first trial, 
intestinal samples were processed in two ways. One part was frozen in liquid nitrogen and ground 
for PCR analysis and in the second part, intestinal tissue was formalin-fixed, paraffin embedded 
and mounted on slides for IHC. Anti-Lawsonia specific antibody was used as primary and anti-
mouse IgG2b conjugated with FITC was the secondary antibody for IHC diagnostic of pathogenic 
bacteria in pig’s small intestine epithelial cells. DAPI was used to stain eukaryotic cell nuclei. 
Fluorescent microscopy was performed using a fluorescent microscope (Zeiss, Axiovert 200M) 
and images were taken with Zeiss Axiocam HRC. 
For the second trial, intestinal mucosa was scraped and filtered according to standard 
isolation protocol (4) and L. intracellularis isolate was used to infect McCoy cells and propagate 
in vitro. In vitro growth and propagation was monitored using flow cytometry and qPCR as 
explained above.  
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A.1.3 Results and discussion 
A.1.3.1 Clinical analysis and IHC from Experiment 1 
Clinical signs characteristic for PE were not observed in infected animals. There was no 
signs of watery diarrhea or blood in the feces. Weight of the animals was not significantly altered. 
Infected animals had normal body temperature and preserved appetite.  
Results from our IHC from experiment 1 showed that pathogenic L. intracellularis was 
detected in intestinal samples using anti-Lawsonia primary antibody with a FITC-conjugated 
secondary antibody. L. intracellularis infects intestinal epithelial crypts preferably in small 
intestines, and the process is characterized by proliferation of immature enterocytes, loss of goblet 
cells and destruction of normal epithelial architecture. Green fluorescence detected in intestinal 
crypts matched with typical patterns of pathogenic L. intracellularis localization during intestinal 
epithelial cells infection (7) (Fig. A.1A). White arrows point to the L. intracellularis infected 
crypts, where we see bacteria in green. Note that on both A and B, additional fluorescent signals 
localized in subepithelial spaces are also observed. This background fluorescence may be natural 
fluorescence of the gut or it may be an artifact from the extended time for tissue processing during 
formalin-fixation. In addition to the detection of fluorescent bacteria, lack of goblet cells and loss 
of normal epithelial architecture is obvious, especially when infected crypts (see white arrows) are 
compared to the uninfected crypts on the left side of (A) and throughout (B). Uninfected crypts 
have goblet cells in abundance, dark oval spaces, and no fluorescent signals beyond background 
levels detected in epithelial cells. IHC analysis of ileum samples from non-infected, negative 
control animal, showed that intestinal epithelial histology is preserved, with a normal number of 
goblet cells and no proliferation of immature cells in the crypts. Also, there are no fluorescent 
signals detected in epithelial crypts (Fig.A.1B) 
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Figure A.1 IHC of the ileum of L. intracellularis infected piglet and uninfected pig. Blue 
fluorescence represents DAPI stained eukaryotic cell nuclei; green fluorescence represents fluorescent 
signal from the bound secondary FITC antibody; white arrows indicate the intestinal crypts infected by 
pathogenic bacteria. (A); intestinal mucosa from uninfected pig labeled with anti-Lawsonia primary 
antibody and FITC secondary antibody (B);   
 
 
A.1.3.2 qPCR from Experiment 1 
DNA extraction was performed on ileum samples processed for PCR analysis. TaqMan 
probe and 16S primers, explained above, were applied for detecting specific bacteria. The 
differences in this DNA extraction compared to DNA extraction from Lawsonia infected cell 
culture involved using a different buffer (250 mM NaOH, 2 mM EDTA) and in longer time heating 
on 95 ̊C to disrupt intestinal tissue cells. The Ct value of the sample from infected ileum was 
25.0826; the Ct value of uninfected ileum from newborn piglet (negative control) was 36.7 and 
the Ct value of the uninfected ileum spiked with 105 avirulent L. intracellualris (positive control) 
was 21.41. Lower Ct values indicate higher quantity of L. intracellularis DNA which confirms 
infected tissue IHC positive status. In conclusion, we used IHC and PCR to confirm that the 
pathogenic bacteria from a L. intracellularis infected gilt remained infectious.  . 
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A.1.3.3 Results from Experiment 2  
Limited data on clinical signs received from the farm that experienced an outbreak of PE 
indicated that the gilt succumbed to the PHE in two days despite being previously vaccinated with 
Enterisol® vaccine.   
Flow cytometry analysis was used to monitor infection of McCoy cells with pathogenic L. 
intracellularis isolated from the gut of infected animal received in 2018. For passaging, McCoy 
cells were grown in T-25 flasks. Non-infected McCoy cells, McCoy cells stained with mouse 
isotype primary and APC-conjugated secondary and McCoy cells stained with anti-L. 
intracellularis primary and APC-conjugated secondary antibody served as negative controls. 
Detection of L. intracellularis inside McCoy cells was achieved by methanol permeabilization of 
the cells and staining with specific primary antibody against outer membrane protein of L. 
intracellularis and secondary anti-mouse IgG2b conjugated with APC. The APC signal is detected 
in FL-4 channel in flow cytometry analysis. McCoy cells without bacteria were set as a negative 
control and gate B was determined (Fig. A.2A).  
McCoy cells stained with anti-L. intracellularis primary and APC-conjugated secondary 
antibody showed 12.56% events in the FL-4 channel indicating that there was some nonspecific 
binding of the anti-L. intracellularis antibody to non-infected McCoy cells. McCoy cells infected 
with non-pathogenic L. intracellularis were used as a positive control (Fig. A.2C) showed 89.29% 
events in the FL-4 channel in Gate B. These results indicate successful staining and invasion of 
avirulent bacteria in the first passage. Flow cytometric analysis indicated that pathogenic L. 
intracellularis isolated from the infected pig showed 43.78% events in the FL-4 channel (Fig. 
A.2D). When corrected for the non-specific binding of the primary antibody to McCoy cells 
(shown in Fig. A.2B), McCoy cells infected with non-pathogenic L. intracellularis  had 76.73% 
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events in the FL-4 channel and McCoy cells infected with pathogenic L. intracellularis had 
31.12% events in the FL-4 channel (Fig. A.2 C and D). The qPCR results showed that McCoy 
cells infected with vaccine strain had a Ct of 22.1; McCoy cells infected with L. intracellularis 
intestinal isolate had a Ct of 26.2 while uninfected McCoy cells had a Ct of 34.6, and thus 
confirming the presence of bacteria after propagation in McCoy cells.  
McCoy cells infected with a non-pathogenic or pathogenic bacteria display similar density 
plot as non-infected cells and absence of dead cells in lower forward/side scatter (data not shown), 
which is expected due to non-cytopathogenic nature of L. intracellularis in in vitro cell cultures. 
 
 
Figure A.2. Dot blots and gating for flow cytometry analysis of L. inttracellularis passage 1 in McCoy 
cells:  A) gates on live McCoy cells forward scatter/APC plot, 0.28% of fluorescent events, B) McCoy cells 
stained with anti-L. intracellularis antibody and APC secondary antibody 12.56% of fluorescent events, C) 
McCoy cells infected with 104 vaccine strain L. intracellularis stained with anti-LI antibody and APC 
secondary antibody, 89.29% of fluorescent events, D) McCoy cells infected with intestinal isolate L. 
intracellularis stained with anti-L. intracellularis antibody and APC-conjugated secondary antibody, 
43.78% of fluorescent events. Thirty thousand events were acquired for each sample. 
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Next, we wanted to determine if the bacteria continued to grow and replicate after other 
passages of McCoy cells. The McCoy cells were lysed and the bacterial pellet was acquired 
(explained in detail above). The bacterial pellet was suspended in DMEM + 7% FBS and 500 μl 
was used to infect each T-25 flask for passage number 2. To correlate infection with flow-
cytometry, duplicate T-25 flasks were used wherein one flask was used for the next passage and 
the second flask was used for flow cytometry and PCR. Running two flasks allowed us to have the 
same environment for bacterial growth in each flask (the same number of McCoy cells, volume of 
medium, gas environment and days of bacteria growth) thus acquiring representative samples for 
bacterial growth monitoring analysis.  
Fig. A.3 shows the flow cytometric analysis of the second passaging of non-pathogenic 
and pathogenic L. intracellularis. Cells and bacteria were processed as indicated above with the 
only difference being that the isotype control was added as an additional negative control (Fig. 
A.3A). Also, due to the presence of nonspecific binding of the anti-L. intracellularis antibody to 
McCoy cells observed in Fig. A.2, we included additional washes after staining. 
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Figure A.3. Dot blots and gating for flow cytometry analysis of L. intracellularis passage 2 in McCoy 
cells:  A) gates on live McCoy cells stained with anti-mouse isotype and APC-conjugated secondary 
antibody,  forward scatter/APC plot, 11.50% of fluorescent events, B) McCoy cells stained with anti-LI 
antibody and APC secondary antibody 9.74% of fluorescent events, C) McCoy cells infected with 2nd 
passage vaccine strain L. intracellularis stained with anti-L. intracellularis antibody and APC-conjugated 
secondary antibody, 95.7% of fluorescent events, D) McCoy cells infected with 2nd passage intestinal isolate 
L. intracellularis stained with anti-L. intracellularis antibody and APC-conjugated secondary antibody, 
95.85% of fluorescent events. Thirty thousand events were acquired for each sample.  
 
Uninfected McCoy cells were used to set the gating parameters (data not shown). McCoy 
cells stained with mouse isotype antibody had 11.5% events in the FL-4 channel implying that 
indeed there is nonspecific binding of antibodies to this type of cell line (Fig. A.2A). Although we 
introduced additional washes after staining, non-specific binding of the anti-L. intracellularis 
antibody to non-infected McCoy cells was also observed in this passage with 9.74% events (Fig. 
A.3, B). Results from flow cytometry analysis of the second passage of vaccine and intestinal 
isolate L. intracellularis showed higher percentages of events in the FL-4 channel compared to the 
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flow cytometry analysis of the first passage. McCoy cells infected with non-pathogenic strain had 
95.7% of events in the FL-4 channel (Fig. A.3C) and McCoy cells infected with L. intracellularis 
intestinal isolate had 99.85% events in the FL-4 channel (Fig. A.3D). When subtracted for the 
percentages of fluorescence events due to nonspecific binding, McCoy cells infected with second 
passage of non-pathogenic strain had 86.23% events and McCoy cells infected with second 
passage of intestinal isolate L. intracellularis had 90.11% events. This increase in fluorescent 
events in passage two compared to the first passage indicates that both strains were actively 
growing in cell culture and that bacteria were multiplying in passage two. These findings 
correspond to previous reports of L. intracellularis growth in vitro where bacteria was present in 
high infected cells (HIC) with HIC density of 80% after seven days of infection (Lawson et al 
1993).  
We repeated the passaging of L. intracellularis into McCoy cells for a third time. Our 
negative controls, McCoy cells stained with isotype and McCoy cells stained with anti-L. 
intracellularis antibody, had negligible fluorescence, 0.18% and 0.27% respectively (Fig A.3A, 
B), which indicates that additional washings between staining with primary and secondary 
antibody was efficient to reduce non-specific binding of primary antibodies to McCoy cells. Flow 
cytometry analysis of third passage showed that McCoy cells infected with second passage of L. 
intracellularis vaccine strain had 47.31% events and McCoy cells infected with second passage of 
L. intracellularis intestinal isolate had 36.6% of fluorescence events in the FL-4 channel (Fig. A.4 
C and D).  
Comparing the results of the third and second passage, we observed a decrease in 
fluorescence events in both strains indicating reduced growth of bacteria in this passage. We 
speculate that the use of Ziplock bags filled with the required tri-gas mixture was not suitably 
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maintained over time. Possible leaking of gases may have disturbed the gas environment necessary 
for bacterial growth. Recently, our lab acquired Tri-gas incubator which will allow us to have a 
controlled gas environment necessary for L. intracellularis growth for future experiments. 
 
Figure A.4. Dot blots and gating for flow cytometry analysis of L. intracellularis passage 3 in McCoy 
cells:  A) gates on live McCoy cells stained with anti-mouse isotype and APC secondary antibody,  forward 
scatter/APC plot, 0.18% of fluorescent events, B) McCoy cells stained with anti- L. intracellularis antibody 
and APC secondary antibody 0.27% of fluorescent events, C) McCoy cells infected with 3rd  passage 
vaccine strain L. intracellularis stained with anti- L. intracellularis antibody and APC secondary antibody, 
47.31% of fluorescent events, D) McCoy cells infected with 3rd  passage intestinal isolate L. intracellularis 
stained with anti- L. intracellularis antibody and APC secondary antibody, 36.6% of fluorescent events. 
Thirty thousand events were acquired for each sample. 
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A.1.4 Conclusion 
In summary, we were able to process intestines from two cases of gilts diagnosed with 
PHE and used the intestinal homogenate to infect piglets. We were able to detect L. intracellularis 
in the intestine of infected piglets by using IHC and qPCR suggesting that the infection was 
successful. However, although a high number of bacteria were present in ileum crypts of piglets 
infected with L. intracellularis intestinal homogenate, we did not reproduce symptoms of PHE 
when it was used for infection. Clinical symptoms were mild with no diarrhea or melena. These 
findings may correspond to findings from the previous reports where younger animals have PIA 
form of disease while older animals, like gilts or breeding boars, tend to develop more acute and 
severe PHE form of the disease (6). As discussed previously in this thesis, the marked difference 
in clinical symptoms of PIA and PHE is related to the age of animal and maturation of the immune 
system and not due to genomic differences in bacterial isolates.  
The L. intracellularis growth was monitored using flow cytometry and this method is 
accurate and efficient to estimate L. intracellularis infection, in vitro. Flow cytometry offers an 
unbiased analysis of the percentage of McCoy cells infected with L. intracellularis. We were able 
to follow infection for the three passages and to estimate the percentage of infected cells in each 
passage. In future, our lab will utilize the Tri-gas incubator to increase the number of successful 
passages of L. intracellularis intestinal isolate in vitro and to monitor passaging of bacteria with 
flow cytometry.  
Student contribution: M.O. designed and performed all the experiments here-in, and 
wrote the Appendix. 
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A.2 Contributions to peer review articles 
A.2.1 “Evidence for a common mucosal immune system in the pig” 
Heather L. Wilson and Milan R. Obradovic 
(As published in the Molecular Immunology, 2015; July, 66 (1): 22-34.) 
Abstract:  
The majority of lymphocytes activated at mucosal sites receive instructions to home back to the 
local mucosa, but a portion also seed distal mucosa sites. By seeding distal sites with antigen-
specific effector or memory lymphocytes, the foundation is laid for the animal's mucosal immune 
system to respond with a secondary response should to this antigen be encountered at this site in 
the future. The common mucosal immune system has been studied quite extensively in rodent 
models but less so in large animal models such as the pig. Reasons for this paucity of reported 
induction of the common mucosal immune system in this species may be that distal mucosal sites 
were examined but no induction was observed and therefore it was not reported. However, we 
suspect that the majority of investigators simply did not sample distal mucosal sites and therefore 
there is little evidence of immune response induction in the literature. It is our hope that more pig 
immunologists and infectious disease experts who perform mucosal immunizations or inoculations 
on pigs will sample distal mucosal sites and report their findings, whether results are positive or 
negative. In this review, we highlight papers that show that immunization/inoculation using one 
route triggers mucosal immune system induction locally, systemically, and within at least one 
distal mucosal site. Only by understanding whether immunizations at one site triggers immunity 
throughout the common mucosal immune system can we rationally develop vaccines for the pig, 
and through these works we can gather evidence about the mucosal immune system that may be 
extrapolated to other livestock species or humans. 
 
Dr. Wilson and I collected and critically evaluated the published data for evidence for a 
common mucosal immune system in pigs.  
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A.2.2   “Development of flow cytometry-based adherence assay for Neisseria 
gonorrhoeae using 5′-carboxyfluorosceinsuccidyl ester” 
Sidharath Dev Thakur, Milan Obradovic, Jo-Anne R. Dillon, Siew Hon Ng, Heather L. Wilson  
(BMC Microbiol. 2019 Mar 25;19(1):67. doi: 10.1186/s12866-019-1438-2) 
 
Abstract 
Background: Neisseria gonorrhoeae is an obligate human pathogen and its adherence to host 
cells is essential for its pathogenesis. Gonococcal adherence assays are based on the enumeration 
of bacteria attached to human cells on solid media. Because conventional adherence assays are 
based on bacterial counts, they are often time consuming to perform and prone to observer bias. 
A flow cytometry based method, using the cell-permeable fluorescent dye 5′-carboxyfluoroscein 
succidyl ester (CFSE), was developed to dramatically increase the number of adherent N. 
gonorrhoeae quantified per assay while improving repeatability and removing observer bias. 
Methods: Piliated N. gonorrhoeae F62were stained with CFSE then the staining reaction was 
quenched with foetal bovine serum. Human cervical ME-180 cells were infected with CFSE-
stained N. gonorrhoeae (multiplicity of the infection 100:1) for 2 h. Infected cells were washed to 
remove loosely adhered bacteria. Flow cytometry was used to quantify the percentage of ME-180 
cells associated with CFSE-stained N. gonorrhoeae and a minimum of 30,000 events were 
recorded. Real time-PCR analysis targeting opagene (encoding N. gonorrhoeae opacity associated 
gonococcal outer membrane protein) was performed on infected ME-180 cells to confirm the flow 
cytometric adherence assay results. A rabbit was immunized with heat-killed N. gonorrhoeaeF62 
to generate hyperimmune serum. The functional compatibility of the assay was confirmed by 
studying the effect of N. gonorrhoeae F62 antiserum on blocking adherence/invasion of CFSE-
stained bacteria to ME-180 cells 
Results: We observed that 20.3% (+/- 1.0) ME-180 cells were associated with CFSE-stained N. 
gonorrhoeae. Heat-inactivated hyperimmune serum, at 1:10 to 1:80 dilutions, significantly 
inhibited gonococcal adherence by 6 and 3 fold, respectively. Real time-PCR analysis targeting 
opa gene confirmed that hyperimmune serum blocked adherence/invasion of N. gonorrhoeae to 
the ME-180 cells in a dilution-dependent manner.  
Conclusions: Flow cytometric analysis was amenable to quick, easy and high-throughput 
quantification of the association of N. gonorrhoeae with ME-180 cells and was functionally 
confirmed using PCR analysis. These approaches may be adapted for in vitro and in vivo adherence 
studies related to gonococcal pathogenesis.   
 
Dr. Sidharth Dev Thakur and I developed and performed neutralization assay and flow 
cytometry, PCR analysis, and cell culture analysis of N. gonnorhea in ME-180 cells. 
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